<SEC-DOCUMENT>0000919574-20-004375.txt : 20200630
<SEC-HEADER>0000919574-20-004375.hdr.sgml : 20200630
<ACCEPTANCE-DATETIME>20200630160615
ACCESSION NUMBER:		0000919574-20-004375
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20200630
DATE AS OF CHANGE:		20200630

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Castor Maritime Inc.
		CENTRAL INDEX KEY:			0001720161
		STANDARD INDUSTRIAL CLASSIFICATION:	DEEP SEA FOREIGN TRANSPORTATION OF FREIGHT [4412]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			1T
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-238990
		FILM NUMBER:		201002367

	BUSINESS ADDRESS:	
		STREET 1:		CHRISTODOULOU CHATZIPAVLOU 223
		STREET 2:		HAWAII ROYAL GARDENS, APART. 16
		CITY:			LIMASSOL
		STATE:			G4
		ZIP:			3036
		BUSINESS PHONE:		357 25357767

	MAIL ADDRESS:	
		STREET 1:		CHRISTODOULOU CHATZIPAVLOU 223
		STREET 2:		HAWAII ROYAL GARDENS, APART. 16
		CITY:			LIMASSOL
		STATE:			G4
		ZIP:			3036
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d8565468_424b3.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Seward & Kissel LLP
         Document created using EDGARfilings PROfile 7.0.1.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <table cellspacing="0" cellpadding="0" id="z1625e00e5eae4fdbafecc94b133a97c8" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 43.26%; vertical-align: top;">
            <div style="font-weight: bold;">PROSPECTUS SUPPLEMENT NO. 1</div>
            <div style="font-weight: bold;">(TO PROSPECTUS DATED JUNE 23, 2020)</div>
          </td>
          <td style="width: 56.74%; vertical-align: top;">
            <div style="text-align: right; font-weight: bold;">Filed Pursuant to Rule 424(b)(3)</div>
            <div style="text-align: right; font-weight: bold;">Registration Nos. 333-238990 and 333-239399</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">51,400,000 Units consisting of</div>
    <div style="text-align: center; font-weight: bold;">Common Shares or Pre-Funded Warrants to Purchase Common Shares</div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">and Class A Warrants to Purchase Common Shares</div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 21pt;"><img width="225" height="154" src="image0.jpg"></div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify; text-indent: 36pt;"><font style="color: #000000;">This is a supplement (&#8220;Prospectus Supplement&#8221;) to the prospectus, dated June 23, 2020 (&#8220;Prospectus&#8221;) of Castor Maritime Inc. (the &#8220;Company&#8221;), which forms a part of the
          Company&#8217;s Registration Statement on Form F-1 (Registration Nos. </font>333-238990 and 333-239399<font style="color: #000000;">), as amended or supplemented from time to time.</font></div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="color: #000000;">&#160;</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">On June 29, 2020, the Company filed a Current Report on Form 6-K&#160;<font style="background-color: #FFFFFF;">(the &#8220;Form 6-K&#8221;)&#160;</font>with the U.S. Securities and Exchange Commission
        (the &#8220;Commission&#8221;) as set forth below.</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-indent: 36pt; color: #000000;">&#160;</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">This Prospectus Supplement should be read in conjunction with, and delivered with, the Prospectus and is qualified by reference to the Prospectus except to the extent that the
        information in this Prospectus Supplement supersedes the information contained in the Prospectus.</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-indent: 36pt; color: #000000;">&#160;</div>
    </div>
    <div style="background-color: #FFFFFF;">
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">This Prospectus Supplement is not complete without, and may not be delivered or utilized except in connection with, the Prospectus, including any amendments or supplements to it.</div>
    </div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-weight: bold;">Investing in our securities involves a high degree of risk. See &#8220;<u>Risk Factors</u>&#8221; beginning on page 12 of the Prospectus for a discussion of information that
      should be considered in connection with an investment in our securities.</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-weight: bold;">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-weight: bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
      is truthful or complete. Any representation to the contrary is a criminal offense.</div>
    <div style="text-align: justify; text-indent: 36pt; color: #000000;">&#160;</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">The date of this prospectus is June 30, 2020.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div> </div>
    <div> <br>
      <div>
        <div style="margin-top: 0.55pt;">
          <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
        <div style="text-align: center; margin-right: 103.25pt; margin-left: 104.2pt; margin-top: 4.55pt; font-family: 'Times New Roman', serif; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; margin-right: 103.25pt; margin-left: 104.2pt; margin-top: 4.55pt; font-family: 'Times New Roman', serif; font-weight: bold;">UNITED STATES</div>
        <div style="text-align: center; margin-right: 103.2pt; margin-left: 104.2pt; margin-top: 0.55pt; font-family: 'Times New Roman', serif; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
        <div style="text-align: center; margin-right: 103.25pt; margin-left: 104.2pt; margin-top: 0.5pt; font-family: 'Times New Roman', serif; font-weight: bold;">Washington, D.C. 20549</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-align: center; margin-right: 103.2pt; margin-left: 104.2pt; font-family: 'Times New Roman', serif; font-size: 14pt; font-weight: bold;">FORM 6-K</div>
        <div style="text-align: center; margin-right: 103.3pt; margin-left: 104.2pt; margin-top: 12.4pt; font-family: 'Times New Roman', serif; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES
          EXCHANGE ACT OF 1934</div>
        <div><br>
        </div>
        <div style="text-align: center; margin-right: 194pt; margin-left: 201.25pt; font-family: 'Times New Roman', serif;">For the month of June 2020 </div>
        <div style="text-align: center; margin-right: 194pt; margin-left: 201.25pt; font-family: 'Times New Roman', serif;">Commission File Number: 001- 38802</div>
        <div style="text-align: center; margin-right: 194pt; margin-left: 201.25pt; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="text-align: center; margin-right: 103.3pt; margin-left: 101.95pt; font-family: 'Times New Roman', serif; font-size: 14pt; font-weight: bold;">Castor Maritime Inc.</div>
        <div style="text-align: center; margin-right: 103.2pt; margin-left: 104.2pt; margin-top: 0.4pt; font-family: 'Times New Roman', serif;">(Translation of registrant&#8217;s name into English)</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-align: center; margin-right: 103.25pt; margin-left: 104.2pt; margin-top: 0.05pt; font-family: 'Times New Roman', serif; font-weight: bold;">223 Christodoulou Chatzipavlou Street, Hawaii Royal Gardens, 3036 Limassol, Cyprus</div>
        <div style="text-align: center; margin-right: 103.2pt; margin-left: 104.2pt; margin-top: 0.5pt; font-family: 'Times New Roman', serif;">(Address of principal executive office)</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="margin-right: 76.45pt; margin-left: 5.95pt; font-family: 'Times New Roman', serif;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F<font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt;" id="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: 'Times New Roman', Times, serif;">&#8999;</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt;" id="TRGRRTFtoHTMLTab">&#160;</font>Form 40-F&#160;&#160;&#160;&#160; &#9744;</div>
        <div style="margin-right: 76.45pt; margin-left: 5.95pt; font-family: 'Times New Roman', serif;"><font style="font-family: 'Times New Roman', Times, serif;"> <br>
          </font></div>
        <div style="margin-right: 50.5pt; margin-left: 5.95pt; font-family: 'Times New Roman', serif;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#160;</div>
        <div style="margin-right: 50.5pt; margin-left: 5.95pt; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="margin-right: 50.5pt; margin-left: 5.95pt; font-family: 'Times New Roman', serif;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#160;</div>
        <div style="margin-right: 50.5pt; margin-left: 5.95pt; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div><br>
        </div>
        <div style="margin-top: 0.4pt;">
          <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">INFORMATION CONTAINED IN THIS FORM 6-K REPORT</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">On June 26, 2020, Castor Maritime Inc. (the &#8220;Company&#8221;) completed a public offering (the &#8220;Offering&#8221;) of 59,110,000
          units of the Company, each unit consisting of (i) one common share, par value $0.001 per share (a &#8220;Common Share&#8221;) or a pre-funded warrant to purchase one Common Share at an exercise price equal to $0.01 per Common Share (a &#8220;Pre-Funded Warrant&#8221;),
          and (ii) one Class A Warrant to purchase one Common Share (a &#8220;Class A Warrant&#8221;), for $0.35 per unit (or $0.34 per unit including a pre-funded warrant).</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">At the time of the closing, the underwriters exercised and closed on their over-allotment option, and purchased an
          additional 7,710,000 Common Shares and 7,710,000 Class A Warrants.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">The aggregate gross proceeds to the Company from the Offering and the exercise of the underwriters&#8217; over-allotment
          option, before underwriting discounts and commissions and estimated expenses payable by the Company, were approximately $20.7 million.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">Attached to this report on Form 6-K as Exhibit 1.1 is a copy of the Underwriting Agreement dated June 23, 2020
          between the Company and Maxim Group LLC, as representative of the underwriters listed on Schedule A therein.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">Attached to this report on Form 6-K as Exhibit 4.1 is a copy of the Warrant Agency Agreement, dated June 26, 2020,
          among the Company and American Stock Transfer &amp; Trust Company, LLC.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">Attached to this report on Form 6-K as Exhibit 4.2 is a copy of the form of Class A Warrant.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">Attached to this report on Form 6-K as Exhibit 4.3 is a copy of the form of Pre-Funded Warrant.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);"> Attached to this report on Form 6-K as Exhibit 5.1 is the opinion of Seward &amp; Kissel LLP relating to the
          legality and validity of the Units.<br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">Attached to this report on Form 6-K as Exhibit 99.1 is a copy of the press release of the Company dated June 23,
          2020 titled &#8220;Castor Maritime Inc. Announces Pricing of Upsized $18.0 Million Underwritten<font style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</font>Public<font style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</font>Offering&#8221;.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif; color: rgb(0, 0, 0);">Attached to this report on Form 6-K as Exhibit 99.2 is a copy of the press release of the Company dated June 26,
          2020 titled &#8220;Castor Maritime Inc. Announces Closing of Upsized $20.7 Million Underwritten Public Offering Including Full Exercise Overallotment Option&#8221;.</div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">The Company has 64,342,876 Common Shares issued and outstanding as of the date hereof. <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-size: 10.5pt;"><font style="font-size: 10pt;">The information contained in this Report on Form 6-K and the exhibit attached hereto
            are hereby incorporated by reference into the Company&#8217;s registration statement on Form F-3 (File No. 333-232052) that was filed with the U.S. Securities and Exchange Commission and became effective on June 21, 2019</font>.</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
        <div style="text-align: center; margin-top: 4.6pt; font-family: 'Times New Roman',serif; font-weight: bold;">SIGNATURES</div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="text-indent: 36pt; font-family: 'Times New Roman', serif;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
          authorized.</div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">Date: June 29, 2020</div>
        <div style="margin-top: 0.45pt;"><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za1303c495cd44062b3b10bd08b501b82">

            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME Inc.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 50%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 6.91%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">By:</div>
              </td>
              <td style="width: 26.42%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">/s/ Petros Panagiotidis</div>
              </td>
              <td style="width: 16.67%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 6.91%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Name:</div>
              </td>
              <td style="width: 26.42%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Petros Panagiotidis</div>
              </td>
              <td style="width: 16.67%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 6.91%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Title:</div>
              </td>
              <td style="width: 26.42%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Chairman, Chief Executive Officer, and Chief Financial Officer</div>
              </td>
              <td style="width: 16.67%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">&#160;</td>
              <td style="width: 6.91%; vertical-align: top;">&#160;</td>
              <td style="width: 26.42%; vertical-align: top;">&#160;</td>
              <td style="width: 16.67%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div style="margin-top: 0.45pt;"><br>
        </div>
        <div style="margin-top: 0.45pt;"><br>
        </div>
        <div style="margin-top: 0.45pt;"><br>
        </div>
        <div style="margin-top: 0.45pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="margin-top: 0.4pt;"><br>
        </div>
        <div style="margin-top: 0.05pt;"><br>
        </div>
      </div>
    </div>
    <div id="DSPFPageBreakArea">
      <hr style="page-break-after: always; color: #FFFFFF;" id="DSPFPageBreak"></div>
    <div>
      <div><br>
      </div>
      <div style="text-align: right;">Exhibit 1.1<br>
      </div>
      <br>
      <div><br>
      </div>
      <div style="text-align: center; margin-top: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">UNDERWRITING AGREEMENT</div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: right; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">June 23, 2020</div>
      <div style="font-family: 'Times New Roman', serif;">Maxim Group LLC</div>
      <div style="font-family: 'Times New Roman', serif;">405 Lexington Avenue, 2nd Fl.</div>
      <div style="font-family: 'Times New Roman', serif;">New York, NY 10174</div>
      <div style="font-family: 'Times New Roman', serif; font-style: italic;">As the Representative of the</div>
      <div style="font-family: 'Times New Roman', serif; font-style: italic;">Several underwriters, if any, named in <u>Schedule I</u> hereto</div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif;">Ladies and Gentlemen:</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">The undersigned, Castor Maritime Inc., a company incorporated under the laws of the Republic of the Marshall Islands (collectively with its subsidiaries and
        affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Castor Maritime Inc., the &#8220;<u>Company</u>&#8221;), hereby confirms its agreement (this &#8220;<u>Agreement</u>&#8221;)
        with the several underwriters (such underwriters, including the Representative (as defined below), the &#8220;<u>Underwriters</u>&#8221; and each an &#8220;<u>Underwriter</u>&#8221;) named in <u>Schedule I</u> hereto for which Maxim Group LLC is acting as representative
        to the several Underwriters (the &#8220;<u>Representative</u>&#8221; and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning
        as Underwriter) on the terms and conditions set forth herein.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman', serif;">It is understood that the several Underwriters are to make a public offering of the Public Securities as soon as the
        Representative deems it advisable to do so.&#160; The Public Securities are to be initially offered to the public at the public offering price set forth in the Prospectus.&#160; The Representative may from time to time thereafter change the public offering
        price and other selling terms.</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', serif;">It is further understood that you will act as the Representative for the Underwriters in the offering and sale of the Closing Securities and,
        if any, the Option Securities in accordance with this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: center; margin-top: 6pt; font-family: 'Times New Roman', serif; font-weight: bold;">ARTICLE I.</div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">DEFINITIONS</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">1.1&#160; &#160; &#160; &#160; &#160; </font><u>Definitions</u>.&#160; In addition to the terms defined elsewhere in this Agreement, for
        all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Action</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(k).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Affiliate</u>&#8221; means with respect to any Person, any other Person that, directly or indirectly through one or more
        intermediaries, controls or is controlled by or is under common control with such Person as such terms are used in and construed under Rule 405 under the Securities Act.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Applicable Laws</u>&#8221; shall have the meaning assigned to such term in Section 3.1(o).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Authorizations</u>&#8221; shall have the meaning assigned to such term in Section 3.1(o).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Authorized Agent</u>&#8221; shall have the meaning ascribed to such term in Section 7.7.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Board of Directors</u>&#8221; means the board of directors of the Company.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Business Day</u>&#8221; means any day which is a any day other than Saturday, Sunday or other day on which commercial
        banks in The City of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;,
        &#8220;shelter-in-place&#8221;, &#8220;non-essential employee&#8221;&#160; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for
        wire transfers) of commercial banks in The City of New York are generally are open for use by customers on such day.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Class A Warrants</u>&#8221; means, collectively, the Common Share Purchase Warrants delivered to the Underwriters in
        accordance with Section 2.1(a) and Section 2.2, which Warrants shall be exercisable immediately and have a term of exercise equal to five (5) years, in the form of <u>Exhibit B-1</u> attached hereto.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Closing</u>&#8221; means the closing of the purchase and sale of the Closing Securities pursuant to Section 2.1.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Closing Date</u>&#8221; means the hour and the date on the Trading Day on which all conditions precedent to (i) the
        Underwriters&#8217; obligations to pay the Closing Purchase Price and (ii) the Company&#8217;s obligations to deliver the Closing Securities, in each case, have been satisfied or waived, but in no event later than 10:00 a.m. (New York City time) on the second
        (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) Trading Day following the date hereof or at such earlier time as shall be agreed upon by the Representative and the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Closing Purchase Price</u>&#8221; shall have the meaning ascribed to such term in Section 2.1(b), which aggregate
        purchase price shall be net of underwriting discounts and commissions.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Closing Securities</u>&#8221; shall have the meaning ascribed to such term in Section 2.1(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Common Shares</u>&#8221; means the common shares of the Company, par value $0.001 per share, and any other class of
        securities into which such securities may hereafter be reclassified or changed.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Common Share Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the
        holder thereof to acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles
        the holder thereof to receive, Common Shares.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Company Auditor</u>&#8221; means <font style="background-color: #FFFFFF; color: #000000;">Deloitte Certified Public
          Accountants S.A.</font>, with offices located at 3a Fragkokklisias &amp; Granikou str., Athens 151 25 Greece.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Company Counsel</u>&#8221; means Seward &amp; Kissel LLP, with offices located at One Battery Park Plaza, New York, New
        York 10004.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Credit Facility</u>&#8221; means any credit facility or loan agreement to which the Company or any of its Subsidiaries
        is a party or their assets are bound as disclosed in the Registration Statement and the Prospectus.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Disclosure Schedules</u>&#8221; means the Disclosure Schedules of the Company delivered concurrently herewith.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Effective Date</u>&#8221; means the date and time as of which the Registration Statement, or the most recent
        post-effective amendment thereto, became effective, or is deemed to have become effective by the Commission, in accordance with the rules and regulations under the Securities Act.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>EGS</u>&#8221; means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York,
        New York 10105.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Environmental Claim</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(n).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Environmental Laws</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(n).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Execution Date</u>&#8221; shall mean the date on which the parties execute and enter into this Agreement.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Exempt Issuance</u>&#8221; means the issuance of (a) Common Shares or equity awards to employees, officers or directors
        of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such
        purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into Common Shares issued and
        outstanding on the date of this Agreement, <font style="font-style: italic;">provided</font> that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price,
        exchange price or conversion price of such securities (other than in connection with automatic price resets, stock splits, adjustments or combinations as set forth in such securities) or to extend the term of such securities, and (c) securities
        issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, <font style="font-style: italic;">provided</font> that such securities are issued as &#8220;restricted securities&#8221; (as
        defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.20(a) herein, and <font style="font-style: italic;">provided</font>
        that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall
        provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is
        investing in securities.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>FCPA</u>&#8221; means the Foreign Corrupt Practices Act of 1977, as amended.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>FINRA</u>&#8221; means the Financial Industry Regulatory Authority.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>GAAP</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(i).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Governmental Authority</u>&#8221; shall have the meaning assigned to such term in Section 3.1(o).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Indebtedness</u>&#8221; means (a) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than
        trade accounts payable incurred in the ordinary course of business), (b) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company&#8217;s
        consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (c) the present value of any lease payments in
        excess of $50,000 due under leases required to be capitalized in accordance with GAAP.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Intellectual Property Rights</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(q).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Liens</u>&#8221; means a lien, claims, charge, pledge, security interest, encumbrance, right of first refusal,
        preemptive right or other restriction.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Lock-Up Agreements</u>&#8221; means the lock-up agreements that are executed delivered on the date hereof by Lock-Up
        Parties, such agreements in the form of <u>Exhibit A</u> attached hereto.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Lock-Up Parties</u>&#8221; means (i) the Company&#8217;s officers and directors and (ii) Thalassa.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Material Adverse Effect</u>&#8221; shall have the meaning assigned to such term in Section 3.1(b).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Materials of Environmental Concern</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(n).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Offering</u>&#8221; shall have the meaning ascribed to such term in Section 2.1(c).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Option Closing Date</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(c).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Option Closing Purchase Price</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(b), which aggregate
        purchase price shall be net of the underwriting discounts and commissions.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Option Securities</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Option Shares</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Option Pre-Funded Warrants</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Option Purchase Warrants</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Over-Allotment Option</u>&#8221; shall have the meaning ascribed to such term in Section 2.2(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Person</u>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association,
        joint venture, limited liability company, joint stock company, Governmental Authority or other entity of any kind.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Pre-Funded Warrants</u>&#8221; means, collectively, the Pre-Funded Common Share purchase warrants delivered to the
        Underwriters in accordance with Section 2.1(a) in the form attached hereto as <u>Exhibit B-2</u>.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Preliminary Prospectus</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(f).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Proceeding</u>&#8221; means an action, claim, suit, investigation or proceeding (including, without limitation, an
        informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Prospectus</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(f).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Public Securities</u>&#8221; means, collectively, the Closing Securities and, if any, the Option Securities.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Registration Statement</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(f).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Required Approvals</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(e).</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Rule 144</u>&#8221; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be
        amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Rule 424</u>&#8221; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be
        amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>SEC Reports</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(i).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Securities</u>&#8221; means the Closing Securities, the Option Securities and the Warrant Shares.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated
        thereunder.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Share Purchase Price</u>&#8221; shall have the meaning ascribed to such term in Section 2.1(b).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Shares</u>&#8221; means, collectively, the shares of Common Shares delivered to the Underwriters in accordance with
        Section 2.1(a) and Section 2.2(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Subsidiary</u>&#8221; means any subsidiary of the Company and shall, where applicable, also include any direct or
        indirect subsidiary of the Company formed or acquired after the date hereof.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Trading Day</u>&#8221; means a day on which the principal Trading Market is open for trading.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Trading Market</u>&#8221; means any of the following markets or exchanges on which the Common Shares are listed or
        quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#160;&#8220;<u>Transaction Documents</u>&#8221; means this Agreement and all exhibits and schedules hereto, the Warrants, the Lock-Up
        Agreements, and any other documents or agreements executed in connection with the transactions contemplated hereunder.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Transfer Agent</u>&#8221; means <font style="background-color: #FFFFFF; color: #000000;">American Stock Transfer &amp;
          Trust Company LLC</font>, the current transfer agent of the Company with a mailing address of <font style="background-color: #FFFFFF; color: #222222;">6201 15th Ave, Brooklyn, NY 11219</font>, a phone number of 718.921.8300 and an email address
        of Admin1@astfinancial.com, and any successor transfer agent of the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Underwriter Information</u>&#8221; shall have the meaning ascribed to such term in Section 3.1(z)(i).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Units</u>&#8221; shall have the meaning ascribed to such term in Section 2.1(a).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Variable Rate Transaction</u>&#8221; shall have the meaning ascribed to such term in Section 4.20(b).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Warrants</u>&#8221; means collectively, the Class A Warrants and the Pre-Funded Warrants.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Warrant Purchase Price</u>&#8221; shall have the meaning ascribed to such term in Section 2.1(b).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#8220;<u>Warrant Shares</u>&#8221; means the shares of Common Shares issuable upon exercise of the Warrants.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">ARTICLE II.</div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">PURCHASE AND SALE</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">2.1&#160; &#160; &#160; &#160; &#160; </font><u>Closing</u>.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; Upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and each
        Underwriter agrees to purchase, severally and not jointly, at the Closing, an aggregate of 51,400,000 units (the &#8220;<u>Units</u>&#8221; or the &#8220;<u>Closing Securities</u>&#8221;) of the Company as set forth on <u>Schedule I</u> hereto, each consisting of one
        Common Share or one Pre-Funded Warrant to purchase one Common Share at an exercise price of $0.01 per Common Share together with one Class A Warrant to purchase one Common Share at an exercise price of $0.35 per share. The Units will not be
        certificated. The Common Shares, Pre-Funded Warrants and Purchase Warrants that comprise the Units are immediately separable and will be issued separately.</div>
      <div style="text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; The aggregate purchase price for the Units shall equal the amount set forth opposite the name of such Underwriter on <u>Schedule


          I</u> hereto (the &#8220;<u>Closing Purchase Price</u>&#8221;). The purchase price for one Unit consisting of one Common Share and one Class A Warrant shall be $0.32375, representing a 7.5% discount to the public offering price per Unit and the purchase
        price for one Unit consisting of one Pre-Funded Warrant and a Class A Warrant to purchase one Warrant Share shall be $0.3145, representing a 7.5% discount to the public offering price per Unit.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; On the Closing Date, each Underwriter shall deliver or cause to be delivered to the Company, via wire
        transfer through the Representative, immediately available funds equal to such Underwriter&#8217;s Closing Purchase Price and the Company shall deliver to, or as directed by, such Underwriter its respective Units and the Company shall deliver the other
        items required pursuant to Section 2.3 deliverable at the Closing.&#160; Upon satisfaction of the covenants and conditions set forth in Sections 2.3 and 2.4, the Closing shall occur at the offices of EGS or such other location as the Company and
        Representative shall mutually agree. The Public Securities are to be offered initially to the public at the offering price set forth on the cover page of the Prospectus (the &#8220;<u>Offering</u>&#8221;).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(d)&#160; &#160; &#160; &#160; &#160; The Company acknowledges and agrees that, with respect to any Notice(s) of Exercise (as defined in the
        Pre-Funded Warrants) delivered by a Holder (as defined in the Pre-Funded Warrants) on or prior to 12:00 p.m. (New York City time) on the Closing Date, which Notice(s) of Exercise may be delivered at any time after the time of execution of this
        Agreement, the Company shall deliver the Warrant Shares (as defined in the Pre-Funded Warrants) subject to such notice(s) to the Holder by 4:00 p.m. (New York City time) on the Closing Date and the Closing Date shall be the Warrant Share Delivery
        Date (as defined in the Pre-Funded Warrants).&#160; The Company acknowledges and agrees that the Holders are third-party beneficiaries of this covenant of the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">2.2&#160; &#160; &#160; &#160; &#160; </font><u>Over-Allotment Option</u>.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; For the purposes of covering any over-allotments in connection with the distribution and sale of the
        Closing Securities, the Representative is hereby granted an option (the &#8220;<u>Over-Allotment Option</u>&#8221;) to purchase, in the aggregate, (i) up to an additional 7,710,000 Common Shares (&#8220;<u>Option Shares</u>&#8221;) and/or Pre-Funded Warrants to purchase
        up to&#160; Common Shares (&#8220;<u>Option</u>&#160;<u>Pre-Funded Warrants</u>&#8221;) and/or (ii) Class A Warrants to purchase up to 7,710,000 Common Shares (&#8220;<u>Option Purchase Warrants</u>&#8221;; together with the Option Shares and the Option Pre-Funded Warrants, the &#8220;<u>Option


          Securities</u>&#8221;).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; In connection with an exercise of the Over-Allotment Option, (a) the purchase price to be paid for any
        Option Shares is equal to the product of $0.3145 multiplied by the number of Option Shares to be purchased, (b) the purchase price to be paid for any Option Pre-Funded Warrants is equal to the product of $0.30525 multiplied by the number of Option
        Pre-Funded Warrants to be purchased and (c) the purchase price to be paid for any Option Purchase Warrants is equal to the product of $0.00925 multiplied by the number of Option Purchase Warrants to be purchased (the aggregate purchase price to be
        paid on an Option Closing Date, the &#8220;<u>Option Closing Purchase Price</u>&#8221;).</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; The Over-Allotment Option granted pursuant to this Section 2.2 may be exercised by the Representative as
        to all (at any time) or any part (from time to time) of the Option Securities within 30 days after the Execution Date.&#160; An Underwriter will not be under any obligation to purchase any Option Securities prior to the exercise of the Over-Allotment
        Option by the Representative.&#160; The Over-Allotment Option granted hereby may be exercised by the giving of oral notice to the Company from the Representative, which must be confirmed in writing by overnight mail or facsimile or other electronic
        transmission setting forth the number of Option Shares and/or Option Warrants to be purchased and the date and time for delivery of and payment for the Option Securities (each, an &#8220;<u>Option Closing Date</u>&#8221;), which will not be later than the
        earlier of 30 days after the Execution Date and (ii) two (2) full Business Days after the date of the notice or such other time as shall be agreed upon by the Company and the Representative, at the offices of EGS<font style="font-weight: bold;">&#160;</font>or


        at such other place (including remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery and payment for the Option Securities does not occur on the Closing Date, each
        Option Closing Date will be as set forth in the notice. Upon exercise of the Over-Allotment Option, the Company will become obligated to convey to the Underwriters, and, subject to the terms and conditions set forth herein, the Underwriters will
        become obligated to purchase, the number of Option Shares and/or Option Pre-Funded Warrants and/or Option Purchase Warrants specified in such notice.&#160; The Representative may cancel the Over-Allotment Option at any time prior to the expiration of
        the Over-Allotment Option by written notice to the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">2.3&#160; &#160; &#160; &#160; &#160; </font><u>Deliveries</u>.&#160; The Company shall deliver or cause to be delivered to each
        Underwriter (if applicable) the following:</div>
      <div style="text-align: justify; text-indent: 31.5pt; margin-left: 40.5pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; At the Closing Date, the Closing Shares and, as to each Option Closing Date, if any, the applicable
        Option Shares, which shares shall be delivered via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; At the Closing Date, the Closing Warrants and, as to each Option Closing Date, if any, the applicable
        Option Warrants via The Depository Trust Company Deposit or Withdrawal at Custodian system for the accounts of the several Underwriters;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; At the Closing Date, legal opinions of Company Counsel addressed to the Underwriters, including, without
        limitation, a negative assurance letter, in customary form reasonably acceptable to the Representative, and as to each Option Closing Date, if any, bring-down opinions from Company Counsel in form and substance reasonably satisfactory to the
        Representative and, with respect to the Subsidiaries, the favorable opinions of foreign legal counsel to the Company addressed to the Underwriters and in form and substance satisfactory to counsel for the Representative;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(d)&#160; &#160; &#160; &#160; &#160; Contemporaneously with the execution of this Agreement, a cold comfort letter, addressed to the
        Underwriters and in form and substance satisfactory in all respects to the Representative from the Company Auditor dated, respectively, as of the date of this Agreement and a bring-down letter dated as of the Closing Date and each Option Closing
        Date, if any;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(e)&#160; &#160; &#160; &#160; &#160; On the Closing Date and on each Option Closing Date, a duly executed and delivered certificate of the
        Chief Executive Officer and Chief Financial Officer of the Company, in customary form reasonably acceptable to the Representative;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(f)&#160; &#160; &#160; &#160; &#160; On the Closing Date and on each Option Closing Date, the duly executed and delivered certificate of the
        Secretary of the Company, in customary form reasonably acceptable to the Representative;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(g)&#160; &#160; &#160; &#160; &#160; Contemporaneously herewith, the Lock-Up Agreements, duly executed and delivered by the Lock-Up Parties;
        and</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(h)&#160; &#160; &#160; &#160; &#160; Such other certificates, opinions or documents as the Representative may have reasonably requested.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">2.4&#160; &#160; &#160; &#160; &#160; </font><u>Closing Conditions</u>. The respective obligations of each Underwriter hereunder in
        connection with the Closing and each Option Closing Date are subject to the following conditions being met:</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; the accuracy in all material respects when made and on the date in question (other than representations
        and warranties of the Company already qualified by materiality, which shall be true and correct in all respects) of the representations and warranties of the Company contained herein (unless as of a specific date therein);</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; all obligations, covenants and agreements of the Company required to be performed at or prior to the date
        in question shall have been performed;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; the delivery by the Company of the items set forth in Section 2.3 of this Agreement;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(d)&#160; &#160; &#160; &#160; &#160; the Registration Statement shall be effective on the date of this Agreement and&#160; at each of the Closing
        Date and each Option Closing Date, if any, no stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall have been instituted or shall be pending or contemplated by the
        Commission and any request on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representative;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(e)&#160; &#160; &#160; &#160; &#160; by the Execution Date, if required by FINRA, the Underwriters shall have received a notice of no
        objections from FINRA as to the amount of compensation allowable or payable to and the terms and arrangements for acting as the Underwriters as described in the Registration Statement;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(f)&#160; &#160; &#160; &#160; &#160; the Closing Shares, the Option Shares and the Warrant Shares have been approved for listing on the
        Trading Market; and</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(g)&#160; &#160; &#160; &#160; &#160; prior to and on each of the Closing Date and each Option Closing Date, if any: (i) there shall have been
        no material adverse change or development involving a prospective material adverse change in the condition or prospects or the business activities, financial or otherwise, of the Company from the latest dates as of which such condition is set forth
        in the Registration Statement, the General Disclosure Package and Prospectus; (ii) no action suit or proceeding, at law or in equity, shall have been pending or threatened against the Company or any Affiliate of the Company before or by any court
        or federal or state commission, board or other administrative agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business, operations, prospects or financial condition or income of the Company, except as
        set forth in the Registration Statement, the General Disclosure Package and Prospectus; (iii) no stop order applicable to the Company shall have been issued under the Securities Act and no proceedings therefor shall have been initiated or
        threatened by the Commission; (iv) the Company has not incurred any material liabilities or obligations, direct or contingent, nor has it entered into any material transactions not in the ordinary course of business, other than pursuant to this
        Agreement and the transactions referred to herein; (v) the Company has not paid or declared any dividends or other distributions of any kind on any class of its capital stock; (vi) the Company has not altered its method of accounting; and (vii) the
        Registration Statement, the General Disclosure Package and the Prospectus and any amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance with the Securities Act and the rules
        and regulations thereunder and shall conform in all material respects to the requirements of the Securities Act and the rules and regulations thereunder, and neither the Registration Statement, the General Disclosure Package nor the Prospectus nor
        any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they
        were made, not misleading.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">If any of the conditions specified in this Section 2.4 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates,
        opinions, written statements or letters furnished to the Representatives or to Representative&#8217;s counsel pursuant to this Section 2.4 shall not be reasonably satisfactory in form and substance to the Representative and to Representative&#8217;s counsel,
        all obligations of the Underwriters hereunder may be cancelled by the Representative at, or at any time prior to, the consummation of the Closing. Notice of such cancellation shall be given to the Company in writing or orally. Any such oral notice
        shall be confirmed promptly thereafter in writing.</div>
      <div style="text-align: center; margin-top: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">ARTICLE III.</div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">REPRESENTATIONS AND WARRANTIES</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">3.1&#160; &#160; &#160; &#160; &#160; </font><u>Representations and Warranties of the Company</u>.&#160; Except as set forth in the SEC
        Reports or the Disclosure Schedules, which SEC Reports or Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the SEC Reports or the
        corresponding section of the Disclosure Schedules, the Company represents and warrants to the Underwriters as of the Execution Date, as of the Closing Date and as of each Option Closing Date, if any, as follows:</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; <u>Subsidiaries</u>.&#160; All of the Subsidiaries of the Company are set forth on <u>Schedule 3.1(a)</u>.&#160;
        The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are
        fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.&#160; If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be
        disregarded.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; <u>Organization and Qualification</u>.&#160; The Company and each of the Subsidiaries is an entity duly
        incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its
        business as currently conducted.&#160; Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents.&#160; Each of
        the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such
        qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any
        Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the
        Company&#8217;s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &#8220;<u>Material Adverse Effect</u>&#8221;) and no Proceeding has been instituted in any such jurisdiction
        revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; <u>Authorization; Enforcement</u>.&#160; The Company has the requisite corporate power and authority to enter
        into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder.&#160; The execution and delivery of this
        Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action
        is required by the Company, the Board of Directors or the Company&#8217;s shareholders in connection herewith or therewith other than in connection with the Required Approvals.&#160; This Agreement and each other Transaction Document to which the Company is a
        party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
        accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#8217; rights generally, (ii) as
        limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by Applicable Law.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">13</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(d)&#160; &#160; &#160; &#160; &#160; <u>No Conflicts</u>.&#160; The execution, delivery and performance by the Company of this Agreement and the
        other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the
        Company&#8217;s or any Subsidiary&#8217;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a
        default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation
        (with or without notice, lapse of time or both) of, any agreement, Credit Facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which
        any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any Applicable Law or other restriction of any court or Governmental Authority to
        which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii),
        such as could not have or reasonably be expected to result in a Material Adverse Effect.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(e)&#160; &#160; &#160; &#160; &#160; <u>Filings, Consents and Approvals</u>.&#160; The Company is not required to obtain any consent, waiver, authorization or order
        of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other Governmental Authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction
        Documents, other than: (i) the filing with the Commission of the Prospectus, (ii) such filings as are required to be made under applicable state securities laws and (iii) application(s) to each applicable Trading Market for the listing of the
        Shares and Warrant Shares for trading thereon in the time and manner required thereby (collectively, the &#8220;<u>Required Approvals</u>&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(f)&#160; &#160; &#160; &#160; &#160; <u>Registration Statement</u>.&#160; The Company has filed with the Commission the Registration Statement, including any related
        Preliminary Prospectus or Prospectuses, for the registration of the Securities under the Securities Act, which Registration Statement has been prepared by the Company in conformity with the requirements of the Securities Act and the rules and
        regulations of the Commission under the Securities Act. The registration of the Common Shares under the Exchange Act has been declared effective by the Commission on the date hereof.&#160; Copies of such Registration Statement and of each amendment
        thereto, if any, including the related Preliminary Prospectuses, heretofore filed by the Company with the Commission have been delivered to the Underwriters. The term &#8220;<u>Registration Statement</u>&#8221; means such registration statement on Form F-1
        (File No. 333-238990), as amended, as of the relevant Effective Date, including financial statements, all exhibits and any information deemed to be included or incorporated by reference therein, including any information deemed to be included
        pursuant to Rule 430A or Rule 430B of the Securities Act and the rules and regulations thereunder, as applicable. If the Company files a registration statement to register a portion of the Securities and relies on Rule 462(b) of the Securities Act
        and the rules and regulations thereunder for such registration statement to become effective upon filing with the Commission (the &#8220;<u>Rule 462 Registration Statement</u>&#8221;), then any reference to the &#8220;Registration Statement&#8221; shall be deemed to
        include the Rule 462 Registration Statement, as amended from time to time. The term &#8220;<u>Preliminary Prospectus</u>&#8221; as used herein means a preliminary prospectus as contemplated by Rule 430 or Rule 430A of the Securities Act and the rules and
        regulations thereunder as included at any time as part of, or deemed to be part of or included in, the Registration Statement. The term &#8220;<u>Prospectus</u>&#8221; means the final prospectus in connection with this Offering as first filed with the
        Commission pursuant to Rule 424(b) of the Securities Act and the rules and regulations thereunder or, if no such filing is required, the form of final prospectus included in the Registration Statement at the Effective Date, except that if any
        revised prospectus or prospectus supplement shall be provided to the Representative by the Company for use in connection with the Securities which differs from the Prospectus (whether or not such revised prospectus or prospectus supplement is
        required to be filed by the Company pursuant to Rule 424(b)), the term &#8220;Prospectus&#8221; shall also refer to such revised prospectus or prospectus supplement, as the case may be, from and after the time it is first provided to the Representative for
        such use. Any reference herein to the terms &#8220;amend&#8221;, &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include: (i) the filing of any document under
        the Exchange Act after the Effective Date, the date of such Preliminary Prospectus or the date of the Prospectus, as the case may be, which is incorporated therein by reference, and (ii) any such document so filed.&#160; All references in this Agreement
        to the Registration Statement, a Preliminary Prospectus and the Prospectus, or any amendments or supplements to any of the foregoing shall be deemed to include any copy thereof filed with the Commission pursuant to its Electronic Data Gathering,
        Analysis and Retrieval System (&#8220;<u>EDGAR</u>&#8221;).&#160; The term &#8220;<u>General Disclosure Package</u>&#8221; means, collectively, the Permitted Free Writing Prospectus(es) (as defined below) issued at or prior to the date hereof, the most recent preliminary
        prospectus related to this offering, and the information included on <u>Schedule 3.1(f)</u> hereto.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">14</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(g)&#160; &#160; &#160; &#160; &#160; <u>Issuance of Securities</u>.&#160; The Public Securities are duly authorized and, when issued and paid for in accordance with
        the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.&#160; The Warrant Shares are duly authorized and, when issued in accordance with the terms of the
        Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.&#160; The Company has reserved from its duly authorized capital stock the maximum number of Common Shares issuable pursuant to this
        Agreement and the Warrants.&#160; The Securities are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. All corporate action required to be taken for
        the authorization, issuance and sale of the Securities has been duly and validly taken. The Securities<font style="font-weight: bold;">&#160;</font>conform in all material respects to all statements with respect thereto contained in the Registration
        Statement, the General Disclosure Package and the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(h)&#160; &#160; &#160; &#160; &#160; <u>Capitalization</u>.&#160; The capitalization of the Company as of the date hereof is as set forth on <u>Schedule


          3.1(h)</u>, which <u>Schedule 3.1(h)</u> shall also include the number of Common Shares owned beneficially, and of record, by Affiliates of the Company as of the date hereof.&#160; Except as set forth on <u>Schedule 3.1(h)</u>, the Company has not
        issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&#8217;s stock option plans, the issuance of Common Shares to employees pursuant
        to the Company&#8217;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Share Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act.&#160; No Person has any right of
        first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.&#160; Except as set forth on <u>Schedule 3.1(h)</u> and as a result of the purchase and sale of
        the Securities, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or
        giving any Person any right to subscribe for or acquire, any Common Shares or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue
        additional Common Shares or Common Share Equivalents or capital stock of any Subsidiary.&#160; Other than as set forth on <u>Schedule 3.1(h)</u>, the issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue Common
        Shares or other securities to any Person (other than the Underwriters) and will not result in a right of any holder of Company securities or instruments to adjust the exercise, conversion, exchange or reset price under any such securities or
        instruments. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
        Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or &#8220;phantom stock&#8221; plans or agreements or any similar plan or agreement. All of the outstanding shares
        of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any
        preemptive rights or similar rights to subscribe for or purchase securities.&#160; The authorized shares of the Company conform in all material respects to all statements relating thereto contained in the Registration Statement, the General Disclosure
        Package and the Prospectus. The offers and sales of the Company&#8217;s securities were at all relevant times either registered under the Securities Act and the applicable state securities or Blue Sky laws or, based in part on the representations and
        warranties of the purchasers, exempt from such registration requirements.&#160; No further approval or authorization of any shareholder, the Board of Directors or others is required for the issuance and sale of the Securities.&#160; Other than as set forth
        on <u>Schedule 3.1(h)</u>, there are no shareholders agreements, voting agreements or other similar agreements with respect to the Company&#8217;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of
        the Company&#8217;s shareholders.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">15</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(i)&#160; &#160; &#160; &#160; &#160; <u>SEC Reports; Financial Statements</u>.&#160; The Company has filed all reports, schedules, forms,
        statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the
        Company was required by Applicable Law to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus, being collectively referred to herein as the &#8220;<u>SEC


          Reports</u>&#8221;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension.&#160; As of their respective dates, the SEC Reports complied in all material
        respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
        or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160; The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of
        the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing.&#160; Such financial statements have
        been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (&#8220;<u>GAAP</u>&#8221;), except as may be otherwise specified in such financial statements or the notes
        thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates
        thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The agreements and documents described in the Registration Statement,
        the Preliminary Prospectus, the General Disclosure Package, the Prospectus, and the SEC Reports conform in all material respects to the descriptions thereof contained therein and there are no agreements or other documents required by the Securities
        Act and the rules and regulations thereunder to be described in the Registration Statement, the Preliminary Prospectus, the General Disclosure Package, the Prospectus or the SEC Reports or to be filed with the Commission as exhibits to the
        Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or affected and (i)&#160;that is referred to in
        the Registration Statement, the General Disclosure Package, the Prospectus or the SEC Reports, or (ii)&#160;is material to the Company&#8217;s business, has been duly authorized and validly executed by the Company, is in full force and effect in all material
        respects and is enforceable against the Company and, to the Company&#8217;s knowledge, the other parties thereto, in accordance with its terms, except (x)&#160;as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws
        affecting creditors&#8217; rights generally, (y)&#160;as enforceability of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z)&#160;that the remedy of specific performance and injunctive and other forms
        of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company, and neither the Company
        nor, to the best of the Company&#8217;s knowledge, any other party is in default thereunder and, to the best of the Company&#8217;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default
        thereunder. To the best of the Company&#8217;s knowledge, performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing Applicable Law or order or decree of any Governmental
        Authority or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation, those relating to environmental laws and regulations.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(j)&#160; &#160; &#160; &#160; &#160; <u>Material Changes; Undisclosed Events, Liabilities or Developments</u>.&#160; Since the date of the latest
        audited financial statements included within the SEC Reports, except as set forth on <u>Schedule 3.1(j)</u>, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse
        Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be
        reflected in the Company&#8217;s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of
        cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except
        pursuant to existing Company stock option plans and the issuance of Common Share Equivalents as disclosed in the SEC Reports.&#160; The Company does not have pending before the Commission any request for confidential treatment of information.&#160; Except
        for the issuance of the Securities contemplated by this Agreement or as set forth on <u>Schedule 3.1(j)</u>, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with
        respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this
        representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made. Unless otherwise disclosed in an SEC Report filed prior to the date hereof, the Company has not:
        (i)&#160;issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii)&#160;declared or paid any dividend or made any other distribution on or in respect to its capital stock.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">16</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(k)&#160; &#160; &#160; &#160; &#160; <u>Litigation</u>.&#160; There has not been, and to the knowledge of the Company there is not pending or
        contemplated, any action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by
        any court, arbitrator, Governmental Authority (federal, state, county, local or foreign) (collectively, an &#8220;<u>Action</u>&#8221;). There are no Actions that (i) adversely affects or challenges the legality, validity or enforceability of any of the
        Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect.&#160; Neither the Company nor any Subsidiary, nor any director or officer thereof, is or
        has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.&#160; There has not been, and to the knowledge of the Company, there is not pending or
        contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company.&#160; The Commission has not issued any stop order or other order suspending the effectiveness of any registration
        statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(l)&#160; &#160; &#160; &#160; &#160; <u>Labor Relations</u>.&#160; No labor dispute exists or, to the knowledge of the Company, is imminent with
        respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect.&#160; None of the Company&#8217;s or its Subsidiaries&#8217; employees is a member of a union that relates to such employee&#8217;s relationship
        with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good.&#160; To the
        knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or
        non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any
        liability with respect to any of the foregoing matters that would reasonably be expected to have a Material Adverse Effect.&#160; The Company and its Subsidiaries are in compliance with all Applicable Laws relating to employment and employment
        practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.&#160; The Company and each of the
        Subsidiaries (A) is in compliance, in all material respects, with Applicable Laws (including pursuant to the Occupational Health and Safety Act or its foreign equivalents) relating to the protection of human health and safety in the workplace (&#8220;<u>Occupational


          Laws</u>&#8221;); (B) has received all Authorizations or other approvals required of it under applicable Occupational Laws to conduct its business as currently conducted; and (C) is in compliance, in all material respects, with all terms and conditions
        of such Authorizations or approval.&#160; No action, proceeding, revocation proceeding, writ, injunction or claim is pending or, to the Company&#8217;s knowledge, threatened against the Company or any of its Subsidiaries relating to Occupational Laws, and the
        Company does not have knowledge of any facts, circumstances or developments relating to its operations or cost accounting practices that could reasonably be expected to form the basis for or give rise to such actions, suits, investigations or
        proceedings.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(m)&#160; &#160; &#160; &#160; &#160; <u>Compliance</u>.&#160; Neither the Company nor any Subsidiary is in default under or in violation of (and
        no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default
        under or that it is in violation of, any Credit Facility or other indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or
        violation has been waived), except as could not have or reasonably be expected to result in a Material Adverse Effect.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">17</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(n)&#160; &#160; &#160; &#160; &#160; <u>Environmental Laws</u>.&#160; Neither the Company nor any of its Subsidiaries is in violation of any
        applicable international, national, state or local convention, law, regulation, order, governmental license, convention, treaty (including those promulgated by the International Maritime Organization) or other requirement relating to pollution or
        protection of human health or safety (as they relate to exposure to Materials of Environmental Concern (as defined below)) or protection of the environment (including, without limitation, ambient air, surface water, groundwater, land surface or
        subsurface strata) or protection of natural resources, including without limitation, conventions, laws or regulations relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, wastes, toxic
        substances, hazardous substances, petroleum, petroleum products or other hydrocarbons (collectively, &#8220;<u>Materials of Environmental Concern</u><font style="font-weight: bold; font-style: italic;">&#8221;</font>), or otherwise relating to the manufacture,
        processing, distribution, use, treatment, storage, disposal, transport or handling of Materials of Environmental Concern (collectively, &#8220;<u>Environmental Laws</u><font style="font-weight: bold; font-style: italic;">&#8221;</font>), nor has the Company or
        any Subsidiary received any written communication, whether from a Governmental Authority, citizens group, employee or otherwise, that alleges that the Company or any such Subsidiary is in violation of any Environmental Law or governmental license
        required pursuant to Environmental Law; except, in each case, as would not, individually or in the aggregate, have a Material Adverse Effect; (b) there is no claim, action or cause of action filed with a court or Governmental Authority and no
        investigation, or other action with respect to which the Company or any Subsidiary has received written notice alleging potential liability for investigatory costs, cleanup costs, governmental response costs, natural resources damages, property
        damages, personal injuries, attorneys' fees or penalties arising out of, based on or resulting from the presence, or release into the environment, of any Material of Environmental Concern at any location owned, leased or operated by the Company or
        any Subsidiary, now or in the past, or from any vessel owned, leased or operated by the Company or any Subsidiary, now or in the past (collectively, &#8220;<u>Environmental Claim</u><font style="font-weight: bold; font-style: italic;">&#8221;</font>), pending
        or, to the knowledge of the Company, threatened against the Company or any Subsidiary or any person or entity whose liability for any Environmental Claim the Company or any Subsidiary has retained or assumed either contractually or by operation of
        law, except as would not, individually or in the aggregate, have a Material Adverse Effect; (c) to the knowledge of the Company, there are no past or present actions, activities, circumstances, conditions, events or incidents, including, without
        limitation, the release, emission, discharge, presence or disposal of any Material of Environmental Concern, that reasonably would be expected to result in a violation of any Environmental Law, require expenditures to be incurred pursuant to
        Environmental Law, or form the basis of an Environmental Claim against the Company, any Subsidiary or against any person or entity whose liability for any Environmental Claim the Company or any Subsidiary has retained or assumed either
        contractually or by operation of law, except as would not, individually or in the aggregate, have a Material Adverse Effect (for the avoidance of doubt, the operation of vessels in the ordinary course of business shall not be deemed, by itself, an
        action, activity, circumstance or condition set forth in this clause (c)); and (d) none of the Company or any Subsidiary is subject to any pending proceeding under Environmental Law to which a Governmental Authority is a party and which the Company
        reasonably believes is likely to result in monetary sanctions of US$100,000 or more. The Company has reasonably concluded that any existing compliance and remediation costs and liabilities arising under Environmental Laws and resulting from the
        business, operations or properties of the Company or any Subsidiary would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, except as set forth in or contemplated in the Registration Statement and the
        Prospectus. In the ordinary course of its business, the Company conducts a periodic review of the effect of Environmental Laws on the business, operations and properties of the Company and the Subsidiaries, in the course of which it identifies and
        evaluates associated costs and liabilities (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any Authorizations, any related constraints on
        operating activities and any potential liabilities to third parties).&#160; No facts or circumstances have come to the Company's attention that could result in costs or liabilities that could be expected, individually or in the aggregate, to have a
        Material Adverse Effect.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">18</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(o)&#160; &#160; &#160; &#160; &#160; <u>Law and Permits</u>.&#160; Except as described in the Registration Statement or the Prospectus, the
        Company and each of the Subsidiaries: (i) is and at all times since January 1, 2019 has been in material compliance with all United States (federal, state and local) and foreign statutes, rules, regulations, codes, treaties, or guidance applicable
        to the Company or the Subsidiaries (&#8220;<u>Applicable Laws</u>&#8221;); (B) since January 1, 2019 has not received any notice of adverse finding, warning letter, untitled letter or other correspondence or notice from any Governmental Authority (as defined
        below) alleging or asserting noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (&#8220;<u>Authorizations</u>&#8221;);
        (C) since January 1, 2019 has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Authority or third party alleging that any product operation or
        activity is in violation of any Applicable Laws or Authorizations and has no knowledge that any such Governmental Authority or third party intends to assert any such claim, litigation, arbitration, action, suit, investigation or proceeding; (D)
        since January 1, 2019 has not received notice that any Governmental Authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and the Company has no knowledge that any such Governmental
        Authority is considering such action; and (E) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws
        or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct in all material respects on the date filed (or were corrected or supplemented
        by a subsequent submission), except in the case of (A) through (E) above, as could not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect. &#8220;<u>Governmental Authority</u>&#8221; means any federal, provincial,
        state, local, foreign or other governmental, quasi-governmental or administrative agency, court or body or any other type of regulatory authority or body, including, without limitation, the Nasdaq Capital Market.&#160; The aggregate of all pending legal
        or governmental proceedings to which the Company or any Subsidiary is a party or of which any of their respective property or assets is the subject which are not described in the Registration Statement and the Prospectus, including ordinary routine
        litigation incidental to the business, would not result in a Material Adverse Effect.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(p)&#160; &#160; &#160; &#160; &#160; <u>Title to Assets</u>.&#160; The Company and the Subsidiaries have good and marketable title in fee simple
        to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens arising
        under any Credit Facility, (ii) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (iii) Liens for the
        payment of foreign, federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties.&#160; Any real property and facilities held under
        lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(q)&#160; &#160; &#160; &#160; &#160; <u>Intellectual Property</u>.&#160; The Company and each of its Subsidiaries owns, possesses, or can acquire
        on reasonable terms, all Intellectual Property (as defined below) necessary for the conduct of their respective businesses as now conducted or as described in the Registration Statement and the Prospectus to be conducted.&#160; Except as would not
        result in a Material Adverse Effect, (A) there are no rights of third parties to any such Intellectual Property owned by the Company, except as otherwise disclosed to the Representative in writing by the Company prior to the date hereof; (B) to the
        knowledge of the Company, there is no infringement, misappropriation or violation&#160; by third parties of any such Intellectual Property; (C) there is no pending or, to the knowledge of the Company, threatened, action, suit, proceeding or claim by
        others challenging the Company&#8217;s or any Subsidiary&#8217;s rights in or to any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim; (D) the Intellectual Property owned by the Company
        and each of the Subsidiaries, and to the knowledge of the Company, the Intellectual Property licensed to the Company, each of the Subsidiaries, has not been adjudged invalid or unenforceable, in whole or in part, and there is no pending or, to the
        knowledge of the Company, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property, and the Company is unaware of any facts which would form a reasonable basis for any such claim;
        (E) there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding or claim by others that the Company or any of its Subsidiaries infringes, misappropriates or otherwise violates any Intellectual Property or other
        proprietary rights of others, and neither the Company nor any of the Subsidiaries has received any written notice of such claim; and (F) to the Company&#8217;s knowledge, no employee of the Company or any of its Subsidiaries is in or has ever been in
        violation of any term of any employment contract, patent disclosure agreement, invention assignment agreement, non-competition agreement, non-solicitation agreement, nondisclosure agreement or any restrictive covenant to or with a former employer
        where the basis of such violation relates to such employee&#8217;s employment with the Company or any of its Subsidiaries or actions undertaken by the employee while employed with the Company or any of its Subsidiaries.&#160; &#8220;<u>Intellectual Property</u>&#8221;
        shall mean all patents, patent applications, trade and service marks, trade and service&#160; mark registrations, trade names, copyrights, licenses, inventions, trade secrets, domain names, technology, know-how and other intellectual property.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">19</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(r)&#160; &#160; &#160; &#160; &#160; <u>Insurance</u>.&#160; The Company and the Subsidiaries are insured by insurers of recognized financial
        responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage.&#160;
        Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue
        its business without a significant increase in cost.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(s)&#160; &#160; &#160; &#160; &#160; <u>Transactions With Affiliates and Employees</u>.&#160; Except as disclosed in the Registration Statement
        and the Prospectus, none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any
        Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
        providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from, any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee
        has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses
        incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(t)&#160; &#160; &#160; &#160; &#160; <u>Sarbanes-Oxley; Internal Accounting Controls</u>.&#160; The Company and the Subsidiaries are in compliance
        with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof
        and as of the Closing Date.&#160; <font style="color: #000000;">The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with
          management&#8217;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in
          accordance with management&#8217;s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The
          Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that
          information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms.&#160; The Company&#8217;s
          certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
          the &#8220;</font><font style="color: #000000;"><u>Evaluation Date</u></font><font style="color: #000000;">&#8221;).&#160; The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the
          effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date.&#160; Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the
          Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.</font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">20</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(u)&#160; &#160; &#160; &#160; &#160; <u>Certain Fees</u>.&#160; Except as set forth in the Registration Statement, the General Disclosure Package
        and Prospectus, no brokerage or finder&#8217;s fees or commissions are or will be payable by the Company, any Subsidiary or Affiliate of the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other
        Person with respect to the transactions contemplated by the Transaction Documents.&#160; There are no other arrangements, agreements or understandings of the Company or, to the Company&#8217;s knowledge, any of its shareholders that may affect the
        Underwriters&#8217; compensation, as determined by FINRA.&#160; Other than payments to the Underwriters for this Offering, the Company has not made and has no agreements, arrangements or understanding to make any direct or indirect payments (in cash,
        securities or otherwise) to: (i)&#160;any person, as a finder&#8217;s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company persons who raised or provided capital to the Company; (ii)&#160;
        any FINRA member; or (iii)&#160;any person or entity that has any direct or indirect affiliation or association with any FINRA member, within the 180-day period preceding the initial filing of the Registration Statement through the 90-day period after
        the Effective Date. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member or its affiliates, except as specifically authorized herein.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(v)&#160; &#160; &#160; &#160; &#160; <u>Investment Company</u>. The Company is not, and is not an Affiliate of, and immediately after receipt
        of payment for the Securities will not be or be an Affiliate of, an &#8220;investment company&#8221; within the meaning of the Investment Company Act of 1940, as amended.&#160; The Company shall conduct its business in a manner so that it will not become an
        &#8220;investment company&#8221; subject to registration under the Investment Company Act of 1940, as amended.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(w)&#160; &#160; &#160; &#160; &#160; <u>Registration Rights</u>.&#160; No Person has any right to cause the Company or any Subsidiary to effect
        the registration under the Securities Act of any securities of the Company or any Subsidiary, other than those rights that have been waived or satisfied.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(x)&#160; &#160; &#160; &#160; &#160; <u>Listing and Maintenance Requirements</u>.&#160; The Common Shares are registered pursuant to Section 12(b)
        or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Shares under the Exchange Act nor has the Company received any
        notification that the Commission is contemplating terminating such registration.&#160; The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Shares are or have been listed or quoted
        to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all
        such listing and maintenance requirements. The Common Shares are currently eligible for electronic transfer through The Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to The
        Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(y)&#160; &#160; &#160; &#160; &#160; <u>Application of Takeover Protections</u>.&#160; The Company and the Board of Directors have taken all
        necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti&#8209;takeover provision under the Company&#8217;s
        certificate of incorporation (or similar charter documents) or the laws of its state or jurisdiction of incorporation that is or could become applicable as a result of the Underwriters and the Company fulfilling their obligations or exercising
        their rights under the Transaction Documents.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">21</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(z)&#160; &#160; &#160; &#160; &#160; <u>Disclosure; 10b-5</u>.</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(i)&#160; &#160; &#160; &#160; &#160; The Registration Statement (and any further documents to be filed with the Commission) contains all
        exhibits and schedules as required by the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, if any, at the time it became effective, complied in all material respects with the Securities Act and the
        Exchange Act and the applicable rules and regulations under the Securities Act and did not and, as amended or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to be
        stated therein or necessary to make the statements therein not misleading. The Preliminary Prospectus and the Prospectus, each as of its respective date, comply in all material respects with the Securities Act and the Exchange Act and the
        applicable rules and regulations. The Prospectus, as amended or supplemented, did not and will not contain as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
        therein, in light of the circumstances under which they were made, not misleading.&#160; As of its date and the date hereof, the General Disclosure Package did not and does not include any untrue statement of a material fact or omitted to state any
        material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160; The representations set forth in this Section 3(z)(i) do not apply to statements or omissions in the
        Registration Statement or the Prospectus based upon information furnished to the Company in writing by the Representative expressly for use therein, <font style="color: #000000;">it being understood and agreed that the only such information
          furnished by the Representative consists of </font><font style="background-color: #FFFFFF; color: #000000;">the name of the Underwriters appearing in the table under the first paragraph, and the concession figures appearing in the fifth
          paragraph, under the caption &#8220;Underwriting&#8221; in the final Prospectus (the &#8220;</font><font style="background-color: #FFFFFF; color: #000000;"><u>Underwriter Information</u></font><font style="background-color: #FFFFFF; color: #000000;">&#8221;)</font></div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(ii)&#160; &#160; &#160; &#160; &#160;&#160; The SEC Reports, when they were filed with the Commission, conformed in all material respects to the
        requirements of the Securities Act and the Exchange Act, as applicable, and the applicable rules and regulations, and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to
        state a material fact necessary to make the statements therein (with respect to the SEC Reports incorporated by reference in the Prospectus), in light of the circumstances under which they were made not misleading; and any further documents so
        filed and incorporated by reference in the Prospectus, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act and the applicable rules and regulations, as applicable, and
        will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances under which they were made not misleading.</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(iii)&#160; &#160; &#160; &#160; &#160;&#160; The press releases disseminated by the Company during the twelve (12) months preceding the date of
        this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which
        they were made and when made, not misleading.</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(iv)&#160; &#160; &#160; &#160; &#160;&#160; No post-effective amendment to the Registration Statement reflecting any facts or events arising after
        the date thereof which represent, individually or in the aggregate, a fundamental change in the information set forth therein is required to be filed with the Commission.&#160; There are no documents required to be filed with the Commission in
        connection with the transaction contemplated hereby that (x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period. There are no contracts or other documents required to be
        described in the Preliminary Prospectus or Prospectus, or to be filed as exhibits or schedules to the Registration Statement, which have not been described or filed as required.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">22</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><a name="z_Toc430524909"></a><a name="z_Toc449254780"></a>(aa)&#160; &#160; &#160; &#160; &#160; <u>No Integrated Offering</u>.&#160; Neither the
        Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering
        of the Securities to be integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(bb)&#160; &#160; &#160; &#160; &#160; <u>Solvency</u>.&#160; Based on the consolidated financial condition of the Company as of the Closing Date,
        after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&#8217;s assets exceeds the amount that will be required to be paid on or in respect of the Company&#8217;s
        existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company&#8217;s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including
        its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof as such matters are described in the Registration
        Statement, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all
        amounts on or in respect of its liabilities when such amounts are required to be paid.&#160; The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable
        on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year
        from the Closing Date.&#160; <u>Schedule 3.1(bb)</u> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. Neither the Company
        nor any Subsidiary is in default with respect to any Indebtedness.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><a name="z_DV_C40"></a>(cc)&#160; &#160; &#160; &#160; &#160; <u>Tax Status</u>.&#160; Except for matters that would not, individually or in the
        aggregate, have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns,
        reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
        declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.&#160; There are no unpaid taxes in any
        material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.&#160; The provisions for taxes payable, if any, shown on the financial statements
        filed with or as part of the Registration Statement are sufficient for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated financial statements.&#160; The term &#8220;taxes&#8221; mean all
        federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation,
        premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest and any penalties, additions to tax, or additional amounts with respect thereto.&#160; The term
        &#8220;returns&#8221; means all returns, declarations, reports, statements, and other documents required to be filed in respect to taxes.&#160; The Company did not qualify as a &#8220;passive foreign investment company&#8221; within the meaning of Section 1297 of the United
        States Internal Revenue Code of 1986, as amended, for its most recently completed taxable year.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(dd)&#160; &#160; &#160; &#160; &#160; <u>Foreign Corrupt Practices</u>.&#160; Neither the Company nor any Subsidiary, nor to the knowledge of the
        Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or
        domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution
        made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of Applicable Law, or (iv) violated in any material respect any provision of FCPA or any foreign equivalent.&#160; The
        Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the FCPA or any foreign equivalent.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">23</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(ee)&#160; &#160; &#160; &#160; &#160; <u>Accountants</u>.&#160; To the knowledge and belief of the Company, the Company Auditor (i) is an
        independent registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company&#8217;s Annual Report for the fiscal year ending December 31, 2020.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(ff)&#160; &#160; &#160; &#160; &#160; <u>Maritime Representations</u>.</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(i)&#160; &#160; &#160; &#160; &#160;&#160; Each of the vessels described in the Registration Statement and the Prospectus as being owned by the Company or any
        Subsidiary as described therein (&#8220;<u>Owned Vessels</u>&#8221;) has been duly and validly registered in the name of a Subsidiary under the laws and regulations and flag of the nation of its registration; no other action is necessary to establish and
        perfect such entity&#8217;s title to and interest in any of the Owned&#160; Vessels as against any third party; and each Owned Vessel is owned directly by the Company or such Subsidiary free and clear of all Liens, except such as are described in the
        Registration Statement and the Prospectus.&#160;&#160;Each such Subsidiary has good title to the applicable Owned Vessel, free and clear of all Liens and all defects of the title of record except for maritime Liens incurred in the ordinary course and those
        Liens arising under Credit Facilities, each as disclosed in the Registration Statement and the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(ii)&#160; &#160; &#160; &#160; &#160; Except as described in the Registration Statement and the Prospectus, neither the Company nor any of its Subsidiaries is a
        party to any memorandum of agreement or option agreement to purchase any vessels.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(iii)&#160; &#160; &#160; &#160; &#160;&#160; Any vessel currently being built for the Company or any Subsidiary (a &#8220;<u>NewBuild Vessel</u><font style="font-style: italic;">&#8221;</font>) is disclosed in the Registration Statement or the Prospectus.&#160;&#160;Each applicable Subsidiary has all rights, title and interest as purchaser of each NewBuild Vessel under a shipbuilding contract for such NewBuild Vessels (each, a
        &#8220;<u>Shipbuilding Contract</u>&#8221;), free of any Liens except for those arising under Credit Facilities or as disclosed in the Registration Statement or the Prospectus and all installments which were due to be paid under each Shipbuilding Contract up
        to and including the date hereof have been duly paid or extended upon the mutual consent of the parties to such Shipbuilding Contract and there are no defaults or breaches by the applicable Subsidiary or, to the Company's knowledge, by the builder
        of the applicable NewBuild Vessel, under any Shipbuilding Contract, in any such case which would permit the builder to terminate such Shipbuilding Contract or entitle the builder to delay delivery of the applicable NewBuild Vessel for more than ten
        (10) days.&#160;&#160;Each Shipbuilding Contract has been duly authorized and has been executed and delivered by the respective parties thereto, and the Company has no reason to believe that such agreements do not constitute valid and binding agreements of
        each such party enforceable in all material respects against each such party in accordance with its terms.</div>
      <div style="background-color: #FFFFFF;">
        <div><br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(iv)&#160; &#160; &#160; &#160; &#160;&#160; Each of the Owned Vessels is in good standing with respect to the payment of past and current taxes, fees and other amounts
        payable under the laws of the jurisdiction in which it is registered, except where such lien or defect of title or record would not result in a Material Adverse Effect.</div>
      <div style="background-color: #FFFFFF;">
        <div><br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(v)&#160; &#160; &#160; &#160; &#160;&#160; Each of the Owned Vessels is operated in compliance with the rules, codes of practice, conventions, protocols, guidelines or
        similar requirements or restrictions imposed, published or promulgated by any Governmental Authority, classification society or insurer applicable to the respective Owned Vessel (collectively, &#8220;<u>Maritime Guidelines</u>&#8221;) and all applicable
        international, national, state and local conventions, laws, regulations, orders, governmental licenses and other requirements (including, without limitation, all Environmental Laws), in each case as in effect on the date hereof, except where such
        failure to be in compliance would not result in a Material Adverse Effect. The Company and each applicable Subsidiary are qualified to own or lease, as the case may be, and operate such Owned Vessels under all applicable international, national,
        state and local conventions, laws, regulations, orders, governmental licenses and other requirements (including, without limitation, all Environmental Laws) and Maritime Guidelines, including the laws, regulations and orders of each such vessel's
        flag state, in each case as in effect on the date hereof, except where such failure to be so qualified would not result in a Material Adverse Effect.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">24</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="background-color: #FFFFFF;">
        <div><br>
        </div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(vi)&#160; &#160; &#160; &#160; &#160;&#160; Each of the Owned Vessels is classed by a classification society which is a full member of the International Association of
        Classification Societies and such Owned Vessels are in class with valid class and trading certificates, without any overdue recommendations, in each case based on the classification and certification requirements in effect on the date hereof.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(gg)&#160; &#160; &#160; &#160; &#160; <u>Stock Option Plans</u>. Each stock option granted by the Company under the Company&#8217;s stock option
        plan was granted (i) in accordance with the terms of the Company&#8217;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Shares on the date such stock option would be considered granted under GAAP
        and Applicable Law. No stock option granted under the Company&#8217;s stock option plan has been backdated.&#160; The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or
        otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(hh)&#160; &#160; &#160; &#160; &#160; <u>Office of Foreign Assets Control</u>.&#160; Neither the Company nor any Subsidiary nor, to the Company's
        knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(ii)&#160; &#160; &#160; &#160; &#160; <u>U.S. Real Property Holding Corporation</u>.&#160; The Company is not and has never been a U.S. real
        property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon the Representative&#8217;s request.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(jj)&#160; &#160; &#160; &#160; &#160;&#160; <u>Bank Holding Company Act</u>. Neither the Company nor any of its Subsidiaries or Affiliates is
        subject to the Bank Holding Company Act of 1956, as amended (the &#8220;<u>BHCA</u>&#8221;) and to regulation by the Board of Governors of the Federal Reserve System (the &#8220;<u>Federal Reserve</u>&#8221;).&#160; Neither the Company nor any of its Subsidiaries or Affiliates
        owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to
        regulation by the Federal Reserve.&#160; Neither the Company nor any of its Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
        Reserve.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(kk)&#160; &#160; &#160; &#160;&#160; <u>Money Laundering</u>.&#160; The operations of the Company and its Subsidiaries are and have been conducted
        at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations
        thereunder (collectively, the &#8220;<u>Money Laundering Laws</u>&#8221;), and no Action or Proceeding by or before any court or Governmental Authority or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is
        pending or, to the knowledge of the Company or any Subsidiary, threatened.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(ll)&#160; &#160; &#160; &#160; &#160; <u>Board of Directors</u>.&#160; The Board of Directors is comprised of the persons set forth under the
        heading of the Prospectus captioned &#8220;Management.&#8221; The qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
        applicable to the Company and the rules of the Trading Market.&#160; In addition, at least a majority of the persons serving on the Board of Directors qualify as &#8220;independent&#8221; as defined under the rules of the Trading Market.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(mm)&#160; &#160;&#160; &#160; <u>D&amp;O Questionnaires</u>.&#160; To the Company&#8217;s knowledge, all information contained in the
        questionnaires most recently completed by each of the Company&#8217;s directors and officers is true and correct in all respects and the Company has not become aware of any information which would cause the information disclosed in such questionnaires
        become inaccurate and incorrect.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">25</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(nn)&#160; &#160; &#160; &#160; &#160; <u>FINRA Affiliation</u>.&#160; To the Company&#8217;s knowledge, no officer, director or any beneficial owner of
        5% or more of the Company&#8217;s Common Shares or Common Share Equivalents has any direct or indirect affiliation or association with any FINRA member (as determined in accordance with the rules and regulations of FINRA) that is participating in the
        Offering. Except for securities purchased on the open market, no Company Affiliate is an owner of stock or other securities of any member of FINRA.&#160; No Company Affiliate has made a subordinated loan to any member of FINRA.&#160; No proceeds from the
        sale of the Securities (excluding underwriting compensation as disclosed in the Registration Statement and the Prospectus) will be paid to any FINRA member, any persons associated with a FINRA member or an affiliate of a FINRA member. Except as
        disclosed in the Prospectus, the Company has not issued any warrants or other securities or granted any options, directly or indirectly, to the Representatives or any of the Underwriters named on <u>Schedule I</u> hereto within the 180-day period
        prior to the initial filing date of the Prospectus.&#160; Except for securities issued to the Representatives as disclosed in the Prospectus and securities sold by the Representatives on behalf of the Company, no person to whom securities of the Company
        have been privately issued within the 180-day period prior to the initial filing date of the Prospectus is a FINRA member, is a person associated with a FINRA member or is an affiliate of a FINRA member.&#160; No FINRA member participating in the
        Offering has a conflict of interest with the Company. For this purpose, a &#8220;conflict of interest&#8221; exists when a FINRA member, the parent or affiliate of a FINRA member or any person associated with a FINRA member in the aggregate beneficially own 5%
        or more of the Company&#8217;s outstanding subordinated debt or common equity, or 5% or more of the Company&#8217;s preferred equity. &#8220;FINRA member participating in the Offering&#8221; includes any associated person of a FINRA member that is participating in the
        Offering, any member of such associated person&#8217;s immediate family and any affiliate of a FINRA member that is participating in the Offering.&#160; &#8220;Any person associated with a FINRA member&#8221; means (1) a natural person who is registered or has applied
        for registration under the rules of FINRA and (2) a sole proprietor, partner, officer, director, or branch manager of a FINRA member, or other natural person occupying a similar status or performing similar functions, or a natural person engaged in
        the investment banking or securities business who is directly or indirectly controlling or controlled by a FINRA member.&#160; When used in this Section 3.1(nn) the term &#8220;affiliate of a FINRA member&#8221; or &#8220;affiliated with a FINRA member&#8221; means an entity
        that controls, is controlled by or is under common control with a FINRA member. The Company will advise the Representative and EGS if it learns that any officer, director or owner of 5% or more of the Company&#8217;s outstanding Common Shares or Common
        Share Equivalents is or becomes an affiliate or associated person of a FINRA member firm.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(oo)&#160; &#160; &#160; &#160; &#160; <u>Consent to Jurisdiction</u>.&#160; The Company has the power to submit, and pursuant to Section 7.7 of
        this Agreement has legally, validly, effectively and irrevocably submitted, to the jurisdiction of any federal or state court in the State of New York, County of New York, and has the power to designate, appoint and empower, and pursuant to Section
        7.7 of this Agreement has legally, validly and effectively designated, appointed and empowered, an agent for service of process in any suit or proceeding based on or arising under this Agreement in any federal or state court in the State of New
        York.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(pp)&#160; &#160; &#160; &#160; &#160; <u>Officers&#8217; Certificate</u>.&#160; Any certificate signed by any duly authorized officer of the Company and
        delivered to the Representative or EGS shall be deemed a representation and warranty by the Company to the Underwriters as to the matters covered thereby.</div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">ARTICLE IV.</div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">OTHER AGREEMENTS OF THE PARTIES</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.1&#160; &#160; &#160; &#160; &#160; </font><u>Amendments to Registration Statement</u>.&#160;&#160; The Company has delivered, or will as
        promptly as practicable deliver, to the Underwriters complete conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof, and conformed copies of the Registration Statement
        (without exhibits), the Prospectus, as amended or supplemented, and the General Disclosure Package in such quantities and at such places as an Underwriter reasonably requests.&#160; Neither the Company nor any of its directors and officers has
        distributed and none of them will distribute, prior to the Closing Date, any offering material in connection with the offering and sale of the Securities other than the Prospectus, the General Disclosure Package and the Registration Statement. The
        Company shall not file any such amendment or supplement to which the Representative shall reasonably object in writing.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">26</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.2&#160; &#160; &#160; &#160; &#160; </font><u>Federal Securities Laws</u>.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; <u>Compliance</u>.&#160; During the time when a Prospectus is required to be delivered under the Securities Act, the Company will
        use its best efforts to comply with all requirements imposed upon it by the Securities Act and the rules and regulations thereunder and the Exchange Act and the rules and regulations thereunder, as from time to time in force, so far as necessary to
        permit the continuance of sales of or dealings in the Securities in accordance with the provisions hereof and the Prospectus. If at any time when a Prospectus relating to the Securities is required to be delivered under the Securities Act, any
        event shall have occurred as a result of which, in the opinion of counsel for the Company or counsel for the Underwriters, the Prospectus, as then amended or supplemented, includes an untrue statement of a material fact or omits to state any
        material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, or if it is necessary at any time to amend the Prospectus to comply with the
        Securities Act, the Company will notify the Underwriters promptly and prepare and file with the Commission, subject to Section 4.1 hereof, an appropriate amendment or supplement in accordance with Section 10 of the Securities Act.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; <u>Exchange Act Registration</u>.&#160; For a period of three years from the Execution Date, the Company will
        use its best efforts to maintain the registration of the Common Shares under the Exchange Act. The Company will not deregister the Common Shares under the Exchange Act without the prior written consent of the Representative.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; <u>Free Writing Prospectuses</u>.&#160; The Company represents and agrees that it has not made and will not make any offer
        relating to the Securities that would constitute an issuer free writing prospectus, as defined in Rule 433 of the rules and regulations under the Securities Act, without the prior written consent of the Representative. Any such free writing
        prospectus consented to by the Representative is herein referred to as a <font style="font-weight: bold;">&#8220;</font><u>Permitted Free Writing Prospectus</u>.&#8221; The Company represents that it will treat each Permitted Free Writing Prospectus as an
        &#8220;issuer free writing prospectus&#8221; as defined in rule and regulations under the Securities Act, and has complied and will comply with the applicable requirements of Rule 433 of the Securities Act, including timely Commission filing where required,
        legending and record keeping.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.3&#160; &#160; &#160; &#160; &#160; </font><u>Delivery to the Underwriters of Prospectuses</u>.&#160; The Company will deliver to the Underwriters, without
        charge, from time to time during the period when the Prospectus is required to be delivered under the Securities Act or the Exchange Act such number of copies of each Prospectus as the Underwriters may reasonably request and, as soon as the
        Registration Statement or any amendment or supplement thereto becomes effective, deliver to you two original executed Registration Statements, including exhibits, and all post-effective amendments thereto and copies of all exhibits filed therewith
        or incorporated therein by reference and all original executed consents of certified experts.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.4&#160; &#160; &#160; &#160; &#160; </font><u>Effectiveness and Events Requiring Notice to the Underwriters</u>.&#160; <font style="background-color: #FFFFFF; color: #000000;">The Company will notify the Underwriters and holders of the Warrants immediately and confirm the notice in writing: (i)&#160;of the effectiveness of the Registration Statement and any amendment thereto; (ii)&#160;of the issuance
          by the Commission of any stop order or of the initiation, or the threatening, of any proceeding for that purpose; (iii)&#160;of the issuance by any state securities commission of any proceedings for the suspension of the qualification of the
          Securities for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv)&#160;of the mailing and delivery to the Commission for filing of any amendment or supplement to the Registration
          Statement or Prospectus; (v)&#160;of the receipt of any comments or request for any additional information from the Commission; and (vi)&#160;of the happening of any event during the period described in this Section 4.4 that, in the judgment of the
          Company, makes any statement of a material fact made in the Registration Statement, the General Disclosure Package or the Prospectus untrue or that requires the making of any changes in the Registration Statement, the General Disclosure Package
          or the Prospectus in order to make the statements therein, in light of the circumstances under which they were made, not misleading. If the Commission or any state securities commission shall enter a stop order or suspend such qualification at
          any time, the Company will make every reasonable effort to obtain promptly the lifting of such order.</font></div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">27</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.5&#160; &#160; &#160; &#160; &#160; </font><u>Review of Financial Statements</u>.&#160; For a period of three (3) years from the Execution Date or until
        such earlier time as no Warrants remain outstanding, the Company, at its expense, shall cause its regularly engaged independent registered public accountants to review (but not audit) the Company&#8217;s financial information for its semi-annual report
        covering the six-month period ended June 30.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.6&#160; &#160; &#160; &#160; &#160; </font><u>Reports to the Underwriters; Expenses of the Offering; Other Compensation of the
          Underwriters</u>.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; <u>Periodic Reports, etc</u>.&#160; For a period of three years from the Execution Date, the Company will
        furnish or make available to the Underwriters copies of such financial statements and other periodic and special reports as the Company from time to time furnishes generally to holders of any class of its securities and also promptly furnish or
        make available to the Underwriters: (i) a copy of each periodic report the Company shall be required to file with the Commission; (ii) a copy of every press release and every news item and article with respect to the Company or its affairs which
        was released by the Company; (iii) a copy of each Form 6-K prepared and filed by the Company; (iv) a copy of each registration statement filed by the Company under the Securities Act; (v) such additional documents and information with respect to
        the Company and the affairs of any future Subsidiaries of the Company as the Representative may from time to time reasonably request; <font style="font-style: italic;">provided</font> that the Underwriters shall each sign, if requested by the
        Company, a Regulation FD compliant confidentiality agreement which is reasonably acceptable to the Representative in connection with such Underwriter&#8217;s receipt of such information. Documents filed with the Commission pursuant to its EDGAR system
        shall be deemed to have been delivered to the Underwriters pursuant to this Section.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; <u>Transfer Agent</u>.&#160; For a period of three (3) years from the Execution Date, the Company shall retain
        the Transfer Agent or a nationally recognized transfer and registrar agent.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; <u>Trading Reports</u>.&#160; During such time as the Closing Shares and Warrant Shares are listed on the
        Trading Market, the Company shall provide to the Underwriters, at the Company&#8217;s expense, such reports published by the Trading Market relating to price and trading of such securities, as the Underwriters shall reasonably request.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(d)&#160; &#160; &#160; &#160; &#160; <u>General Expenses Related to the Offering</u>.&#160; The Company hereby agrees to pay on each of the Closing
        Date and each Option Closing Date, if any, to the extent not paid at the Closing Date, all expenses incident to the performance of the obligations of the Company under this Agreement, including, but not limited to: (a) all filing fees and
        communication expenses relating to the registration of the Securities to be sold in the Offering (including the Option Securities) with the Commission; (b) all FINRA Public Offering Filing System fees associated with the review of the Offering by
        FINRA; (c) all fees and expenses relating to the listing of such Closing Shares, Option Shares and Warrant Shares on the Trading Market and such other stock exchanges as the Company and the Representative together determine; (d) all fees, expenses
        and disbursements relating to background checks of the Company&#8217;s officers and directors; (e) all fees, expenses and disbursements relating to the registration or qualification of such Securities under the &#8220;blue sky&#8221; securities laws of such states
        and other foreign jurisdictions as the Representative may reasonably designate (including, without limitation, all filing and registration fees and the fees and disbursements of the Representative&#8217;s counsel at Closing); (f) all fees and expenses
        associated with the i-Deal system and NetRoadshow; (g) the costs of all mailing and printing of the Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses as the
        Representative may reasonably deem necessary; (h) the costs of preparing, printing and delivering certificates representing the Securities; (i) fees and expenses of the Transfer Agent for the Securities (including, without limitation, any fees
        required for same-day processing of any instruction letter delivered by the Company); (j) stock transfer taxes, if any, payable upon the transfer of Securities from the Company to the Underwriters; (k) the fees and expenses of the Company&#8217;s
        accountants; (l) the fees and expenses of the Company&#8217;s legal counsel and other agents and representatives;&#160; and (m) the legal fees and expenses of the Representative<a name="z_DV_X22"></a><a name="z_DV_C35"></a>&#160;<a name="z_DV_C38"></a> with a
        limitation of $75,000.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">28</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(e)&#160; &#160; &#160; &#160; &#160; <u>Right of First Refusal</u>. Upon the Closing and for a period of six (6) months from the commencement of
        sales of the Offering, the Company hereby grants the Representative the right of first refusal to act as lead left book runner and lead left manager and/or lead left placement agent, with at least 75.0% of the economics for a two-handed transaction
        and 50% of the economics for a three-handed transaction, for any and all future public and private equity, equity-linked, convertible or debt offerings of the Company's securities.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(f)&#160; &#160; &#160; &#160; &#160; <u>Future Offerings</u>.&#160; If within nine (9) months of the Closing, the Company completes any financing of
        equity, equity-linked, convertible or debt or other capital-raising activity of the Company for which the Representative is not acting as underwriter or placement agent (other than the exercise by any person or entity of any options, warrants or
        other convertible securities) with any of the investors that participated in the Offering (excluding any investors that either held securities of the Company prior to the Closing or that were introduced by the Company to the Representative), then
        the Company shall pay to the Representative upon the closing of such financing a cash fee equal to 7.5% of the aggregate amount of such financing and the other compensation set forth herein, in each case only with respect to the portion of such
        financing received from such investors. If within six (6) months of the Closing or the (ii) expiration of the Engagement Period (each, an &#8220;Event&#8221;), the Company completes any financing of equity, equity-linked, convertible or debt or other
        capital-raising activity of the Company for which the Representative is not acting as underwriter or placement agent (other than the exercise by any person or entity of any options, warrants or other convertible securities) with any of the
        investors that participated in in person meetings, conference calls or virtual meetings in relation to the Offering (excluding any investors that either held securities of the Company prior to an Event or that were introduced by the Company to the
        Representative), then the Company shall pay to the Representative upon the closing of such financing a cash fee equal to 7.5% of the aggregate amount of such financing and the other compensation set forth herein, in each case only with respect to
        the portion of such financing received from such investors. The &#8220;Engagement Period&#8221; shall be the period from the date hereof until the later of (a) October 30, 2020 and (b) the 60th day following the effectiveness of the Registration Statement.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;">(g)&#160; &#160; &#160; &#160; &#160; <u>Warrant Solicitation Fee</u>. The Company hereby agrees to pay the Representative a warrant solicitation
        fee of six percent (6%) of the gross proceeds received by the Company for each exercise of a Purchase Warrant sold in the Offering that has been solicited by the Representative at the request of the Company. The warrant solicitation fee will be in
        compliance with FINRA Rule 5110(f)(2)(J) and payable in cash.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.7&#160; &#160; &#160; &#160; &#160; </font><u>Application of Net Proceeds</u>.&#160; The Company will apply the net proceeds from the Offering received by
        it in a manner consistent with the application described under the caption &#8220;Use Of Proceeds&#8221; in the Prospectus.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.8&#160; &#160; &#160; &#160; &#160; </font><u>Delivery of Earnings Statements to Security Holders</u>.&#160; The Company will make generally available to
        its security holders as soon as practicable, but not later than the first day of the sixteenth full calendar month following the Execution Date, an earnings statement (which need not be certified by independent public or independent certified
        public accountants unless required by the Securities Act or the rules and regulations under the Securities Act, but which shall satisfy the provisions of Rule 158(a) under Section 11(a) of the Securities Act) covering a period of at least twelve
        consecutive months beginning after the Execution Date.&#160; The Form 20-F filed with the Commission pursuant to its EDGAR system shall fulfill the requirements of this Section 4.8.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.9&#160; &#160; &#160; &#160; &#160; </font><u>Stabilization</u>.&#160; Neither the Company, nor, to its knowledge, any of its employees, directors or
        shareholders (without the consent of the Representative) has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably be expected to cause or result in, under the Exchange Act, or
        otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">29</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.10&#160; &#160; &#160; &#160; &#160; </font><u>Internal Controls</u>.&#160; The Company will maintain a system of internal accounting controls sufficient
        to provide reasonable assurances that: (i)&#160;transactions are executed in accordance with management&#8217;s general or specific authorization; (ii)&#160;transactions are recorded as necessary in order to permit preparation of financial statements in accordance
        with GAAP and to maintain accountability for assets; (iii)&#160;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv)&#160;the recorded accountability for assets is compared with existing assets at
        reasonable intervals and appropriate action is taken with respect to any differences.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.11&#160; &#160; &#160; &#160; &#160; </font><u>Accountants</u>.&#160; For a period of three (3) years from the Effective Date, the Company shall continue
        to retain the Auditor or another nationally recognize independent registered public accounting firm with experience in the maritime industry.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.12&#160; &#160; &#160; &#160; &#160; </font><u>FINRA</u>.&#160; The Company shall advise the Underwriters (who shall make an appropriate filing with FINRA)
        if it is aware that any officer, director, 5% or greater shareholder of the Company or Person that received the Company&#8217;s unregistered equity securities in the past 180 days is or becomes an affiliate or associated person of a FINRA member firm
        prior to the earlier of the termination of this Agreement or the conclusion of the distribution of the Offering.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.13&#160; &#160; &#160; &#160; &#160; </font><u>No Fiduciary Duties</u>.&#160; The Company acknowledges and agrees that the Underwriters&#8217; responsibility to
        the Company is solely contractual and commercial in nature, based on arms-length negotiations and that neither the Underwriters nor their affiliates or any selected dealer shall be deemed to be acting in a fiduciary capacity, or otherwise owes any
        fiduciary duty to the Company or any of its affiliates in connection with the Offering and the other transactions contemplated by this Agreement.&#160; N<font style="color: #000000;">otwithstanding anything in this Agreement to the contrary, the Company
          acknowledges that the Underwriters may have financial interests in the success of the Offering that are not limited to the difference between the price to the public and the purchase price paid to the Company by the Underwriters for the shares
          and the Underwriters have no obligation to disclose, or account to the Company for, any of such additional financial interests.&#160; The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have
          against the Underwriters with respect to any breach or alleged breach of fiduciary duty.</font></div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.14&#160; &#160; &#160; &#160; &#160; </font><u>Warrant Shares</u>.&#160; If all or any portion of a Warrant is exercised at a time
        when there is an effective registration statement to cover the issuance of the Warrant Shares or if the Warrant is exercised via cashless exercise at a time when such Warrant Shares would be eligible for resale under Rule 144 by a non-affiliate of
        the Company, the Warrant Shares issued pursuant to any such exercise shall be issued free of all restrictive legends.&#160; If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the
        sale or resale of the Warrant Shares) is not effective or is not otherwise available for the sale of the Warrant Shares, the Company shall immediately notify the holders of the Warrants in writing that such registration statement is not then
        effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale of the Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the
        Company to issue, or any holder thereof to sell, any of the Warrant Shares in compliance with applicable federal and state securities laws).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.15&#160; &#160; &#160; &#160; &#160; </font><u>Board Composition and Board Designations</u>.&#160; The Company shall ensure that:
        (i)&#160;the qualifications of the persons serving as board members and the overall composition of the Board of Directors comply with the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder and with the listing requirements of the Trading
        Market and (ii) if applicable, at least one member of the Board of Directors qualifies as a &#8220;financial expert&#8221; as such term is defined under the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">30</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.16&#160; &#160; &#160; &#160; &#160; </font><u>Securities Laws Disclosure; Publicity</u>.&#160; At the request of the Representative,
        by 9:00 a.m. (New York City time) on the date hereof, the Company shall issue a press release disclosing the material terms of the Offering.&#160; The Company and the Representative shall consult with each other in issuing any other press releases with
        respect to the Offering, and neither the Company nor any Underwriter shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of such Underwriter, or
        without the prior consent of such Underwriter, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall
        promptly provide the other party with prior notice of such public statement or communication.&#160; The Company will not issue press releases or engage in any other publicity, without the Representative&#8217;s prior written consent, for a period ending at
        5:00 p.m. (New York City time) on the first business day following the 10th day following the Closing Date, other than normal and customary releases issued in the ordinary course of the Company&#8217;s business.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.17&#160; &#160; &#160; &#160; &#160; </font><u>Shareholder Rights Plan</u>.&#160; No claim will be made or enforced by the Company or,
        with the consent of the Company, any other Person, that any Underwriter of the Securities is an &#8220;Acquiring Person&#8221; under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or
        similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Underwriter of Securities could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><a name="z_Toc430524929"></a><a name="z_Toc449254796"></a><font style="color: #000000;">4.18&#160; &#160; &#160; &#160; &#160; </font><u>Reservation of Common
          Shares</u>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of Common Shares for the purpose of enabling the Company to
        issue Option Shares pursuant to the Over-Allotment Option and Warrant Shares pursuant to any exercise of the Warrants.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.19&#160; &#160; &#160; &#160; &#160; </font><u>L</u><a name="z_Toc430524930"></a><a name="z_Toc449254797"></a><u>isting of Common
          Shares</u>. The Common Shares have been approved for trading on the Trading Market. The Company agrees to use its commercial best efforts to effect and maintain the trading of the Common Shares on the Trading Market for at least three (3) years
        after the Closing Date.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.20&#160; &#160; &#160; &#160; &#160; </font><u>Subsequent Equity Sales</u>.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; From the date hereof until sixty (60) days after the Closing Date, neither the Company nor any Subsidiary
        shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Shares or Common Share Equivalents without the prior written consent of the Representative.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; From the date hereof until sixty (60) days after the Closing Date, the Company shall be prohibited from
        effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Shares or Common Share Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &#8220;<u>Variable Rate
          Transaction</u>&#8221; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional Common Shares either (A) at a
        conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the Common Shares at any time after the initial issuance of such debt or equity securities or (B) with
        a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the
        business of the Company or the market for the Common Shares or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined
        price.&#160; Any Underwriter shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; Notwithstanding the foregoing, this Section 4.20 shall not apply in respect of an Exempt Issuance, except
        that no Variable Rate Transaction shall be an Exempt Issuance.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">31</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman', serif;">4.21&#160; &#160; &#160; &#160; &#160; <u>Capital Changes</u>.&#160; Until sixty (60) days after the Closing Date, the Company shall not undertake a
        reverse or forward stock split or reclassification of the Common Shares without the prior written consent of the Representative, which consent shall not be unreasonably withheld.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">4.22&#160; &#160; &#160; &#160; &#160; </font><u>Research Independence</u>.<font style="color: #000000;"> The Company acknowledges
          that each Underwriter&#8217;s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such
          Underwriter&#8217;s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers.&#160; The Company hereby
          waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent
          research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter&#8217;s investment banking divisions.&#160; The Company acknowledges that the Representative is a full
          service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.</font></div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">ARTICLE V.</div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">DEFAULT BY UNDERWRITERS</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">If on the Closing Date or any Option Closing Date, if any, any Underwriter shall fail to purchase and pay for the portion of the Closing
        Securities or Option Securities, as the case may be, which such Underwriter has agreed to purchase and pay for on such date (otherwise than by reason of any default on the part of the Company), the Representative, or if the Representative is the
        defaulting Underwriter, the non-defaulting Underwriters, shall use their reasonable efforts to procure within 36 hours thereafter one or more of the other Underwriters, or any others, to purchase from the Company such amounts as may be agreed upon
        and upon the terms set forth herein, the Closing Securities or Option Securities, as the case may be, which the defaulting Underwriter or Underwriters failed to purchase.&#160; If during such 36 hours the Representative shall not have procured such
        other Underwriters, or any others, to purchase the Closing Securities or Option Securities, as the case may be, agreed to be purchased by the defaulting Underwriter or Underwriters, then&#160; (a) if the aggregate number of&#160; Closing Securities or Option
        Securities, as the case may be, with respect to which such default shall occur does not exceed 10% of the Closing Securities or Option Securities, as the case may be, covered hereby, the other Underwriters shall be obligated, severally, in
        proportion to the respective numbers of Closing Securities or Option Securities, as the case may be, which they are obligated to purchase hereunder, to purchase the Closing Securities or Option Securities, as the case may be, which such defaulting
        Underwriter or Underwriters failed to purchase, or (b) if the aggregate number of Closing Securities or Option Securities, as the case may be, with respect to which such default shall occur exceeds 10% of the Closing Securities or Option
        Securities, as the case may be, covered hereby, the Company or the Representative will have the right to terminate this Agreement without liability on the part of the non-defaulting Underwriters or of the Company except to the extent provided in
        Article VI hereof.&#160; In the event of a default by any Underwriter or Underwriters, as set forth in this Article V, the applicable Closing Date may be postponed for such period, not exceeding seven (7) days, as the Representative, or if the
        Representative is the defaulting Underwriter, the non-defaulting Underwriters, may determine in order that the required changes in the Prospectus or in any other documents or arrangements may be effected.&#160; The term &#8220;Underwriter&#8221; includes any person
        substituted for a defaulting Underwriter.&#160; Any action taken under this Section shall not relieve any defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">32</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">ARTICLE VI.</div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">INDEMNIFICATION</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">6.1&#160; &#160; &#160; &#160; &#160; </font><u>Indemnification of the Underwriters</u>.&#160; Subject to the conditions set forth below, the Company agrees
        to indemnify and hold harmless the Underwriters, and each dealer selected by each Underwriter that participates in the offer and sale of the Securities (each a &#8220;<u>Selected Dealer</u>&#8221;) and each of their respective directors, officers and employees
        and each Person, if any, who controls such Underwriter or any Selected Dealer (&#8220;<u>Controlling Person</u>&#8221;) within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, against any and all loss, liability, claim, damage
        and expense whatsoever (including but not limited to any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, commenced or threatened, or any claim whatsoever, whether arising out of
        any action between such Underwriter and the Company or between such Underwriter and any third party or otherwise) to which they or any of them may become subject under the Securities Act, the Exchange Act or any other statute or at common law or
        otherwise or under the laws of foreign countries, arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (i) any Preliminary Prospectus, if any, the Registration Statement or the Prospectus (as
        from time to time each may be amended and supplemented); (ii) any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities, including any &#8220;road show&#8221;
        or investor presentations made to investors by the Company (whether in person or electronically); or (iii) any application or other document or written communication (in this Article VI, collectively called &#8220;<u>application</u>&#8221;) executed by the
        Company or based upon written information furnished by the Company in any jurisdiction in order to qualify the Securities under the securities laws thereof or filed with the Commission, any state securities commission or agency, Trading Market or
        any securities exchange; or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, unless
        such statement or omission was made in reliance upon and in conformity with written information furnished to the Company by the Representative expressly for use in any Preliminary Prospectus, the Registration Statement or Prospectus, or any
        amendment or supplement thereto, or in any application, as the case may be, it being agreed that such written information consists solely of the Underwriter Information.&#160; With respect to any untrue statement or omission or alleged untrue statement
        or omission made in the Preliminary Prospectus, if any, the indemnity agreement contained in this Section 6.1 shall not inure to the benefit of&#160; an Underwriter to the extent that any loss, liability, claim, damage or expense of such Underwriter
        results from the fact that a copy of the Prospectus was not given or sent to the Person asserting any such loss, liability, claim or damage at or prior to the written confirmation of sale of the Securities to such Person as required by the
        Securities Act and the rules and regulations thereunder, and if the untrue statement or omission has been corrected in the Prospectus, unless such failure to deliver the Prospectus was a result of non-compliance by the Company with its obligations
        under this Agreement. The Company agrees promptly to notify each Underwriter of the commencement of any litigation or proceedings against the Company or any of its officers, directors or Controlling Persons in connection with the issue and sale of
        the Public Securities or in connection with the Registration Statement or Prospectus.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">6.2&#160; &#160; &#160; &#160; &#160; </font><u>Procedure</u>.&#160; If any action is brought against an Underwriter, a Selected Dealer or
        a Controlling Person in respect of which indemnity may be sought against the Company pursuant to Section 6.1, such Underwriter, such Selected Dealer or Controlling Person, as the case may be, shall promptly notify the Company in writing of the
        institution of such action and the Company shall assume the defense of such action, including the employment and fees of counsel (subject to the reasonable approval of such Underwriter or such Selected Dealer, as the case may be) and payment of
        actual expenses. Such Underwriter, such Selected Dealer or Controlling Person shall have the right to employ its or their own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of such Underwriter, such
        Selected Dealer or Controlling Person unless (i) the employment of such counsel at the expense of the Company shall have been authorized in writing by the Company in connection with the defense of such action, or (ii) the Company shall not have
        employed counsel to have charge of the defense of such action, or (iii) such indemnified party or parties shall have reasonably concluded that there may be defenses available to it or them which are different from or additional to those available
        to the Company (in which case the Company shall not have the right to direct the defense of such action on behalf of the indemnified party or parties), in any of which events the reasonable fees and expenses of not more than one additional firm of
        attorneys selected by such Underwriter (in addition to local counsel), Selected Dealer and/or Controlling Person shall be borne by the Company. Notwithstanding anything to the contrary contained herein, if any Underwriter, Selected Dealer or
        Controlling Person shall assume the defense of such action as provided above, the Company shall have the right to approve the terms of any settlement of such action which approval shall not be unreasonably withheld.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">33</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">6.3&#160; &#160; &#160; &#160; &#160; </font><u>Indemnification of the Company</u>.&#160; Each Underwriter severally and not jointly agrees
        to indemnify and hold harmless the Company, its directors, officers and employees and agents who control the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act against any and all loss, liability,
        claim, damage and expense described in the foregoing indemnity from the Company to such Underwriter, as incurred, but only with respect to untrue statements or omissions, or alleged untrue statements or omissions made in any Preliminary Prospectus,
        if any, the Registration Statement or Prospectus or any amendment or supplement thereto or in any application, in reliance upon, and in strict conformity with, written information furnished to the Company by the Representative expressly for use in
        such Preliminary Prospectus, the Registration Statement or Prospectus or any amendment or supplement thereto or in any such application, it being agreed that such written information consists solely of the Underwriter Information.&#160; In case any
        action shall be brought against the Company or any other Person so indemnified based on any Preliminary Prospectus, if any, the Registration Statement or Prospectus or any amendment or supplement thereto or any application, and in respect of which
        indemnity may be sought against such Underwriter, such Underwriter shall have the rights and duties given to the Company, and the Company and each other Person so indemnified shall have the rights and duties given to such Underwriter by the
        provisions of this Article VI.<font style="color: #000000;"> Notwithstanding the provisions of this Section 6.3, no Underwriter shall be required to indemnify the Company for any amount in excess of the underwriting discounts and commissions
          applicable to the Securities purchased by such Underwriter.&#160; The Underwriters' obligations in this Section 6.3 to indemnify the Company are several in proportion to their respective underwriting obligations and not joint.</font></div>
      <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">6.4&#160; &#160; &#160; &#160; &#160; </font><u>Contribution Rights</u>.&#160; In order to provide for just and equitable contribution
        under the Securities Act in any case in which (i) any Person entitled to indemnification under this Article VI makes a claim for indemnification pursuant hereto but it is judicially determined (by the entry of a final judgment or decree by a court
        of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this Article VI provides for indemnification in such
        case, or (ii) contribution under the Securities Act, the Exchange Act or otherwise may be required on the part of any such Person in circumstances for which indemnification is provided under this Article VI, then, and in each such case, the Company
        and each Underwriter, severally and not jointly, shall contribute to the aggregate losses, liabilities, claims, damages and expenses of the nature contemplated by said indemnity agreement incurred by the Company and such Underwriter, as incurred,
        in such proportions that such Underwriter is responsible for that portion represented by the percentage that the underwriting discount appearing on the cover page of the Prospectus bears to the initial offering price appearing thereon and the
        Company is responsible for the balance; provided, that, no Person guilty of a fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such
        fraudulent misrepresentation. For purposes of this Section, each director, officer and employee of such Underwriter or the Company, as applicable, and each Person, if any, who controls such Underwriter or the Company, as applicable, within the
        meaning of Section 15 of the Securities Act shall have the same rights to contribution as such Underwriter or the Company, as applicable.&#160; <font style="color: #000000;">Notwithstanding the provisions of this Section 6.4, no Underwriter shall be
          required to contribute any amount in excess of the underwriting discounts and commissions applicable to the Securities purchased by such Underwriter.&#160; The Underwriters' obligations in this Section 6.4 to contribute are several in proportion to
          their respective underwriting obligations and not joint.</font></div>
      <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">6.5&#160; &#160; &#160; &#160; &#160; </font><u>Contribution Procedure</u>.&#160; Within fifteen days after receipt by any party to this
        Agreement (or its representative) of notice of the commencement of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against another party (&#8220;<u>contributing party</u>&#8221;), notify the
        contributing party of the commencement thereof, but the failure to so notify the contributing party will not relieve it from any liability which it may have to any other party other than for contribution hereunder. In case any such action, suit or
        proceeding is brought against any party, and such party notifies a contributing party or its representative of the commencement thereof within the aforesaid fifteen days, the contributing party will be entitled to participate therein with the
        notifying party and any other contributing party similarly notified. Any such contributing party shall not be liable to any party seeking contribution on account of any settlement of any claim, action or proceeding affected by such party seeking
        contribution without the written consent of such contributing party. The contribution provisions contained in this Section 6.5 are intended to supersede, to the extent permitted by law, any right to contribution under the Securities Act, the
        Exchange Act or otherwise available.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">34</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">ARTICLE VII.</div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">MISCELLANEOUS</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.1&#160; &#160; &#160; &#160; &#160; </font><u>Termination</u>.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(a)&#160; &#160; &#160; &#160; &#160; <u>Termination Right</u>.&#160; The Representative shall have the right to terminate this Agreement at any
        time prior to any Closing Date, (i)&#160;if any domestic or international event or act or occurrence has materially disrupted, or in its opinion will in the immediate future materially disrupt, general securities markets in the United States; or (ii)&#160;if
        trading on any Trading Market shall have been suspended or materially limited, or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been required by FINRA or by order of the
        Commission or any other Government Authority having jurisdiction, or (iii)&#160;if the United States shall have become involved in a new war or an increase in major hostilities, or (iv)&#160;if a banking moratorium has been declared by a New York State or
        federal authority, or (v)&#160;if a moratorium on foreign exchange trading has been declared which materially adversely impacts the United States securities markets, or (vi)&#160;if the Company shall have sustained a material loss by fire, flood, accident,
        hurricane, earthquake, theft, sabotage or other calamity or malicious act which, whether or not such loss shall have been insured, will, in the Representative&#8217;s opinion, make it inadvisable to proceed with the delivery of the Securities, or
        (vii)&#160;if the Company is in material breach of any of its representations, warranties or covenants hereunder, or (viii)&#160;if the Representative shall have become aware after the date hereof of such a material adverse change in the conditions or
        prospects of the Company, or such adverse material change in general market conditions as in the Representative&#8217;s judgment would make it impracticable to proceed with the offering, sale and/or delivery of the Securities or to enforce contracts made
        by the Underwriters for the sale of the Securities.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(b)&#160; &#160; &#160; &#160; &#160; <u>Expenses</u>.&#160; In the event this Agreement shall be terminated pursuant to Section 7.1(a), within the
        time specified herein or any extensions thereof pursuant to the terms herein, the Company shall be obligated to pay to the Representative its actual and accountable out of pocket expenses related to the transactions contemplated herein then due and
        payable up to $15,000 (<font style="font-size: 11pt;"><u>provided</u></font><font style="font-size: 11pt;">, </font><font style="font-size: 11pt;"><u>however</u></font><font style="font-size: 11pt;">, that such expense cap in no way limits or
          impairs the indemnification and contribution provisions of this Agreement</font>).</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">(c)&#160; &#160; &#160; &#160; &#160; <u>Indemnification</u>.&#160; Notwithstanding any contrary provision contained in this Agreement, any
        election hereunder or any termination of this Agreement, and whether or not this Agreement is otherwise carried out, the provisions of Article VI shall not be in any way effected by such election or termination or failure to carry out the terms of
        this Agreement or any part hereof.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.2&#160; &#160; &#160; &#160; &#160; </font><u>Entire Agreement</u>.&#160; The Transaction Documents, together with the exhibits and
        schedules thereto, any Preliminary Prospectus and the Prospectus, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with
        respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.&#160; This Agreement supersedes that certain Engagement Agreement, dated May 19, 2020, by and between the Company and the
        Representative.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.3&#160; &#160; &#160; &#160; &#160; </font><u>Notices</u>.&#160; Any and all notices or other communications or deliveries required or
        permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail attachment
        at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via
        facsimile at the facsimile number or e-mail attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice
        is required to be given.&#160; The address for such notices and communications shall be as set forth on the signature pages attached hereto.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">35</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.4&#160; &#160; &#160; &#160; &#160; </font><u>Amendments; Waivers</u>.&#160; No provision of this Agreement may be waived, modified,
        supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Representative.&#160;&#160; No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
        to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the
        exercise of any such right.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.5&#160; &#160; &#160; &#160; &#160; </font><u>Headings</u>.&#160; The headings herein are for convenience only, do not constitute a
        part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.6&#160; &#160; &#160; &#160; &#160; </font><u>Successors and Assigns</u>.&#160; This Agreement shall be binding upon and inure to the
        benefit of the parties and their successors and permitted assigns.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.7&#160; &#160; &#160; &#160; &#160; </font><u>Governing Law; Agent for Service of Process</u>.&#160; This Agreement will be governed
        by, and construed in accordance with, the laws of the State of New York applicable to agreements made and to be performed entirely in such State, without regard to the conflicts of laws principles thereof. This Agreement may not be assigned by
        either party without the prior written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. Any right to trial by jury with respect
        to any dispute arising under this Agreement or any transaction or conduct in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New York or into the Federal Court located in New
        York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably waives
        personal service of process and consents to process being served in any such suit, action or proceeding by delivering a copy thereof via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under
        this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. The
        Company agrees that a final judgment in any such action, proceeding or counterclaim brought in any such court shall be conclusive and binding upon the Company and may be enforced in any other courts to the jurisdiction of which the Company is or
        may be subject, by suit upon such judgment.&#160; If either party shall commence an action or proceeding to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed by the other party
        for its attorney's fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding<font style="color: #000000;">.</font>&#160; In addition to and without limiting the foregoing, the Company has
        confirms that it has appointed Company Counsel, as its authorized agent (the &#8220;<u>Authorized Agent</u>&#8221;) upon whom process may be served in any suit, action or proceeding arising out of or based upon the this Agreement or the Transaction Documents
        or the transactions contemplated herein which may be instituted in any New York federal or state court, by the Representative, the directors, officers, partners, employees and agents of the Representative and each affiliate of the Representative,
        and expressly accept the non-exclusive jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as
        said agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby
        authorizes and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Company. If the Authorized Agent shall cease to act as agent
        for service of process, the Company shall appoint, without unreasonable delay, another such agent in the United States, and notify you of such appointment. Notwithstanding the foregoing, any action arising out of or based upon this Agreement may be
        instituted by the Representative, the directors, officers, partners, employees and agents of the Representative and each respective affiliate of the Representative, in any court of competent jurisdiction in the Republic of the Marshall Islands.&#160;
        This paragraph shall survive any termination of this Agreement, in whole or in part.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.8&#160; &#160; &#160; &#160; &#160; </font><u>Survival</u>.&#160; The representations and warranties contained herein shall survive
        the Closing and the Option Closing, if any, and the delivery of the Securities.</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">36</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.9&#160; &#160; &#160; &#160; &#160; </font><u>Execution</u>.&#160; This Agreement may be executed in two or more counterparts, all of
        which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same
        counterpart.&#160; In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &#8220;.pdf&#8221; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such
        signature is executed) with the same force and effect as if such facsimile or &#8220;.pdf&#8221; signature page were an original thereof.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.10&#160; &#160; &#160; &#160; &#160; </font><u>Severability</u>. If any term, provision, covenant or restriction of this
        Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be
        affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
        covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
        invalid, illegal, void or unenforceable.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.11&#160; &#160; &#160; &#160; &#160; </font><u>Remedies</u>.&#160; In addition to being entitled to exercise all rights provided
        herein or granted by law, including recovery of damages, the Underwriters and the Company will be entitled to specific performance under the Transaction Documents.&#160; The parties agree that monetary damages may not be adequate compensation for any
        loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be
        adequate.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.12&#160; &#160; &#160; &#160; &#160; </font><u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking
        of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.13&#160; &#160; &#160; &#160; &#160; </font><u>Construction</u>. The parties agree that each of them and/or their respective
        counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the
        interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and Common Shares in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock
        dividends, stock combinations and other similar transactions of the Common Shares that occur after the date of this Agreement.</div>
      <div style="text-align: justify; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="color: #000000;">7.14&#160; &#160; &#160; &#160; &#160; </font><font style="font-weight: bold;"><u>WAIVER OF JURY TRIAL</u></font><font style="font-weight: bold;">.&#160; IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES EACH KNOWINGLY AND
          INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVE FOREVER ANY RIGHT TO TRIAL BY JURY.</font></div>
      <div><br>
      </div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">[Signature Page Follows]</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">37</font></div>
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">If the foregoing correctly sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that
        purpose, whereupon this letter shall constitute a binding agreement among the Company and the several Underwriters in accordance with its terms.</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7eefb34c7d8048b2b5da7a8606094aa4">

          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 51.75%; vertical-align: top;" colspan="3">
              <div style="font-family: 'Times New Roman', serif;">Very truly yours,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 51.75%; vertical-align: top;" colspan="3">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 51.75%; vertical-align: top;" colspan="3">
              <div style="font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 51.75%; vertical-align: top;" colspan="3">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 7.96%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">By:</div>
            </td>
            <td style="width: 27.45%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="font-family: 'Times New Roman', serif;">/s/ Petros Panagiotidis</div>
            </td>
            <td style="width: 16.34%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 7.96%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Name:</div>
            </td>
            <td style="width: 27.45%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Petros Panagiotidis</div>
            </td>
            <td style="width: 16.34%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 7.96%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Title:</div>
            </td>
            <td style="width: 27.45%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Chairman, Chief Executive Officer and Chief Financial Officer</div>
            </td>
            <td style="width: 16.34%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 48.25%; vertical-align: top;">&#160;</td>
            <td style="width: 7.96%; vertical-align: top;">&#160;</td>
            <td style="width: 27.45%; vertical-align: top;">&#160;</td>
            <td style="width: 16.34%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif;">Address for Notice:</div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif;"><font style="color: #000000;">223 Christodoulou Chatzipavlou Street, Hawaii Royal Gardens, 3036 Limassol, Cyprus,</font> Attention: Petros Panagiotidis, Facsimile: + 357 25 357 767; email:
        petrospan@castormaritime.com</div>
      <div style="font-family: 'Times New Roman', serif;">Copy (which shall not constitute notice) to:</div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif;">Seward &amp; Kissel LLP, One Battery Park Plaza, New York, New York 10004, <font style="color: #000000;">Attention: Gary J. Wolfe, Esq., Facsimile: (212) 480-8421, Email: wolfe@sewkis.com</font></div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif;">Accepted on the date first above written.</div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif; font-weight: bold;">MAXIM GROUP LLC</div>
      <div style="font-family: 'Times New Roman', serif; font-style: italic;">As the Representative of the several</div>
      <div style="font-family: 'Times New Roman', serif; font-style: italic;">Underwriters listed on Schedule I</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8d5978725fd74187b074e9f157a39484">

          <tr>
            <td style="width: 13.83%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">By:</div>
            </td>
            <td style="width: 27.72%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="font-family: 'Times New Roman', serif;">/s/ Clifford A. Teller</div>
            </td>
            <td style="width: 58.46%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.83%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Name:</div>
            </td>
            <td style="width: 27.72%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Clifford A. Teller</div>
            </td>
            <td style="width: 58.46%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.83%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Title:</div>
            </td>
            <td style="width: 27.72%; vertical-align: top;">
              <div style="font-family: 'Times New Roman', serif;">Executive Managing Director, Investment Banking</div>
            </td>
            <td style="width: 58.46%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 13.83%; vertical-align: top;">&#160;</td>
            <td style="width: 27.72%; vertical-align: top;">&#160;</td>
            <td style="width: 58.46%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Address for Notice:</div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif;">405 Lexington Avenue, New York, NY 10174, Attention: Clifford A. Teller, Facsimile: (212) 895-3783, email: cteller@maximgrp.com</div>
      <div><br>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman', serif;">Copy (which shall not constitute notice) to:</div>
      <div><br>
      </div>
      <div style="font-family: 'Times New Roman', serif;">Ellenoff Grossman &amp; Schole LLP, 1345 Avenue of the Americas, New York, NY 10105, Attention: Barry I. Grossman, Esq., Facsimile: (212) 370-7889, email: bigrossman@egsllp.com</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">SCHEDULE I</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif; font-variant: small-caps; font-weight: bold;">Schedule of Underwriters</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="2" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z27e67a87c517464e9a7cecb635cd8b05">

          <tr>
            <td style="width: 29.8%; vertical-align: bottom; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; font-weight: bold; margin-left: 18pt;">Underwriter</div>
            </td>
            <td style="width: 23.4%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">Number&#160;of<br>
                Units including Common Shares<br>
                to&#160;be&#160;Purchased</div>
            </td>
            <td style="width: 23.4%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">Number&#160;of<br>
                Units Including Pre-Funded<br>
                Warrants<br>
                to&#160;be<br>
                Purchased</div>
            </td>
            <td style="width: 23.4%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; font-weight: bold; margin-left: 18pt;">Closing<font style="font-family: 'Times New Roman', serif;"><br>
                </font>Purchase Price</div>
            </td>
          </tr>
          <tr>
            <td style="width: 29.8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; margin-left: 18pt;">Maxim Group LLC</div>
            </td>
            <td style="width: 23.4%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif;">36,700,000</div>
            </td>
            <td style="width: 23.4%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif;">14,700,000</div>
            </td>
            <td style="width: 23.4%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; margin-left: 18pt;">$</div>
            </td>
          </tr>
          <tr>
            <td style="width: 29.8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; margin-left: 18pt;">Total</div>
            </td>
            <td style="width: 23.4%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif;">36,700,000</div>
            </td>
            <td style="width: 23.4%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman', serif;">14,700,000</div>
            </td>
            <td style="width: 23.4%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman',serif; margin-left: 18pt;">$</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;"><u>EXHIBIT A</u></div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">FORM OF LOCK-UP AGREEMENT</div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif;">[attached hereto]</div>
      <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; text-indent: 36pt; margin-top: 12pt; color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">LOCK-UP AGREEMENT</div>
      <div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">June 23, 2020</div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">Maxim Group LLC</div>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">405 Lexington Avenue</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">New York, NY 10174</div>
      </div>
      <div>
        <div><br>
        </div>
        <div style="color: #000000; font-family: 'Times New Roman', serif; font-weight: bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Re: Public Offering of Castor Maritime Inc.</div>
        <div><br>
        </div>
        <div style="color: #000000; font-family: 'Times New Roman', serif;">Ladies and Gentlemen:</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned, a holder of common shares, par value $0.001 per share (the &#8220;<font style="font-weight: bold;">Shares</font>&#8221;), or rights to acquire
          Shares, of Castor Maritime Inc., a company incorporated under the laws of the Republic of the Marshall Islands (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), understands that you are the representative (the &#8220;<font style="font-weight: bold;">Representative</font>&#8221;) of the several underwriters (collectively, the &#8220;<font style="font-weight: bold;">Underwriters</font>&#8221;) named or to be named in the final form of <font style="font-weight: bold;">Schedule A</font> to the
          underwriting agreement (the &#8220;<font style="font-weight: bold;">Underwriting Agreement</font>&#8221;) to be entered into among the Underwriters and the Company, providing for the public offering (the &#8220;<font style="font-weight: bold;">Public Offering</font>&#8221;)


          of units of the Company, each consisting of one Share or one pre-funded warrant to purchase one Share and one Class A warrant to purchase one Share (the &#8220;<font style="font-weight: bold;">Securities</font>&#8221;) pursuant to a Registration Statement on
          Form F-1 (File No. 333-238990) previously filed with U.S. Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;).&#160; Capitalized terms used herein and not otherwise defined shall have the meanings set forth for them
          in the Underwriting Agreement.</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In consideration of the Underwriters&#8217; agreement to enter into the Underwriting Agreement and to proceed with the Public Offering
          of the Securities, and for other good and valuable consideration, receipt of which is hereby acknowledged, the undersigned hereby agrees, for the benefit of the Company, the Representative and the other Underwriters that, without the prior
          written consent of the Representative, the undersigned will not, during the period specified in the following paragraph (the &#8220;<font style="font-weight: bold;">Lock-Up Period</font>&#8221;), directly or indirectly, unless otherwise provided herein, (a)
          <a name="OLE_LINK1"></a>o<a name="OLE_LINK2"></a>ffer, sell, agree to offer or sell, solicit offers to purchase, convert, exercise, exchange, grant any call option or purchase any put option with respect to, pledge, encumber, assign, borrow or
          otherwise dispose of or transfer (each a &#8220;<font style="font-weight: bold;">Transfer</font>&#8221;) any Relevant Security (as defined below) or otherwise publicly disclose the intention to do so, or (b) establish or increase any &#8220;put equivalent
          position&#8221; or liquidate or decrease any &#8220;call equivalent position&#8221; (in each case within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221;) and the rules and
          regulations thereunder) with respect to any Relevant Security, as defined below, or otherwise enter into any swap, derivative or other transaction or arrangement that Transfers to another, in whole or in part, any economic consequence of
          ownership of a Relevant Security, whether or not such transaction is to be settled by the delivery of Relevant Securities, other securities, cash or other consideration<a name="z_DV_M9"></a>, or otherwise publicly disclose the intention to do
          so.&#160; As used herein, the term &#8220;<font style="font-weight: bold;">Relevant Security</font>&#8221; means any Shares, warrant to purchase Shares or any other security of the Company or any other entity that is convertible into, or exercisable or
          exchangeable for, Shares or any other equity security of the Company<a name="z_DV_M10"></a>, in each case owned beneficially or otherwise by the undersigned on the date set forth on the front cover of the final prospectus used in connection with
          the Public Offering of the Securities (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;) or acquired by the undersigned during the Lock-Up Period.</div>
        <div style="text-align: justify; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Lock-Up Period will commence on the date of this Lock-up Agreement and continue and include the date that is 60 days after
          the closing of the Public Offering.</div>
      </div>
      <div>
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In addition, the undersigned further agrees that, without the prior written consent of the Representative, during the Lock-Up Period the undersigned
          will not: (i) file or participate in the filing with the SEC of any registration statement or circulate or participate in the circulation of any preliminary or final prospectus or other disclosure document, in each case with respect to any
          proposed offering or sale of a Relevant Security, or (ii) exercise any rights the undersigned may have to require registration with the SEC of any proposed offering or sale of a Relevant Security.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In furtherance of the undersigned&#8217;s obligations hereunder, the undersigned <a name="z_DV_M28"></a>hereby authorizes the Company during the Lock-Up
          Period to cause any transfer agent for the Relevant Securities to decline to transfer, and to note stop transfer restrictions on the stock register and other records relating to Relevant Securities for which the undersigned is the record owner
          and the transfer of which would be a violation of this Lock-Up Agreement and, in the case of Relevant Securities for which the undersigned is the beneficial but not the record owner, agrees that during the Lock-Up Period it will cause the record
          owner to cause the relevant transfer agent to decline to transfer, and to note stop transfer restrictions on the stock register and other records relating to such Relevant Securities<a name="z_DV_M29"></a> to the extent such transfer would be a
          violation of this Lock-Up Agreement.</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; margin-bottom: 6pt; color: #000000; font-family: 'Times New Roman', serif;">Notwithstanding the foregoing, the undersigned may transfer the undersigned&#8217;s Relevant Securities:</div>
        <div><br>
        </div>
        <div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z5c922760737f43129fc9d4bf92084595" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(i)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">as a <font style="font-style: italic;">bona fide</font> gift or gifts,</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zd02fca26732540a899fc8ecb0a9c47c0" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(ii)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">to any trust for the direct or indirect benefit of the undersigned or a member or members of the immediate family of the undersigned,</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1f3804439d984ddcb4d048297ff16170" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(iii)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">if the undersigned is a corporation, partnership, limited liability company, trust or other business entity (1) to another corporation, partnership, limited liability
                        company, trust or other business entity that is a direct or indirect affiliate (as defined in Rule 405 under the Securities Act of 1933, as amended) of the undersigned, (2) to limited partners, limited liability company members or
                        stockholders of the undersigned, or (3) in connection with a sale, merger or transfer of all or substantially all of the assets of the undersigned or any other change of control of the undersigned, not undertaken for the purpose of
                        avoiding the restrictions imposed by this Lock-Up Agreement,</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z63521cd401484aff971d0a9f69f79b0a" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(iv)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">if the undersigned is a trust, to the beneficiary of such trust,</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z476218cc4b9e4117ac2dd5449b083f38" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(v)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">by testate or intestate succession,</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zddfaaccc26a14b0e82b26a4d02823e07" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(vi)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement,</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z03f652356bfc44a2a1b05869b21ad00e" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(vii)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">to cover the payment of the exercise prices or the payment of taxes associated with the exercise or vesting of equity awards that were issued under any equity
                        compensation plan of the Company, or</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="text-align: justify; margin-bottom: 12pt;">
            <div>
              <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z68802d1e6b3c4bcabfdc23931cc8fca1" class="DSPFListTable">

                  <tr>
                    <td style="width: 36pt;"><br>
                    </td>
                    <td style="width: 36pt; vertical-align: top; align: right; color: #000000; font-family: 'Times New Roman', serif;">(viii)</td>
                    <td style="width: auto; vertical-align: top; text-align: justify;">
                      <div style="color: #000000; font-family: 'Times New Roman', serif;">pursuant to the Underwriting Agreement;</div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
        </div>
      </div>
      <div>
        <div style="text-align: justify; margin-bottom: 6pt; color: #000000; font-family: 'Times New Roman', serif;"><font style="font-style: italic;">provided,</font> in the case of clauses (i)-(vi), that (A) such transfer shall not involve a disposition
          for value, (B) the transferee agrees in writing with the Underwriters and the Company to be bound by the terms of this Lock-Up Agreement, and (C) such transfer would not require any filing under Section 16(a) of the Exchange Act and no such
          filing is voluntarily made; and <font style="font-style: italic;">provided, further</font>, in the case of clause (vii), that the equity awards being exercised or that have vested were outstanding prior to the date of the Underwriting Agreement
          and that such equity awards have not been amended since the date of the Underwriting Agreement.</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', serif;">For purposes of this Lock-Up Agreement, &#8220;immediate family&#8221; shall mean any relationship by blood, marriage or adoption, not more remote than
          first cousin.</div>
      </div>
      <div>
        <div><br>
        </div>
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby represents and warrants that the undersigned has full power and authority to enter into this Lock-Up Agreement and that this
          Lock-Up Agreement has been duly authorized (if the undersigned is not a natural person) and constitutes the legal, valid and binding obligation of the undersigned, enforceable in accordance with its terms. Upon request, the undersigned will
          execute any additional documents necessary in connection with the enforcement hereof. Any obligations of the undersigned shall be binding upon the successors and assigns of the undersigned from the date of this Lock-Up Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned understands that, if the Underwriting Agreement does not become effective, or if the Underwriting Agreement (other than the
          provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery of the Securities to be sold thereunder, the undersigned shall be released from all obligations under this Lock-Up Agreement.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman', serif;">The undersigned, whether or not participating in the Public Offering, understands that the Underwriters are entering into the Underwriting
          Agreement and proceeding with the Public Offering in reliance upon this Lock-Up Agreement.</div>
        <div><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Lock-Up Agreement shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of
          laws principles thereof.&#160; Delivery of a signed copy of this Lock-Up Agreement by facsimile or e-mail/.pdf transmission shall be effective as the delivery of the original hereof.</div>
      </div>
      <div>
        <div><br>
        </div>
      </div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zf3fa2271cdd34587819b0b24c20fe583">

          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="2">
              <div style="color: #000000; font-family: 'Times New Roman', serif;">Very truly yours,</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="2">
              <div style="color: #000000; font-family: 'Times New Roman', serif;">Name (printed):</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 50%; vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 19.74%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', serif;">Title (if applicable):</div>
            </td>
            <td style="width: 30.26%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 19.74%; vertical-align: top;">&#160;</td>
            <td style="width: 30.26%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 19.74%; vertical-align: top;">&#160;</td>
            <td style="width: 30.26%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 19.74%; vertical-align: top;">
              <div style="color: #000000; font-family: 'Times New Roman', serif;">Entity (if applicable):</div>
            </td>
            <td style="width: 30.26%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 19.74%; vertical-align: top;">&#160;</td>
            <td style="width: 30.26%; vertical-align: top;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top;">&#160;</td>
            <td style="width: 19.74%; vertical-align: top;">&#160;</td>
            <td style="width: 30.26%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
      <div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;"><u>EXHIBIT B-1</u></div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">FORM OF CLASS A WARRANT</div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif;">[attached hereto]</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
        <div style="page-break-after: always;" id="DSPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;"><u>EXHIBIT B-2</u></div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">FORM OF PRE-FUNDED WARRANT</div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;[attached hereto]</div>
      <div style="background-color: #FFFFFF;">
        <div><br>
        </div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div style="background-color: #FFFFFF;">
        <div><br>
        </div>
      </div>
      <div style="margin-top: 12pt;"><br>
      </div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <div id="DSPFPageBreakArea">
      <hr style="page-break-after: always; color: #FFFFFF;" id="DSPFPageBreak"></div>
    <div>
      <div><br>
      </div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 4.1</font><br>
      </div>
      <div> <br>
      </div>
      <div> <br>
      </div>
      <div>
        <div>
          <div>
            <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">CASTOR MARITIME INC.</div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">and</div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">AMERICAN STOCK TRANSFER &amp; TRUST COMPANY, as</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">Warrant Agent</div>
        <div><br>
        </div>
        <div>
          <div><br>
          </div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">Warrant Agency Agreement</div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">Dated as of June 26, 2020</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;"><u>WARRANT AGENCY AGREEMENT</u></div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">WARRANT AGENCY AGREEMENT, dated as of June 26, 2020 (&#8220;<u>Agreement</u>&#8221;), between Castor Maritime Inc., a corporation organized under the laws of the
          Republic of the Marshall Islands (the &#8220;<u>Company</u>&#8221;), and American Stock Transfer &amp; Trust Company. (the &#8220;<u>Warrant Agent</u>&#8221;).</div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">W I T N E S S E T H</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">WHEREAS, pursuant to a registered offering by the Company of 51,400,000 Units (the &#8220;<u>Offering</u>&#8221;), with each Unit consisting of one Common Share of the
          Company, par value $0.001 per share (the &#8220;<u>Common Share</u>&#8221;) (or one pre-funded warrant to purchase one Common Shares at an exercise price of $0.01 per share (the &#8220;<u>Pre-Funded Warrants</u>&#8221;) for any purchaser who, as a result of purchasing
          securities in the Offering, would, together with its affiliates and other related parties, beneficially own more than 4.99% of the Company&#8217;s outstanding Common Shares immediately following the consummation of the Offering) and one Class A warrant
          (collectively, the &#8220;<u>Warrants</u>&#8221;) to purchase one Common Share (the &#8220;<u>Warrant Shares</u>&#8221;) at a price of $ 0.35 per share (or 100 % of the price of each Unit sold in the Offering); and</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">WHEREAS, the Company granted an over-allotment option to purchase up to fifteen percent (15%) of&#160; the aggregate number of Shares and/or Prefunded Warrants
          and/or Warrants sold, including warrants to purchase an additional 7,710,000 Common Shares (the &#8220;<u>Over-Allotment Option</u>&#8221;) to the Underwriters; and</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">WHEREAS, upon the terms and subject to the conditions hereinafter set forth and pursuant to an effective registration statement on Form F-1, as amended
          (File No. 333-238990) (the &#8220;<u>Registration Statement</u>&#8221;), and the terms and conditions of the Warrant Certificate, the Company wishes to issue the Warrants in book entry form entitling the respective holders of the Warrants (the &#8220;<u>Holders</u>,&#8221;


          which term shall include a Holder&#8217;s transferees, successors and assigns and &#8220;Holder&#8221; shall include, if the Warrants are held in &#8220;street name,&#8221; a Participant (as defined below) or a designee appointed by such Participant); and</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">WHEREAS, the Common Shares (or Pre-Funded Warrants) and Warrants to be issued in connection with the Offering shall be immediately separable and will be
          issued separately, but will be purchased together in the Offering; and</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">WHEREAS, the Company wishes the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing so to act, in connection with the issuance,
          registration, transfer, exchange, exercise and replacement of the Warrants and, in the Warrant Agent&#8217;s capacity as the Company&#8217;s transfer agent, the delivery of the Warrant Shares (as defined below).</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the parties hereby agree as follows:</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 1. <u>Certain Definitions</u>. For purposes of this Agreement, all capitalized terms not herein defined shall have the meanings hereby indicated:</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(a) &#8220;<u>Affiliate</u>&#8221; has the meaning ascribed to it in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;<u>Exchange Act</u>&#8221;).</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(b) &#8220;<u>Business Day</u>&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which
          the Nasdaq Stock Market is authorized or required by law or other governmental action to close.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(c) &#8220;<u>Close of Business</u>&#8221; on any given date means 5:00 p.m., New York City time, on such date; <u>provided</u>, <u>however</u>, that if such date is
          not a Business Day it means 5:00 p.m., New York City time, on the next succeeding Business Day.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">47</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(d) &#8220;<u>Person</u>&#8221; means an individual, corporation, association, partnership, limited liability company, joint venture, trust, unincorporated
          organization, government or political subdivision thereof or governmental agency or other entity.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(e) &#8220;<u>Warrant Certificate</u>&#8221; means a certificate in substantially the form attached as <u>Exhibit 1</u> hereto, representing such number of Warrant
          Shares as is indicated therein, provided that any reference to the delivery of a Warrant Certificate in this Agreement shall include delivery of a Definitive Certificate or a Global Warrant (each as defined below).</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">All other capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms in the Warrant Certificate.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 2. <u>Appointment of Warrant Agent</u>. The Company hereby appoints the Warrant Agent to act as agent for the Company in accordance with the terms
          and conditions hereof, and the Warrant Agent hereby accepts such appointment.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 3. <u>Global Warrants</u>.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(a) The Warrants shall be registered securities and shall be evidenced by a global warrant (the &#8220;<u>Global Warrants</u>&#8221;), in the form of the Warrant
          Certificate, which shall be deposited with the Warrant Agent and registered in the name of Cede &amp; Co., a nominee of The Depository Trust Company (the &#8220;<u>DTC</u>&#8221;), or as otherwise directed by the DTC. Ownership of beneficial interests in the
          Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) the DTC or its nominee for each Global Warrant or (ii) institutions that have accounts with the DTC (such institution, with
          respect to a Warrant in its account, a &#8220;<u>Participant</u>&#8221;).</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;(b) If the DTC subsequently ceases to make its book-entry settlement system available for the Warrants, the Company may instruct the Warrant Agent
          regarding other arrangements for book-entry settlement. In the event that the Warrants are not eligible for, or it is no longer necessary to have the Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to
          the DTC to deliver to the Warrant Agent for cancellation of each Global Warrant, and the Company shall instruct the Warrant Agent to deliver to each Holder a Warrant Certificate.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(c)&#160; A Holder has the right to elect at any time or from time to time a Warrant Exchange (as defined below) pursuant to a Warrant Certificate Request Notice
          (as defined below). Upon written notice by a Holder to the Company and the Warrant Agent for the exchange of some or all of such Holder&#8217;s Global Warrants for a separate certificate in the form attached hereto as <u>Exhibit 1</u> (such separate
          certificate, a &#8220;<u>Definitive Certificate</u>&#8221;) evidencing the same number of Warrants, which request shall be in the form attached hereto as <u>Exhibit 2</u> (a &#8220;<u>Warrant Certificate Request Notice</u>&#8221; and the date of delivery of such
          Warrant Certificate Request Notice by the Holder, the &#8220;<u>Warrant Certificate Request Notice Date</u>&#8221; and the surrender by the Holder to the Warrant Agent of a number of Global Warrants for the same number of Warrants evidenced by a Warrant
          Certificate, a &#8220;<u>Warrant Exchange</u>&#8221;), the Company and the Warrant Agent shall promptly effect the Warrant Exchange and the Company shall promptly issue and deliver to the Holder a Definitive Certificate for such number of Warrants in the
          name set forth in the Warrant Certificate Request Notice.&#160; Such Definitive Certificate shall be dated the original issue date of the Warrants, shall be manually executed by an authorized signatory of the Company, shall be in the form attached
          hereto as <u>Exhibit 1</u> and shall be reasonably acceptable in all respects to such Holder.&#160; In connection with a Warrant Exchange, the Company agrees to deliver the Definitive Certificate to the Holder within ten (10) Business Days of the
          Warrant Certificate Request Notice pursuant to the delivery instructions in the Warrant Certificate Request Notice (&#8220;<u>Warrant Certificate Delivery Date</u>&#8221;).&#160; If the Company fails for any reason to deliver to the Holder the Definitive
          Certificate subject to the Warrant Certificate Request Notice by the Warrant Certificate Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares evidenced by such
          Definitive Certificate (based on the VWAP (as defined in the Warrants) of the Common Shares on the Warrant Certificate Request Notice Date), $10 per Business Day for each Business Day after such Warrant Certificate Delivery Date until such
          Definitive Certificate is delivered or, prior to delivery of such Warrant Certificate, the Holder rescinds such Warrant Exchange.&#160; The Company covenants and agrees that, upon the date of delivery of the Warrant Certificate Request Notice, the
          Holder shall be deemed to be the holder of the Definitive Certificate and, notwithstanding anything to the contrary set forth herein, the Definitive Certificate shall be deemed for all purposes to contain all of the terms and conditions of the
          Warrants evidenced by such Warrant Certificate and the terms of this Agreement, other than Sections 3(c), 3(d) and 9 herein, shall not apply to the Warrants evidenced by the Definitive Certificate.&#160; Notwithstanding anything herein to the
          contrary, the Company shall act as warrant agent with respect to any Definitive Certificate requested and issued pursuant to this section.&#160; Notwithstanding anything to the contrary contained in this Agreement, in the event of inconsistency
          between any provision in this Agreement and any provision in a Definitive Certificate, as it may from time to time be amended, the terms of such Definitive Certificate shall control.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">48</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(d) A Holder of a Definitive Certificate (pursuant to a Warrant Exchange or otherwise) has the right to elect at any time or from time to time a Global
          Warrants Exchange (as defined below) pursuant to a Global Warrants Request Notice (as defined below). Upon written notice by a Holder to the Company for the exchange of some or all of such Holder&#8217;s Warrants evidenced by a Definitive Certificate
          for a beneficial interest in Global Warrants held in book-entry form through the DTC evidencing the same number of Warrants, which request shall be in the form attached hereto as <u>Exhibit 3</u> (a &#8220;<u>Global Warrants Request Notice</u>&#8221; and
          the date of delivery of such Global Warrants Request Notice by the Holder, the &#8220;<u>Global Warrants Request Notice Date</u>&#8221; and the surrender upon delivery by the Holder of the Warrants evidenced by Definitive Certificates for the same number of
          Warrants evidenced by a beneficial interest in Global Warrants held in book-entry form through the DTC, a &#8220;<u>Global Warrants Exchange</u>&#8221;), the Company shall promptly effect the Global Warrants Exchange and shall promptly direct the Warrant
          Agent to issue and deliver to the Holder Global Warrants for such number of Warrants in the Global Warrants Request Notice, which beneficial interest in such Global Warrants shall be delivered by the DTC&#8217;s Deposit or Withdrawal at Custodian
          system to the Holder pursuant to the instructions in the Global Warrants Request Notice.&#160; In connection with a Global Warrants Exchange, the Company shall direct the Warrant Agent to deliver the beneficial interest in such Global Warrants to the
          Holder within ten (10) Business Days of the Global Warrants Request Notice pursuant to the delivery instructions in the Global Warrant Request Notice (&#8220;<u>Global Warrants Delivery Date</u>&#8221;). If the Company fails for any reason to deliver to the
          Holder Global Warrants subject to the Global Warrants Request Notice by the Global Warrants Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares evidenced by
          such Global Warrants (based on the VWAP (as defined in the Warrants) of the Common Stock on the Global Warrants Request Notice Date), $10 per Business Day for each Business Day after such Global Warrants Delivery Date until such Global Warrants
          are delivered or, prior to delivery of such Global Warrants, the Holder rescinds such Global Warrants Exchange. The Company covenants and agrees that, upon the date of delivery of the Global Warrants Request Notice, the Holder shall be deemed to
          be the beneficial holder of such Global Warrants.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 4. <u>Form of Warrant Certificates</u>. The Warrant Certificate, together with the form of election to purchase Common Shares (&#8220;<u>Notice of
            Exercise</u>&#8221;) and the form of assignment to be printed on the reverse thereof, shall be substantially in the form of <u>Exhibit 1</u> hereto.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 5. <u>Countersignature and Registration</u>. The Global Warrant shall be executed on behalf of the Company by its Chief Executive Officer, Chief
          Financial Officer or Vice President, by facsimile signature, and have affixed thereto the Company&#8217;s seal or a facsimile thereof which shall be attested by the Secretary or an Assistant Secretary of the Company, by facsimile signature. The Global
          Warrant shall be countersigned by the Warrant Agent by facsimile signature and shall not be valid for any purpose unless so countersigned. In case any officer of the Company who shall have signed any of the Global Warrant shall cease to be such
          officer of the Company before countersignature by the Warrant Agent and issuance and delivery by the Company, such Global Warrant, nevertheless, may be countersigned by the Warrant Agent, issued and delivered with the same force and effect as
          though the person who signed such Global Warrant had not ceased to be such officer of the Company; and any Global Warrant may be signed on behalf of the Company by any person who, at the actual date of the execution of such Global Warrant, shall
          be a proper officer of the Company to sign such Global Warrant, although at the date of the execution of this Warrant Agreement any such person was not such an officer.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">The Warrant Agent will keep or cause to be kept, at one of its offices, or at the office of one of its agents, books for registration and transfer of the
          Global Warrants issued hereunder. Such books shall show the names and addresses of the respective Holders of the Global Warrant, the number of warrants evidenced on the face of each of such Global Warrant and the date of each of such Global
          Warrant.&#160; The Warrant Agent will create a special account for the issuance of Global Warrants.&#160; The Company will keep or cause to be kept at one of its offices, books for the registration and transfer of any Definitive Certificates issued
          hereunder and the Warrant Agent shall not have any obligation to keep books and records with respect to any Definitive Warrants.&#160; Such Company books shall show the names and addresses of the respective Holders of the Definitive Certificates, the
          number of warrants evidenced on the face of each such Definitive Certificate and the date of each such Definitive Certificate.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">49</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 6. <u>Transfer, Split Up, Combination and Exchange of Warrant Certificates; Mutilated, Destroyed, Lost or Stolen Warrant Certificates</u>. With
          respect to the Global Warrant, subject to the provisions of the Warrant Certificate and the last sentence of this first paragraph of Section 6 and subject to applicable law, rules or regulations, or any &#8220;stop transfer&#8221; instructions the Company
          may give to the Warrant Agent, at any time after the closing date of the Offering, and at or prior to the Close of Business on the Termination Date (as such term is defined in the Warrant Certificate), any Global Warrant or Global Warrants may be
          transferred, split up, combined or exchanged for another Global Warrant or Global Warrants, entitling the Holder to purchase a like number of Common Shares as the Global Warrant or Global Warrants surrendered then entitled such Holder to
          purchase. Any Holder desiring to transfer, split up, combine or exchange any Global Warrant shall make such request in writing delivered to the Warrant Agent, and shall surrender the Global Warrant to be transferred, split up, combined or
          exchanged at the principal office of the Warrant Agent. Any requested transfer of Warrants, whether in book-entry form or certificate form, shall be accompanied by reasonable evidence of authority of the party making such request that may be
          required by the Warrant Agent. Thereupon the Warrant Agent shall, subject to the last sentence of this first paragraph of Section 6, countersign and deliver to the Person entitled thereto a Global Warrant or Global Warrants, as the case may be,
          as so requested. The Company may require payment from the Holder of a sum sufficient to cover any tax or governmental charge that may be imposed in connection with any transfer, split up, combination or exchange of Global Warrants. The Company
          shall compensate the Warrant Agent per the fee schedule mutually agreed upon by the parties hereto and provided separately on the date hereof.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Upon receipt by the Warrant Agent of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of a Warrant Certificate, which
          evidence shall include an affidavit of loss, or in the case of mutilated certificates, the certificate or portion thereof remaining, and, in case of loss, theft or destruction, of indemnity in customary form and amount (but, with respect to any
          Definitive Certificates, shall not include the posting of any bond by the Holder), and satisfaction of any other reasonable requirements established by Section 8-405 of the Uniform Commercial Code as in effect in the State of Delaware, and
          reimbursement to the Company and the Warrant Agent of all reasonable expenses incidental thereto, and upon surrender to the Warrant Agent and cancellation of the Warrant Certificate if mutilated, the Company will make and deliver a new Warrant
          Certificate of like tenor to the Warrant Agent for delivery to the Holder in lieu of the Warrant Certificate so lost, stolen, destroyed or mutilated.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 14.4pt; font-family: 'Times New Roman', serif;">Section 7. <u>Exercise of Warrants; Exercise Price; Termination Date</u>.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(a) The Warrants shall be exercisable commencing on the Initial Exercise Date. The Warrants shall cease to be exercisable and shall terminate and become
          void as set forth in the Warrant Certificate.&#160; Subject to the foregoing and to Section 7(b) below, the Holder of a Warrant may exercise the Warrant in whole or in part upon surrender of the Warrant Certificate, if required, with the executed
          Notice of Exercise and payment of the Exercise Price, which may be made, at the option of the Holder, by wire transfer or by certified or official bank check in United States dollars, to the Warrant Agent at the principal office of the Warrant
          Agent or to the office of one of its agents as may be designated by the Warrant Agent from time to time. In the case of the Holder of a Global Warrant, the Holder shall deliver the executed Notice of Exercise and the payment of the Exercise Price
          as described herein. Notwithstanding any other provision in this Agreement, a holder whose interest in a Global Warrant is a beneficial interest in a Global Warrant held in book-entry form through the DTC (or another established clearing
          corporation performing similar functions), shall effect exercises by delivering to the DTC (or such other clearing corporation, as applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that
          are required by the DTC (or such other clearing corporation, as applicable). The Company acknowledges that the bank accounts maintained by the Warrant Agent in connection with the services provided under this Agreement will be in its name and
          that the Warrant Agent may receive investment earnings in connection with the investment at Warrant Agent&#8217;s risk and for its benefit of funds held in those accounts from time to time.&#160; Neither the Company nor the Holders will receive interest on
          any deposits or Exercise Price.&#160; No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. The Company hereby acknowledges and
          agrees that, with respect to a holder whose interest in a Global Warrant is a beneficial interest in a Global Warrant held in book-entry form through the DTC (or another established clearing corporation performing similar functions), upon
          delivery of irrevocable instructions to such holder&#8217;s Participant to exercise such warrants, that solely for purposes of Regulation SHO that such holder shall be deemed to have exercised such warrants.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">50</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(b) Upon receipt of a Notice of Exercise for a Cashless Exercise, the Company will promptly calculate and transmit to the Warrant Agent the number of
          Warrant Shares issuable in connection with such Cashless Exercise and deliver a copy of the Notice of Exercise to the Warrant Agent, which shall issue such number of Warrant Shares in connection with such Cashless Exercise.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(c) Upon the exercise of the Warrant Certificate pursuant to the terms of Section 2 of the Warrant Certificate, the Warrant Agent shall cause the Warrant
          Shares underlying such Warrant Certificate or Global Warrant to be delivered to or upon the order of the Holder of such Warrant Certificate or Global Warrant, registered in such name or names as may be designated by such Holder, no later than the
          Warrant Share Delivery Date (as such term is defined in the Warrant Certificate). If the Company is then a participant in the DWAC system of the DTC and either (A) there is an effective registration statement permitting the issuance of the
          Warrant Shares to or resale of the Warrant Shares by Holder or (B) the Warrant is being exercised via Cashless Exercise, then the certificates for Warrant Shares shall be transmitted by the Warrant Agent to the Holder by crediting the account of
          the Holder&#8217;s broker with the DTC through its DWAC system. For the avoidance of doubt, if the Company becomes obligated to pay any amounts to any Holders pursuant to Section 2(d)(i) or 2(d)(iv) of the Warrant Certificate, such obligation shall be
          solely that of the Company and not that of the Warrant Agent. Notwithstanding anything else to the contrary in this Agreement, except in the case of a Cashless Exercise, if any Holder fails to duly deliver payment to the Warrant Agent of an
          amount equal to the aggregate Exercise Price of the Warrant Shares to be purchased upon exercise of such Holder&#8217;s Warrant as set forth in Section 7(a) hereof by the Warrant Share Delivery Date, the Warrant Agent will not obligated to deliver such
          Warrant Shares (via DWAC or otherwise) until following receipt of such payment, and the applicable Warrant Share Delivery Date shall be deemed extended by one day for each day (or part thereof) until such payment is delivered to the Warrant
          Agent.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(d) The Warrant Agent shall deposit all funds received by it in payment of the Exercise Price for all Warrants in the account of the Company maintained with
          the Warrant Agent for such purpose (or to such other account as directed by the Company in writing) and shall advise the Company via email at the end of each day on which notices of exercise are received or funds for the exercise of any Warrant
          are received of the amount so deposited to its account.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 8. <u>Cancellation and Destruction of Warrant Certificates</u>. All Warrant Certificates surrendered for the purpose of exercise, transfer, split
          up, combination or exchange shall, if surrendered to the Company or to any of its agents, be delivered to the Warrant Agent for cancellation or in canceled form, or, if surrendered to the Warrant Agent, shall be canceled by it, and no Warrant
          Certificate shall be issued in lieu thereof except as expressly permitted by any of the provisions of this Agreement. The Company shall deliver to the Warrant Agent for cancellation and retirement, and the Warrant Agent shall so cancel and
          retire, any other Warrant Certificate purchased or acquired by the Company otherwise than upon the exercise thereof. The Warrant Agent shall deliver all canceled Warrant Certificates to the Company, or shall, at the written request of the
          Company, destroy such canceled Warrant Certificates, and in such case shall deliver a certificate of destruction thereof to the Company, subject to any applicable law, rule or regulation requiring the Warrant Agent to retain such canceled
          certificates.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 9. <u>Certain Representations; Reservation and Availability of Common Shares or Cash</u>.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(a) This Agreement has been duly authorized, executed and delivered by the Company and, assuming due authorization, execution and delivery hereof by the
          Warrant Agent, constitutes a valid and legally binding obligation of the Company enforceable against the Company in accordance with its terms, and the Warrants have been duly authorized, executed and issued by the Company and, assuming due
          authentication thereof by the Warrant Agent pursuant hereto and payment therefor by the Holders as provided in the Registration Statement, constitute valid and legally binding obligations of the Company enforceable against the Company in
          accordance with their terms and entitled to the benefits hereof; in each case except as enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar laws relating to or affecting creditors&#8217; rights
          generally or by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">51</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(b) As of the date hereof, the authorized capital stock of the Company consists of (i) 1,950,000,000 Common Shares, of which approximately 11,360,190 Common
          Shares are issued and outstanding, and 60,000,000 Common Shares are reserved for issuance upon exercise of the Warrants, and (ii) 50,000,000 preferred shares, par value $0.001 per share, of which 480,000 Series A Preferred Shares and 12,000
          Series B Preferred Shares are currently issued and outstanding. Except as disclosed in the Registration Statement, there are no other outstanding obligations, warrants, options or other rights to subscribe for or purchase from the Company any
          class of capital stock of the Company.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(c) The Company covenants and agrees that it will cause to be reserved and kept available out of its authorized and unissued Common Shares or its authorized
          and issued Common Shares held in its treasury, free from preemptive rights, the number of Common Shares that will be sufficient to permit the exercise in full of all outstanding Warrants.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(d) The Warrant Agent will create a special account for the issuance of Common Shares upon the exercise of Warrants.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(e) The Company further covenants and agrees that it will pay when due and payable any and all federal and state transfer taxes and charges which may be
          payable in respect of the original issuance or delivery of the Warrant Certificates or certificates evidencing Common Shares upon exercise of the Warrants. The Company shall not, however, be required to pay any tax or governmental charge which
          may be payable in respect of any transfer involved in the transfer or delivery of Warrant Certificates or the issuance or delivery of certificates for Common Shares in a name other than that of the Holder of the Warrant Certificate evidencing
          Warrants surrendered for exercise or to issue or deliver any certificate for Common Shares upon the exercise of any Warrants until any such tax or governmental charge shall have been paid (any such tax or governmental charge being payable by the
          Holder of such Warrant Certificate at the time of surrender) or until it has been established to the Company&#8217;s reasonable satisfaction that no such tax or governmental charge is due.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 10. <u>Common Share Record Date</u>. Each Person in whose name any certificate for Common Shares is issued (or to whose broker&#8217;s account is
          credited Common Shares through the DWAC system) upon the exercise of Warrants shall for all purposes be deemed to have become the holder of record for the Common Shares represented thereby on, and such certificate shall be dated, the date on
          which submission of the Notice of Exercise was made, provided that the Warrant Certificate evidencing such Warrant is duly surrendered (but only if required herein) and payment of the Exercise Price (and any applicable transfer taxes) is received
          on or prior to the Warrant Share Delivery Date; <u>provided</u>, <u>however</u>, that if the date of submission of the Notice of Exercise is a date upon which the Common Shares transfer books of the Company are closed, such Person shall be
          deemed to have become the record holder of such shares on, and such certificate shall be dated, the next succeeding day on which the Common Shares transfer books of the Company are open.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 11. <u>Adjustment of Exercise Price, Number of Common Shares or Number of the Company Warrants</u>. The Exercise Price, the number of shares
          covered by each Warrant and the number of Warrants outstanding are subject to adjustment from time to time as provided in Section 3 of the Warrant Certificate. In the event that at any time, as a result of an adjustment made pursuant to Section 3
          of the Warrant Certificate, the Holder of any Warrant thereafter exercised shall become entitled to receive any shares of capital stock of the Company other than Common Shares, thereafter the number of such other shares so receivable upon
          exercise of any Warrant shall be subject to adjustment from time to time in a manner and on terms as nearly equivalent as practicable to the provisions with respect to the shares contained in Section 3 of the Warrant Certificate and the
          provisions of Sections 7, 11 and 12 of this Agreement with respect to the Common Shares shall apply on like terms to any such other shares.&#160; All Warrants originally issued by the Company subsequent to any adjustment made to the Exercise Price
          pursuant to the Warrant Certificate shall evidence the right to purchase, at the adjusted Exercise Price, the number of Common Shares purchasable from time to time hereunder upon exercise of the Warrants, all subject to further adjustment as
          provided herein.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">52</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 12. <u>Certification of Adjusted Exercise Price or Number of Common Shares</u>. Whenever the Exercise Price or the number of Common Shares issuable
          upon the exercise of each Warrant is adjusted as provided in Section 11 or 13, the Company shall (a) promptly prepare a certificate setting forth the Exercise Price of each Warrant as so adjusted, and a brief statement of the facts accounting for
          such adjustment, (b) promptly file with the Warrant Agent and with each transfer agent for the Common Shares a copy of such certificate and (c) instruct the Warrant Agent to send a brief summary thereof to each Holder of a Warrant Certificate.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 13. <u>Fractional Shares of Common Shares</u>.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(a) The Company shall not issue fractions of Warrants or distribute Warrant Certificates which evidence fractional Warrants. Whenever any fractional Warrant
          would otherwise be required to be issued or distributed, the actual issuance or distribution shall reflect a rounding of such fraction to the nearest whole Warrant (rounded down).</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(b) The Company shall not issue fractions of Common Shares upon exercise of Warrants or distribute stock certificates which evidence fractional Common
          Shares. Whenever any fraction of a Common Share would otherwise be required to be issued or distributed, the actual issuance or distribution in respect thereof shall be made in accordance with Section 2(d)(v) of the Warrant Certificate.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">Section 14. <u>Conditions of the Warrant Agent&#8217;s Obligations</u>. The Warrant Agent accepts its obligations herein set forth upon the terms and
          conditions hereof, including the following to all of which the Company agrees and to all of which the rights hereunder of the Holders from time to time of the Warrant Certificates shall be subject:</div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z468a6278c9854d6080432edfd1cee952" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(a)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Compensation and Indemnification</font>. The Company agrees promptly to pay the Warrant Agent the compensation detailed on the fee schedule mutually
                      agreed upon by the parties hereto and provided separately on the date hereof for all services rendered by the Warrant Agent and to reimburse the Warrant Agent for reasonable out-of-pocket expenses (including reasonable counsel fees)
                      incurred without gross negligence or willful misconduct by the Warrant Agent in connection with the services rendered hereunder by the Warrant Agent. The Company also agrees to indemnify the Warrant Agent for, and to hold it harmless
                      against, any loss, liability or expense incurred without gross negligence, or willful misconduct on the part of the Warrant Agent, arising out of or in connection with its acting as Warrant Agent hereunder, including the reasonable
                      costs and expenses of defending against any claim of such liability. The Warrant Agent shall be under no obligation to institute or defend any action, suit, or legal proceeding in connection herewith or to take any other action likely
                      to involve the Warrant Agent in expense, unless first indemnified to the Warrant Agent&#8217;s satisfaction.&#160; The indemnities provided by this paragraph shall survive the resignation or discharge of the Warrant Agent or the termination of
                      this Agreement.&#160; Anything in this Agreement to the contrary notwithstanding, in no event shall the Warrant Agent be liable under or in connection with the Agreement for indirect, special, incidental, punitive or consequential losses
                      or damages of any kind whatsoever, including but not limited to lost profits, whether or not foreseeable, even if the Warrant Agent has been advised of the possibility thereof and regardless of the form of action in which such damages
                      are sought, and the Warrant Agent&#8217;s aggregate liability to the Company, or any of the Company&#8217;s representatives or agents, under this Section 14(a) or under any other term or provision of this Agreement, whether in contract, tort, or
                      otherwise, is expressly limited to, and shall not exceed in any circumstances, one (1) year&#8217;s fees received by the Warrant Agent as fees and charges under this Agreement, but not including reimbursable expenses previously reimbursed
                      to the Warrant Agent by the Company hereunder.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zca6c646cd28a43b1bf4d9cfb329f195f" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(b)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Agent for the Company</font>. In acting under this Warrant Agreement and in connection with the Warrant Certificates, the Warrant Agent is acting
                      solely as agent of the Company and does not assume any obligations or relationship of agency or trust for or with any of the Holders of Warrant Certificates or beneficial owners of Warrants.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">53</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z16325b0571a44179ba916088e61939b0" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(c)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Counsel</font>. The Warrant Agent may consult with counsel satisfactory to it, which may include counsel for the Company, and the written advice of
                      such counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in accordance with the advice of such counsel.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1387a358c2e24e3aa1ca068414fe8573" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(d)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Documents</font>. The Warrant Agent shall be protected and shall incur no liability for or in respect of any action taken or omitted by it in reliance
                      upon any Warrant Certificate, notice, direction, consent, certificate, affidavit, statement or other paper or document reasonably believed by it to be genuine and to have been presented or signed by the proper parties.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z7308912a081948aba3f314581dec7d2b" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(e)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Certain Transactions</font>. The Warrant Agent, and its officers, directors and employees, may become the owner of, or acquire any interest in,
                      Warrants, with the same rights that it or they would have if it were not the Warrant Agent hereunder, and, to the extent permitted by applicable law, it or they may engage or be interested in any financial or other transaction with
                      the Company and may act on, or as depositary, trustee or agent for, any committee or body of Holders of Warrant Securities or other obligations of the Company as freely as if it were not the Warrant Agent hereunder. Nothing in this
                      Warrant Agreement shall be deemed to prevent the Warrant Agent from acting as trustee under any indenture to which the Company is a party.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb4ccb3aa172e437fa850e4d385a56d10" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(f)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">No Liability for Interest</font>. Unless otherwise agreed with the Company, the Warrant Agent shall have no liability for interest on any monies at
                      any time received by it pursuant to any of the provisions of this Agreement or of the Warrant Certificates.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zab0e6ebd816748e6884ab34e05e6ce91" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(g)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">No Liability for Invalidity</font>. The Warrant Agent shall have no liability with respect to any invalidity of this Agreement or the Warrant
                      Certificates (except as to the Warrant Agent&#8217;s countersignature thereon).</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z754d36860d354208af76ae242197011b" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(h)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">No Responsibility for Representations</font>. The Warrant Agent shall not be responsible for any of the recitals or representations herein or in the
                      Warrant Certificate (except as to the Warrant Agent&#8217;s countersignature thereon), all of which are made solely by the Company.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify;">
          <div>
            <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z1135a3c0fc184699bbaca7db97d2f491" class="DSPFListTable">

                <tr>
                  <td style="width: 36pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', serif;">(i)</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">No Implied Obligations</font>. The Warrant Agent shall be obligated to perform only such duties as are herein and in the Warrant Certificates
                      specifically set forth and no implied duties or obligations shall be read into this Agreement or the Warrant Certificates against the Warrant Agent. The Warrant Agent shall not be under any obligation to take any action hereunder
                      which may tend to involve it in any expense or liability, the payment of which within a reasonable time is not, in its reasonable opinion, assured to it. The Warrant Agent shall not be accountable or under any duty or responsibility
                      for the use by the Company of any of the Warrant Certificates authenticated by the Warrant Agent and delivered by it to the Company pursuant to this Agreement or for the application by the Company of the proceeds of the Warrant
                      Certificate. The Warrant Agent shall have no duty or responsibility in case of any default by the Company in the performance of its covenants or agreements contained herein or in the Warrant Certificates or in the case of the receipt
                      of any written demand from a Holder of a Warrant Certificate with respect to such default, including, without limiting the generality of the foregoing, any duty or responsibility to initiate or attempt to initiate any proceedings at
                      law.</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">54</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 15. <u>Purchase or Consolidation or Change of Name of Warrant Agent</u>. Any corporation into which the Warrant Agent or any successor Warrant
          Agent may be merged or with which it may be consolidated, or any corporation resulting from any merger or consolidation to which the Warrant Agent or any successor Warrant Agent shall be party, or any corporation succeeding to the corporate trust
          business of the Warrant Agent or any successor Warrant Agent, shall be the successor to the Warrant Agent under this Agreement without the execution or filing of any paper or any further act on the part of any of the parties hereto, provided that
          such corporation would be eligible for appointment as a successor Warrant Agent under the provisions of Section 17. In case at the time such successor Warrant Agent shall succeed to the agency created by this Agreement&#160; any of the Warrant
          Certificates shall have been countersigned but not delivered, any such successor Warrant Agent may adopt the countersignature of the predecessor Warrant Agent and deliver such Warrant Certificates so countersigned; and in case at that time any of
          the Warrant Certificates shall not have been countersigned, any successor Warrant Agent may countersign such Warrant Certificates either in the name of the predecessor Warrant Agent or in the name of the successor Warrant Agent; and in all such
          cases such Warrant Certificates shall have the full force provided in the Warrant Certificates and in this Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">In case at any time the name of the Warrant Agent shall be changed and at such time any of the Warrant Certificates shall have been countersigned but not
          delivered, the Warrant Agent may adopt the countersignature under its prior name and deliver such Warrant Certificates so countersigned; and in case at that time any of the Warrant Certificates shall not have been countersigned, the Warrant Agent
          may countersign such Warrant Certificates either in its prior name or in its changed name; and in all such cases such Warrant Certificates shall have the full force provided in the Warrant Certificates and in this Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">Section 16. <u>Duties of Warrant Agent</u>. The Warrant Agent undertakes the duties and obligations imposed by this Agreement upon the following terms
          and conditions, by all of which the Company, by its acceptance hereof, shall be bound:</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(a) The Warrant Agent may consult with legal counsel reasonably acceptable to the Company (who may be legal counsel for the Company), and the opinion of
          such counsel shall be full and complete authorization and protection to the Warrant Agent as to any action taken or omitted by it in good faith and in accordance with such opinion.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(b) Whenever in the performance of its duties under this Agreement the Warrant Agent shall deem it necessary or desirable that any fact or matter be
          proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a
          certificate signed by the Chief Executive Officer, Chief Financial Officer or Vice President of the Company; and such certificate shall be full authentication to the Warrant Agent for any action taken or suffered in good faith by it under the
          provisions of this Agreement in reliance upon such certificate.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(c) Subject to the limitation set forth in Section 14, the Warrant Agent shall be liable hereunder only for its own gross negligence or willful
          misconduct, or for a breach by it of this Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(d) The Warrant Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Agreement or in the Warrant
          Certificate (except its countersignature thereof) by the Company or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Company only.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">55</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(e) The Warrant Agent shall not be under any responsibility in respect of the validity of this Agreement or the execution and delivery hereof (except the
          due execution hereof by the Warrant Agent) or in respect of the validity or execution of any Warrant Certificate (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition
          contained in this Agreement or in any Warrant Certificate; nor shall it be responsible for the adjustment of the Exercise Price or the making of any change in the number of Common Shares required under the provisions of Section 11 or 13 or
          responsible for the manner, method or amount of any such change or the ascertaining of the existence of facts that would require any such adjustment or change (except with respect to the exercise of Warrants evidenced by the Warrant Certificates
          after actual notice of any adjustment of the Exercise Price); nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any Common Shares to be issued pursuant to this Agreement
          or any Warrant Certificate or as to whether any Common Shares will, when issued, be duly authorized, validly issued, fully paid and nonassessable.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(f) Each party hereto agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all
          such further and other acts, instruments and assurances as may reasonably be required by the other party hereto for the carrying out or performing by any party of the provisions of this Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(g) The Warrant Agent is hereby authorized to accept instructions with respect to the performance of its duties hereunder from the Chief Executive
          Officer, Chief Financial Officer or Vice President of the Company, and to apply to such officers for advice or instructions in connection with its duties, and it shall not be liable and shall be indemnified and held harmless for any action taken
          or suffered to be taken by it in good faith in accordance with instructions of any such officer, provided Warrant Agent carries out such instructions without gross negligence or willful misconduct.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(h) The Warrant Agent and any shareholder, director, officer or employee of the Warrant Agent may buy, sell or deal in any of the Warrants or other
          securities of the Company or become pecuniarily interested in any transaction in which the Company may be interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it were not Warrant Agent under
          this Agreement. Nothing herein shall preclude the Warrant Agent from acting in any other capacity for the Company or for any other legal entity.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">(i) The Warrant Agent may execute and exercise any of the rights or powers hereby vested in it or perform any duty hereunder either itself or by or
          through its attorney or agents, and the Warrant Agent shall not be answerable or accountable for any act, default, neglect or misconduct of any such attorney or agents or for any loss to the Company resulting from any such act, default, neglect
          or misconduct, provided reasonable care was exercised in the selection and continued employment thereof.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">56</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">Section 17. <u>Change of Warrant Agent</u>. The Warrant Agent may resign and be discharged from its duties under this Agreement upon 30 days&#8217; notice in
          writing sent to the Company and to each transfer agent of the Common Shares and to the Holders of the Warrant Certificates. The Company may remove the Warrant Agent or any successor Warrant Agent upon 30 days&#8217; notice in writing, sent to the
          Warrant Agent or successor Warrant Agent, as the case may be, and to each transfer agent of the Common Shares, and to the Holders of the Warrant Certificates. If the Warrant Agent shall resign or be removed or shall otherwise become incapable of
          acting, the Company shall appoint a successor to the Warrant Agent. If the Company shall fail to make such appointment within a period of 30 days after such removal or after it has been notified in writing of such resignation or incapacity by the
          resigning or incapacitated Warrant Agent or by the Holder of a Warrant Certificate (who shall, with such notice, submit his Warrant Certificate for inspection by the Company), then the Holder of any Warrant Certificate may apply to any court of
          competent jurisdiction for the appointment of a new Warrant Agent, provided that, for purposes of this Agreement, the Company shall be deemed to be the Warrant Agent until a new warrant agent is appointed. Any successor Warrant Agent, whether
          appointed by the Company or by such a court, shall be a corporation organized and doing business under the laws of the United States or of a state thereof, in good standing, which is authorized under such laws to exercise corporate trust powers
          and is subject to supervision or examination by federal or state authority and which has at the time of its appointment as Warrant Agent a combined capital and surplus of at least $50,000,000. After appointment, the successor Warrant Agent shall
          be vested with the same powers, rights, duties and responsibilities as if it had been originally named as Warrant Agent without further act or deed; but the predecessor Warrant Agent shall deliver and transfer to the successor Warrant Agent any
          property at the time held by it hereunder, and execute and deliver any further assurance, conveyance, act or deed necessary for the purpose. Not later than the effective date of any such appointment, the Company shall file notice thereof in
          writing with the predecessor Warrant Agent and each transfer agent of the Common Shares, and mail a notice thereof in writing to the Holders of the Warrant Certificates. However, failure to give any notice provided for in this Section 17, or any
          defect therein, shall not affect the legality or validity of the resignation or removal of the Warrant Agent or the appointment of the successor Warrant Agent, as the case may be.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">Section 18. <u>Issuance of New Warrant Certificates</u>. Notwithstanding any of the provisions of this Agreement or of the Warrants to the contrary, the
          Company may, at its option, issue new Warrant Certificates evidencing Warrants in such form as may be approved by its Board of Directors to reflect any adjustment or change in the Exercise Price per share and the number or kind or class of shares
          of stock or other securities or property purchasable under the several Warrant Certificates made in accordance with the provisions of this Agreement.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 32.4pt; font-family: 'Times New Roman', serif;">Section 19. <u>Notices</u>. Notices or demands authorized by this Agreement to be given or made (i) by the Warrant Agent or by the Holder of any Warrant
          Certificate to or on the Company, (ii) subject to the provisions of Section 17, by the Company or by the Holder of any Warrant Certificate to or on the Warrant Agent or (iii) by the Company or the Warrant Agent to the Holder of any Warrant
          Certificate shall be deemed given (a) on the date delivered, if delivered personally, (b) on the first Business Day following the deposit thereof with Federal Express or another recognized overnight courier, if sent by Federal Express or another
          recognized overnight courier, (c) on the fourth Business Day following the mailing thereof with postage prepaid, if mailed by registered or certified mail (return receipt requested), and (d) the date of transmission, if such notice or
          communication is delivered via facsimile or email attachment at or prior to 5:30 p.m. (New York City time) on a Business Day and (e) the next Business Day after the date of transmission, if such notice or communication is delivered via facsimile
          or email attachment on a day that is not a Business Day or later than 5:30 p.m. (New York City time) on any Business Day, in each case to the parties at the following addresses (or at such other address for a party as shall be specified by like
          notice):</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z284da1b14fb54085991d5c3f7f274acd">

            <tr>
              <td style="width: 7.24%; vertical-align: top;">&#160;</td>
              <td style="width: 6.26%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">(a)</div>
              </td>
              <td style="width: 86.5%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;"><font style="font-weight: bold;">If to the Company, to</font>:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.24%; vertical-align: top;">&#160;</td>
              <td style="width: 6.26%; vertical-align: top;">&#160;</td>
              <td style="width: 86.5%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.24%; vertical-align: top;">&#160;</td>
              <td style="width: 6.26%; vertical-align: top;">&#160;</td>
              <td style="width: 86.5%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Castor Maritime Inc.<br>
                  223 Christodoulou Chatzipavlou Street<br>
                  Hawaii Royal Gardens<br>
                  3036 Limassol, Cyprus</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.24%; vertical-align: top;">&#160;</td>
              <td style="width: 6.26%; vertical-align: top;">&#160;</td>
              <td style="width: 86.5%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.24%; vertical-align: top;">&#160;</td>
              <td style="width: 6.26%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">(b)</div>
              </td>
              <td style="width: 86.5%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;"><font style="font-weight: bold;">If to the Warrant Agent, to</font>:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.24%; vertical-align: top;">&#160;</td>
              <td style="width: 6.26%; vertical-align: top;">&#160;</td>
              <td style="width: 86.5%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.24%; vertical-align: top;">&#160;</td>
              <td style="width: 6.26%; vertical-align: top;">&#160;</td>
              <td style="width: 86.5%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">American Stock Transfer &amp; Trust Company<br>
                  6201 15th Ave<br>
                  Brooklyn, NY 11219</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">57</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">For any notice delivered by email to be deemed given or made, such notice must be followed by notice sent by overnight courier service to be delivered on the next business day
          following such email, unless the recipient of such email has acknowledged via return email receipt of such email.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(c) If to the Holder of any Warrant Certificate to the address of such Holder as shown on the registry books of the Company. Any notice required to be
          delivered by the Company to the Holder of any Warrant may be given by the Warrant Agent on behalf of the Company. Notwithstanding any other provision of this Agreement, where this Agreement provides for notice of any event to a Holder of any
          Warrant, such notice shall be sufficiently given if given to the DTC (or its designee) pursuant to the procedures of the DTC or its designee.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 20. <u>Supplements and Amendments</u>.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(a) The Company and the Warrant Agent may from time to time supplement or amend this Agreement without the approval of any Holders of Global Warrants in
          order to add to the covenants and agreements of the Company for the benefit of the Holders of the Global Warrants or to surrender any rights or power reserved to or conferred upon the Company in this Agreement, provided that such addition or
          surrender shall not adversely affect the interests of the Holders of the Global Warrants or Warrant Certificates in any material respect.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(b) In addition to the foregoing, with the consent of Holders of Warrants entitled, upon exercise thereof, to receive not less than a majority of the Common
          Shares issuable under Warrants which are not beneficially owned by Affiliates of the Company, the Company and the Warrant Agent may modify this Agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of
          the provisions of this Warrant Agreement or modifying in any manner the rights of the Holders of the Global Warrants; <u>provided</u>, <u>however</u>, that no modification of the terms (including but not limited to the adjustments described in
          Section 11) upon which the Warrants are exercisable or the rights of holders of Warrants to receive liquidated damages or other payments in cash from the Company or reducing the percentage required for consent to modification of this Agreement
          may be made without the consent of the Holder of each outstanding Warrant Certificate affected thereby; <u>provided</u>, <u>further</u>, <u>however</u>, that no amendment hereunder shall affect any terms of any Warrant Certificate issued in a
          Warrant Exchange. As a condition precedent to the Warrant Agent&#8217;s execution of any amendment, the Company shall deliver to the Warrant Agent a certificate from a duly authorized officer of the Company that states that the proposed amendment
          complies with the terms of this Section 20.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 21. <u>Successors</u>. All covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and
          inure to the benefit of their respective successors and assigns hereunder.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Section 22. <u>Benefits of this Agreement</u>. Nothing in this Agreement shall be construed to give any Person other than the Company, the Holders of
          Warrant Certificates and the Warrant Agent any legal or equitable right, remedy or claim under this Agreement.&#160; This Agreement shall be for the sole and exclusive benefit of the Company, the Warrant Agent and the Holders of the Warrant
          Certificates.&#160; Notwithstanding anything to the contrary contained herein, to the extent any provision of a Warrant Certificate conflicts with any provision of this Agreement, the provisions of the Warrant Certificate shall govern and be
          controlling.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 26.55pt; font-family: 'Times New Roman', serif;">Section 23. <u>Governing Law</u>. This Agreement and each Warrant Certificate and Global Warrant issued hereunder shall be governed by, and construed in
          accordance with, the laws of the State of New York, without giving effect to the conflicts of law principles thereof.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 26.55pt; font-family: 'Times New Roman', serif;">Section 24. <u>Counterparts</u>. This Agreement may be executed in any number of counterparts and each of such counterparts shall for all purposes be
          deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 26.55pt; font-family: 'Times New Roman', serif;">Section 25. <u>Captions</u>. The captions of the sections of this Agreement have been inserted for convenience only and shall not control or affect the
          meaning or construction of any of the provisions hereof.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 26.55pt; font-family: 'Times New Roman', serif;">Section 26.&#160; <u>Information</u>. The Company agrees to promptly provide to the Holders of the Warrants any information it&#160; provides to the holders of
          the Common Shares, except to the extent any such information is publicly available on the EDGAR system (or any successor thereof) of the Securities and Exchange Commission.</div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">[<font style="font-style: italic;">Signature page to follow</font>]</div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">58</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z400998b75b4e448fa46b525a9728c0f5">

            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 50.16%; vertical-align: top;" colspan="2">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 50.16%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 50.16%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">By:</div>
              </td>
              <td style="width: 41.48%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">/s/Petros Panagiotidis</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Name:</div>
              </td>
              <td style="width: 41.48%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Petros Panagiotidis</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Title:</div>
              </td>
              <td style="width: 41.48%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Chief Executive Officer</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">&#160;</td>
              <td style="width: 41.48%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 50.16%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 50.16%; vertical-align: top;" colspan="2">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">AMERICAN STOCK TRANSFER &amp; TRUST COMPANY</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 50.16%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">By:</div>
              </td>
              <td style="width: 41.48%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">/s Michael Legregin</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Name:</div>
              </td>
              <td style="width: 41.48%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Michael Legregin</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Title:</div>
              </td>
              <td style="width: 41.48%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Senior Vice President</div>
              </td>
            </tr>
            <tr>
              <td style="width: 49.84%; vertical-align: top;">&#160;</td>
              <td style="width: 8.68%; vertical-align: top;">&#160;</td>
              <td style="width: 41.48%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">59</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">Exhibit 1</div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">&#160;Form of Warrant Certificate</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">60</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">FORM OF CLASS A COMMON SHARE PURCHASE WARRANT</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
        <div style="text-align: justify; text-indent: 144pt; font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6f441ad5245e44258d68bdf87b5e6c4a">

            <tr>
              <td style="width: 51.08%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Warrant Shares: _______</div>
              </td>
              <td style="width: 48.92%; vertical-align: top;">
                <div style="text-align: right; font-family: 'Times New Roman', serif;">Issue Date: June 26, 2020</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">THIS COMMON SHARE PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;<u>Holder</u>&#8221;) is
          entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to 5:00 p.m. (New York City time) on June 25, 2025 (the &#8220;<u>Termination Date</u>&#8221;)


          but not thereafter, to subscribe for and purchase from Castor Maritime Inc., a Marshall Islands corporation (the &#8220;<u>Company</u>&#8221;), up to ______ Common Shares (as subject to adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;).&#160; The purchase price
          of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and The Depository Trust Company or
          its nominee (&#8220;<u>DTC</u>&#8221;) shall initially be the sole registered holder of this Warrant, subject to a Holder&#8217;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this
          sentence shall not apply.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><u>Definitions</u>.&#160; In addition to the terms defined elsewhere in this Warrant, the
          following terms have the meanings indicated in this Section 1.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Affiliate</font>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is
          controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Bid Price</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the
          Common Shares are then listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by
          Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest
          preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or
          agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith
          by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Business Day</font>&#8221; means&#160; any day other than Saturday, Sunday or other day on which commercial banks in The City of New
          York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential
          employee&#8221;&#160; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
          banks in The City of New York are generally are open for use by customers on such day.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Commission</font>&#8221; means the United States Securities and Exchange Commission.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Common Shares</font>&#8221; means common shares of the Company, par value $0.001 per share, and any other class of securities
          into which such securities may hereafter be reclassified or changed.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">61</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Common Share Equivalents</font>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder
          thereof to acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the
          holder thereof to receive, Common Shares.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
          thereunder.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint
          venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221; means the Company&#8217;s registration statement on Form F-1 (File No. 333-238990).</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Securities Act</font>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Subsidiary</font>&#8221; means any subsidiary of the Company, which is actively engaged in a trade or business, and shall, where
          applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Trading Day</font>&#8221; means a day on which the Common Shares are traded on a Trading Market.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Trading Market</font>&#8221; means any of the following markets or exchanges on which the Common Shares are listed or quoted for
          trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Transfer Agent</font>&#8221; means American Stock Transfer &amp; Trust Company, the current transfer agent of the Company with a
          mailing address of 6201 15th Ave., Ste. 3K, Brooklyn, NY 11219, and any successor transfer agent of the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Underwriting Agreement</font>&#8221; means the underwriting agreement, dated as of&#160; June 23, 2020 among the Company and Maxim
          Group LLC as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its terms.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">VWAP</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the
          Common Shares are then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as
          reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the
          nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization
          or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good
          faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Warrant Agency Agreement</font>&#8221; means that certain warrant agency agreement, dated on or about the Issue Date, between
          the Company and the Warrant Agent.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Warrant Agent</font>&#8221; means the Transfer Agent or its affiliate that acts as warrant agent and any successor warrant agent
          of the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">62</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Warrants</font>&#8221; means this Warrant and other Common Share purchase warrants issued by the Company pursuant to the
          Registration Statement.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><u>Exercise</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 68.4pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>.&#160; Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or
          times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).



          Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the
          aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the
          applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.&#160; Notwithstanding anything herein to the
          contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder
          shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
          total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160; The Holder and the
          Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice.&#160; The Holder and
          any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
          hereunder at any given time may be less than the amount stated on the face hereof.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Notwithstanding the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
          Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as
          applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder&#8217;s right to elect to receive a Definitive
          Warrant pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply. Notwithstanding anything to the contrary contained herein, a beneficial holder of the Warrant shall have all of the rights and remedies of
          the &#8220;Holder&#8221; hereunder.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price</u>.&#160; The exercise price per Common Share under this Warrant shall be&#160;$0.35, subject to adjustment hereunder (the &#8220;<u>Exercise



            Price</u>&#8221;).</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cashless Exercise</u>.&#160; If at the time of exercise hereof, there is no effective registration statement registering, or the
          prospectus contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled
          to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
          of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221;
          (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
          of Exercise or (z) the Bid Price of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. (&#8220;<u>Bloomberg</u>&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is
          executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the
          VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on
          such Trading Day;</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">63</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(B) = the Exercise Price of this Warrant, as adjusted hereunder; and</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
          such exercise were by means of a cash exercise rather than a cashless exercise.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="background-color: #FFFFFF;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with
            Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrant being exercised. The Company agrees not to take any position contrary to this Section 2(c).</font></div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="background-color: #FFFFFF;">&#160;</font></div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to
          this Section 2(c).</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mechanics of Exercise</u>.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant Shares Upon Exercise</u>.&#160; The Company shall cause the Warrant Shares purchased hereunder to be
          transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is
          then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless
          exercise, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the
          address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company or the Warrant Agent of the Notice of Exercise, (ii) one (1) Trading Day after delivery of
          the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company or the Warrant Agent of the Notice of Exercise (such date, the &#8220;<u>Warrant Share Delivery
            Date</u>&#8221;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date
          of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the
          Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver or cause the delivery to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the
          Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the date of the applicable Notice of Exercise), $10 per
          Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such
          exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;Standard Settlement Period&#8221; means the standard settlement period,
          expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">64</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at
          the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver or cause the Warrant Agent to deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the
          unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>.&#160; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
          pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&#160; In addition to any other
          rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share
          Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the
          Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including
          brokerage commissions, if any) for the Common Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue
          times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was
          not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For
          example, if the Holder purchases Common Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant to purchase Common Shares with an aggregate sale price giving rise to such purchase
          obligation of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
          the Buy-In and, upon request of the Company, evidence of the amount of such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of
          specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional Shares or Scrip</u>.&#160; No fractional shares or scrip representing fractional shares shall be issued upon
          the exercise of this Warrant.&#160; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an
          amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">65</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>.&#160; Issuance of Warrant Shares shall be made without charge to the Holder for any issue
          or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or
          names as may be directed by the Holder;&#160;<u>provided</u>,&#160;<u>however</u>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the
          Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&#160; The Company shall pay all Transfer Agent
          fees required for same-day processing of any Notice of Exercise and all fees to The Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant
          Shares.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">vii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>.&#160; The Company will not close its shareholder books or records in any manner which prevents the
          timely exercise of this Warrant, pursuant to the terms hereof.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>.&#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
          exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates,
          and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For
          purposes of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which
          such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or
          Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&#160; Common Share Equivalents) subject to a limitation on conversion or
          exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall
          be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
          with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160;&#160; To the extent that the limitation contained in this Section 2(e) applies, the determination of whether
          this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the
          submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
          portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160; In addition, a determination as to any group
          status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding Common Shares,
          a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more
          recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder
          the number of Common Shares then outstanding.&#160; In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its
          Affiliates or Attribution Parties since the date as of which such number of outstanding Common Shares was reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% (or, upon election by the Holder prior to the issuance of any
          Warrants, 9.99%) of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise of this Warrant.&#160; The Holder may, upon notice to the Company, increase or decrease the
          Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common
          Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>&#160;day after such notice is delivered to the Company.&#160; The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
          2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
          such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">66</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><u>Certain Adjustments</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
          makes a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of
          this Warrant), (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding Common Shares into a smaller number of shares or (iv) issues by reclassification of the
          Common Shares any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding
          immediately before such event and of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that
          the aggregate Exercise Price of this Warrant shall remain unchanged.&#160; Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such
          dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Subsequent Rights Offerings</u>.&#160; In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues
          or sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Shares (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire,
          upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any
          limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
          date as of which the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (<u>provided</u>,&#160;<u>however</u>, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right
          would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right
          to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Pro Rata Distributions</u>.&#160; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
          distribution of its assets (or rights to acquire its assets) to all holders of Common Shares, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way
          of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction), except to the extent an adjustment was already made pursuant to Section 3(a) (a "<u>Distribution</u>"), at any time after the
          issuance of this Warrant, then, in each such case, then the Exercise Price shall be decreased, effective immediately after the effective date of such Distribution, by the&#160; amount of cash and/or the fair market value (as determined by the
          Company&#8217;s Board of Directors, in good faith) of any securities or other assets paid on each Common Share in respect of such Distribution in order that subsequent thereto upon exercise of the Warrants the Holder may obtain the equivalent benefit
          of such Distribution.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">67</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
          related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
          conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is
          completed pursuant to which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv) the
          Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively
          converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
          limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Common Shares (not including any
          Common Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;<u>Fundamental
            Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
          Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is the surviving
          corporation, and any additional consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately prior to such
          Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160; For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
          Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner
          reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
          be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&#160; Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or
          any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the
          applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the
          consummation of such Fundamental Transaction; <u>provided</u>, <u>however</u>, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to
          receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
          Warrant, that is being offered and paid to the holders of Common Shares of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of
          Common Shares are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction.&#160; &#8220;<u>Black Scholes Value</u>&#8221; means the value of this Warrant based on the Black-Scholes Option Pricing
          Model obtained from the &#8220;OV&#8221; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a
          period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT
          function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation
          shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately
          prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public
          announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.&#160; The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the
          Holder&#8217;s election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume
          in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
          (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
          similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Shares acquirable and receivable upon exercise of
          this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
          the relative value of the Common Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value
          of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
          succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of
          the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">68</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case
          may be. For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Holder</u>.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman', serif;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3,
          the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
          requiring such adjustment.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman', serif;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notice to Allow Exercise by Holder. If (A) the Company shall declare a Distribution on the Common Shares, (B) the Company
          shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C) the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of capital
          stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Common Shares, any consolidation or merger to which the Company (and its Subsidiaries, taken
          as a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Shares are converted into other securities, cash or property, or (E) the Company shall
          authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email
          address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
          of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are
          to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Shares of record
          shall be entitled to exchange their Common Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any
          defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public
          information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the
          period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman', serif;">(g)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt;" id="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: 'Times New Roman', serif;"><u>Voluntary Adjustment by Company</u>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant reduce the then current Exercise
            Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</font></div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">69</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><u>Transfer of Warrant</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>.&#160; This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the
          principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer
          taxes payable upon the making of such transfer.&#160; Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
          or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to
          the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading
          Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
          having a new Warrant issued.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
          Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section 4(a), as to any transfer which may be
          involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
          exchanges shall be dated the Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Warrant Register</u>. The Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate (as defined in the Warrant
          Agency Agreement), the Company) shall register this Warrant, upon records to be maintained by the Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate, the Company) for that purpose (the &#8220;<u>Warrant Register</u>&#8221;),
          in the name of the record Holder hereof from time to time.&#160; The Company and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
          Holder, and for all other purposes, absent actual notice to the contrary.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><u>Miscellaneous</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Shareholder Until Exercise</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends or other rights as
          a shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of an affidavit of loss
          reasonably satisfactory to the Company evidencing the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably
          satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock
          certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required
          or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">70</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Shares</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient number
          of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
          charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
          provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be listed.&#160; The Company covenants that all Warrant Shares which may be issued upon the exercise
          of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
          and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Except and to the extent as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of Warrant Shares
          underlying such Warrants), the Company shall not by any action, including, without limitation, amending its articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
          securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such
          actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160; Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares
          above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and
          nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be,
          necessary to enable the Company to perform its obligations under this Warrant.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
          the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>.&#160; A<font style="background-color: #FFFFFF;">ll questions concerning the construction, validity, enforcement and
            interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.</font></div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">71</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Jurisdiction; Agent for Process</u>.&#160;<font style="background-color: #FFFFFF;">Each party agrees that all legal proceedings concerning
            the interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents)
            shall be commenced exclusively in the state and federal courts sitting in the City of New York.&#160; Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of
            Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
            claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process
            and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it
            under this Warrant and agrees that, subject to applicable law, such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in
            any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their
            reasonable attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting the foregoing, the Company has confirms that it has appointed
            Seward &amp; Kissel LLP, with a business address at One Battery Park Plaza, New York, New York 10004, as its authorized agent (the &#8220;</font><font style="background-color: #FFFFFF;"><u>Authorized Agent</u></font><font style="background-color: #FFFFFF;">&#8221;) upon whom process may be served in any suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated herein which may be instituted in any New York federal or state court, by a Holder, the
            directors, officers, partners, employees and agents of such Holder and each affiliate of such Holder, and expressly accept the non-exclusive jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby
            represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents that
            may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every
            respect, effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company shall appoint, without unreasonable delay, another such agent in the United States, and notify the
            Holders of such appointment. Notwithstanding the foregoing and except as set forth herein, any action arising out of or based upon this Warrant may be instituted by a Holder, the directors, officers, partners, employees and agents of the Holder
            (if applicable) and each respective affiliate of the Holder, in any court of competent jurisdiction in the Republic of the Marshall Islands.&#160; Notwithstanding the foregoing, nothing in this paragraph shall limit or restrict the federal district
            court in which a Holder may bring a claim under the federal securities laws. This paragraph shall survive any termination of this Warrant, in whole or in part.</font></div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;"><font style="background-color: #FFFFFF;">&#160;</font>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Restrictions</u>.&#160; The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and
          the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
          operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
          which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate
          proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">72</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>.&#160; Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
          limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile, e-mail or sent by a nationally recognized overnight courier service, addressed to:</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">If to the Warrant Agent</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">American Stock Transfer &amp; Trust Company</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">6201 15th Ave, Brooklyn, NY 11219</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Attention:&#160; </div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">e-mail address:</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic; font-weight: bold;"><u>If to the Company</u></div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic; font-weight: bold;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">Castor Maritime Inc.</div>
        <div style="font-family: 'Times New Roman', serif;">223 Christodoulou Chatzipavlou Street</div>
        <div style="font-family: 'Times New Roman', serif;">Hawaii Royal Gardens</div>
        <div style="font-family: 'Times New Roman', serif;">3036 Limassol, Cyprus<br>
          Tel: + 357 25 357 767</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Email:&#160; petrospan@castormaritime.com&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Facsimile: +357 25357796</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Attn: Chief Executive Officer</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or
          deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e-mail address
          or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (a) the time of transmission, if such notice or communication is
          delivered via facsimile at the facsimile number or e-mail attachment at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of
          transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30
          p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
          to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to
          a Current Report on Form 6-K.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
          to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Share or as a shareholder of the Company, whether such liability
          is asserted by the Company or by creditors of the Company.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
          be entitled to specific performance of its rights under this Warrant.&#160;The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby
          agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
          shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time
          to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">73</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the
          one hand, and the Holder or the beneficial owner of this Warrant, on the other hand.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
          under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such
          provisions or the remaining provisions of this Warrant.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a
          part of this Warrant.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Warrant Agency Agreement</u>. If this Warrant is held in global form through DTC (or any successor depository), this Warrant is issued
          subject to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement, the provisions of this Warrant shall govern and be controlling.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">********************</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-style: italic;">(Signature Page Follows)</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">74</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z0a577c60e3284087a32b361e6375c86f">

            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: bottom;" colspan="2">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: bottom;" colspan="2">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 7.76%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">By:</div>
              </td>
              <td style="width: 42.24%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 7.76%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 42.24%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Name:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 7.76%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 42.24%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Title:</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="margin-bottom: 8pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">NOTICE OF EXERCISE</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CASTOR MARITIME INC.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only required if
          exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment shall take the form of (check applicable box):</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman', serif;">[&#160; ] in lawful money of the United States; or</div>
        <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman', serif;">[&#160; ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
          exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z54deab3f53e24788a97d4691442cece7">

            <tr>
              <td style="width: 25%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">DTC number:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 25%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Account name:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 25%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Account number:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 25%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">[SIGNATURE OF HOLDER]</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb5fb97db28c24d9993fa2bef40d25ab8">

            <tr>
              <td style="width: 25.85%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Name of Investing Entity:</div>
              </td>
              <td style="width: 74.15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.85%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif; font-style: italic;">Signature of Authorized Signatory of Investing Entity:</div>
              </td>
              <td style="width: 74.15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.85%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Name of Authorized Signatory:</div>
              </td>
              <td style="width: 74.15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z3a7dfc0dd9be40c4858c8352e70c3cf7">

            <tr>
              <td style="width: 25%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Title of Authorized Signatory:</div>
              </td>
              <td style="width: 75%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Date:</div>
              </td>
              <td style="width: 75%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: right; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: right; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: right; font-family: 'Times New Roman', serif; font-weight: bold;">EXHIBIT B</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">ASSIGNMENT FORM</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase shares.)</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zef0af5ad49ff426184e4ca81939dce03">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Name:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">(Please Print)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Address:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">(Please Print)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Phone Number:</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Email Address:</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Dated: _______________ __, ______</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Holder&#8217;s Signature: _______________</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Holder&#8217;s Address: _______________</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="margin-top: 12pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">Exhibit 2</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">&#160;Form of Warrant Certificate Request Notice</div>
        <div><br>
        </div>
        <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">WARRANT CERTIFICATE REQUEST NOTICE</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">To: American Stock Transfer &amp; Trust Company, as Warrant Agent for Castor Maritime Inc. (the &#8220;Company&#8221;)</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">The undersigned Holder of Common Share Purchase Warrants (&#8220;<u>Warrants</u>&#8221;) in the form of Global Warrants issued
          by the Company hereby elects to receive a Warrant Certificate evidencing the Warrants held by the Holder as specified below:</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z55178ab757fa4a3b9de827a8fdd761b8">

            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">1.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Name of Holder of Warrants in form of Global Warrants:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">2.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Name of Holder in Warrant Certificate (if different from name of Holder of Warrants in form of Global Warrants):&#160; ______________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">3.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Number of Warrants in name of Holder in form of Global Warrants:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">4.</div>
              </td>
              <td style="width: 57.81%; vertical-align: top;" colspan="2">
                <div style="font-family: 'Times New Roman', serif;">Number of Warrants for which Warrant Certificate shall be issued:</div>
              </td>
              <td style="width: 27.81%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">5.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Number of Warrants in name of Holder in form of Global Warrants after issuance of Warrant Certificate, if any: ___________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">6.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Warrant Certificate shall be delivered to the following address:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>

        </table>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">The undersigned hereby acknowledges and agrees that, in connection with this Warrant Exchange and the issuance of the Warrant
          Certificate, the Holder is deemed to have surrendered the number of Warrants in form of Global Warrants in the name of the Holder equal to the number of Warrants evidenced by the Warrant Certificate.</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze378f10ce50e4064901dd6f433e5ba98">

            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 91.39%; vertical-align: top;" colspan="2">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">[SIGNATURE OF HOLDER]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 91.39%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Name of Investing Entity:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Name of Authorized Signatory:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Title of Authorized Signatory:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Date:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">Exhibit 3</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">&#160;Form of Global Warrant Request Notice</div>
        <div><br>
        </div>
        <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">GLOBAL WARRANT REQUEST NOTICE</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">To: American Stock Transfer &amp; Trust Company, as Warrant Agent for Castor Maritime Inc. (the &#8220;Company&#8221;)</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">The undersigned Holder of Common Share Purchase Warrants (&#8220;<u>Warrants</u>&#8221;) in the form of Warrants Certificates
          issued by the Company hereby elects to receive a Global Warrant evidencing the Warrants held by the Holder as specified below:</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zcb28d2d504344609a2687e6cb9b70d09">

            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">1.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Name of Holder of Warrants in form of Warrant Certificates:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">2.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Name of Holder in Global Warrant (if different from name of Holder of Warrants in form of Warrant Certificates): ______________________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">3.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Number of Warrants in name of Holder in form of Warrant Certificates:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">4.</div>
              </td>
              <td style="width: 57.81%; vertical-align: top;" colspan="2">
                <div style="font-family: 'Times New Roman', serif;">Number of Warrants for which Global Warrant shall be issued:</div>
              </td>
              <td style="width: 27.81%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">5.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Number of Warrants in name of Holder in form of Warrant Certificates after issuance of Global Warrant, if any: ____________________</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">6.</div>
              </td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">
                <div style="font-family: 'Times New Roman', serif;">Global Warrant shall be delivered to the following address:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 85.61%; vertical-align: top;" colspan="3">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 7.65%; vertical-align: top;">&#160;</td>
              <td style="width: 6.74%; vertical-align: top;">&#160;</td>
              <td style="width: 42.8%; vertical-align: top;">&#160;</td>
              <td style="width: 42.81%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>

        </table>
        <div style="margin-bottom: 12pt;"><br>
        </div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">The undersigned hereby acknowledges and agrees that, in connection with this Global Warrant Exchange and the issuance of the Global
          Warrant, the Holder is deemed to have surrendered the number of Warrants in form of Warrant Certificates in the name of the Holder equal to the number of Warrants evidenced by the Global Warrant.</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z8ccb098bfcd74337af60a559714684ce">

            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 91.39%; vertical-align: top;" colspan="2">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">[SIGNATURE OF HOLDER]</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 91.39%; vertical-align: top;" colspan="2">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Name of Investing Entity:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Name of Authorized Signatory:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Title of Authorized Signatory:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">
                <div style="margin-right: 36pt; font-family: 'Times New Roman', serif;">Date:</div>
              </td>
              <td style="width: 45.7%; vertical-align: top; border-bottom: #000000 2px solid;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 8.61%; vertical-align: top;">&#160;</td>
              <td style="width: 45.69%; vertical-align: top;">&#160;</td>
              <td style="width: 45.7%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div><br>
        </div>
        <div><br>
        </div>
      </div>
      <div><br>
      </div>
    </div>
    <div id="DSPFPageBreakArea">
      <hr style="page-break-after: always; color: #FFFFFF;" id="DSPFPageBreak"></div>
    <div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 4.2</font><br>
      </div>
      <div><br>
      </div>
      <div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">FORM OF CLASS A COMMON SHARE PURCHASE WARRANT</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc638a2aed0024d7eb52ed0a6026ee69a">

            <tr>
              <td style="width: 51.08%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Warrant Shares: _______</div>
              </td>
              <td style="width: 48.92%; vertical-align: top;">
                <div style="text-align: right; font-family: 'Times New Roman', serif;">Issue Date: June 26, 2020</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">THIS COMMON SHARE PURCHASE WARRANT (the &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, _____________ or its assigns (the &#8220;<u>Holder</u>&#8221;) is
          entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to 5:00 p.m. (New York City time) on June 25, 2025 (the &#8220;<u>Termination Date</u>&#8221;)



          but not thereafter, to subscribe for and purchase from Castor Maritime Inc., a Marshall Islands corporation (the &#8220;<u>Company</u>&#8221;), up to ______ Common Shares (as subject to adjustment hereunder, the &#8220;<u>Warrant Shares</u>&#8221;).&#160; The purchase price
          of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant shall initially be issued and maintained in the form of a security held in book-entry form and The Depository Trust Company or
          its nominee (&#8220;<u>DTC</u>&#8221;) shall initially be the sole registered holder of this Warrant, subject to a Holder&#8217;s right to elect to receive a Warrant in certificated form pursuant to the terms of the Warrant Agency Agreement, in which case this
          sentence shall not apply.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 1.&#160; &#160; &#160; &#160; &#160;&#160; </font><u>Definitions</u>.&#160; In addition to the terms defined elsewhere in this Warrant, the following
          terms have the meanings indicated in this Section 1.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Affiliate</font>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is
          controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Bid Price</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the
          Common Shares are then listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by
          Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest
          preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or
          agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith
          by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Business Day</font>&#8221; means&#160; any day other than Saturday, Sunday or other day on which commercial banks in The City of New
          York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;, &#8220;non-essential
          employee&#8221;&#160; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
          banks in The City of New York are generally are open for use by customers on such day.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Commission</font>&#8221; means the United States Securities and Exchange Commission.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Common Shares</font>&#8221; means common shares of the Company, par value $0.001 per share, and any other class of securities
          into which such securities may hereafter be reclassified or changed.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Common Share Equivalents</font>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder
          thereof to acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the
          holder thereof to receive, Common Shares.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
          thereunder.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Person</font>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint
          venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Registration Statement</font>&#8221; means the Company&#8217;s registration statement on Form F-1 (File No. 333-238990).</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Securities Act</font>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Subsidiary</font>&#8221; means any subsidiary of the Company, which is actively engaged in a trade or business, and shall, where
          applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Trading Day</font>&#8221; means a day on which the Common Shares are traded on a Trading Market.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Trading Market</font>&#8221; means any of the following markets or exchanges on which the Common Shares are listed or quoted for
          trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Transfer Agent</font>&#8221; means American Stock Transfer &amp; Trust Company, the current transfer agent of the Company with a
          mailing address of 6201 15th Ave., Ste. 3K, Brooklyn, NY 11219, and any successor transfer agent of the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Underwriting Agreement</font>&#8221; means the underwriting agreement, dated as of&#160; June 23, 2020 among the Company and Maxim
          Group LLC as representative of the underwriters named therein, as amended, modified or supplemented from time to time in accordance with its terms.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">VWAP</font>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the
          Common Shares are then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as
          reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the
          nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization
          or agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good
          faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Warrant Agency Agreement</font>&#8221; means that certain warrant agency agreement, dated on or about the Issue Date, between
          the Company and the Warrant Agent.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Warrant Agent</font>&#8221; means the Transfer Agent or its affiliate that acts as warrant agent and any successor warrant agent
          of the Company.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#8220;<font style="font-weight: bold;">Warrants</font>&#8221; means this Warrant and other Common Share purchase warrants issued by the Company pursuant to the
          Registration Statement.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">81</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 2.&#160; &#160; &#160; &#160; &#160;&#160; </font><u>Exercise</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 68.4pt; font-family: 'Times New Roman', serif;">a)&#160; &#160; &#160; &#160; &#160; <u>Exercise of Warrant</u>.&#160; Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or
          times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#8220;<u>Notice of Exercise</u>&#8221;).


          Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the
          aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer or cashier&#8217;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the
          applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.&#160; Notwithstanding anything herein to the
          contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder
          shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
          total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased.&#160; The Holder and the
          Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice.&#160; The Holder and
          any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase
          hereunder at any given time may be less than the amount stated on the face hereof.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Notwithstanding the foregoing in this Section 2(a), a holder whose interest in this Warrant is a beneficial interest in certificate(s) representing this
          Warrant held in book-entry form through DTC (or another established clearing corporation performing similar functions), shall effect exercises made pursuant to this Section 2(a) by delivering to DTC (or such other clearing corporation, as
          applicable) the appropriate instruction form for exercise, complying with the procedures to effect exercise that are required by DTC (or such other clearing corporation, as applicable), subject to a Holder&#8217;s right to elect to receive a Definitive
          Warrant pursuant to the terms of the Warrant Agency Agreement, in which case this sentence shall not apply. Notwithstanding anything to the contrary contained herein, a beneficial holder of the Warrant shall have all of the rights and remedies of
          the &#8220;Holder&#8221; hereunder.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Exercise Price</u>.&#160; The exercise price per Common Share under this Warrant shall be&#160;$0.35, subject to adjustment hereunder (the &#8220;<u>Exercise


            Price</u>&#8221;).</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Cashless Exercise</u>.&#160; If at the time of exercise hereof, there is no effective registration statement registering, or the prospectus
          contained therein is not available for the issuance of the Warrant Shares to the Holder, then this Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless exercise&#8221; in which the Holder shall be entitled to receive
          a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
          of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221;
          (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice
          of Exercise or (z) the Bid Price of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. (&#8220;<u>Bloomberg</u>&#8221;) as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is
          executed during &#8220;regular trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the
          VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on
          such Trading Day;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">82</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(B) = the Exercise Price of this Warrant, as adjusted hereunder; and</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-right: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if
          such exercise were by means of a cash exercise rather than a cashless exercise.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="background-color: #FFFFFF;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with
            Section 3(a)(9) of the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrant being exercised. The Company agrees not to take any position contrary to this Section 2(c).</font></div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="background-color: #FFFFFF;">&#160;</font></div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Notwithstanding anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to
          this Section 2(c).</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">d)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Mechanics of Exercise</u>.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">i.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of Warrant Shares Upon Exercise</u>.&#160; The Company shall cause the Warrant Shares purchased hereunder to be
          transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;<u>DWAC</u>&#8221;) if the Company is
          then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless
          exercise, and otherwise by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the
          address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company or the Warrant Agent of the Notice of Exercise, (ii) one (1) Trading Day after delivery of
          the aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company or the Warrant Agent of the Notice of Exercise (such date, the &#8220;<u>Warrant Share Delivery
            Date</u>&#8221;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date
          of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the
          Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver or cause the delivery to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the
          Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the date of the applicable Notice of Exercise), $10 per
          Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such
          exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &#8220;Standard Settlement Period&#8221; means the standard settlement period,
          expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market with respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">83</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>.&#160; If this Warrant shall have been exercised in part, the Company shall, at
          the request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver or cause the Warrant Agent to deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the
          unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">iii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Rescission Rights</u>.&#160; If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares
          pursuant to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">iv.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>.&#160; In addition to any other
          rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share
          Delivery Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the
          Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including
          brokerage commissions, if any) for the Common Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue
          times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was
          not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.&#160; For
          example, if the Holder purchases Common Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of this Warrant to purchase Common Shares with an aggregate sale price giving rise to such purchase
          obligation of $10,000, under clause (A) of the immediately preceding sentence, the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of
          the Buy-In and, upon request of the Company, evidence of the amount of such loss.&#160; Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of
          specific performance and/or injunctive relief with respect to the Company&#8217;s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">v.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Fractional Shares or Scrip</u>.&#160; No fractional shares or scrip representing fractional shares shall be issued upon
          the exercise of this Warrant.&#160; As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an
          amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">84</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">vi.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>.&#160; Issuance of Warrant Shares shall be made without charge to the Holder for any issue
          or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or
          names as may be directed by the Holder;&#160;<u>provided</u>,&#160;<u>however</u>, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the
          Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.&#160; The Company shall pay all Transfer Agent
          fees required for same-day processing of any Notice of Exercise and all fees to The Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant
          Shares.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">vii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Closing of Books</u>.&#160; The Company will not close its shareholder books or records in any manner which prevents the
          timely exercise of this Warrant, pursuant to the terms hereof.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">e)&#160; &#160; &#160; &#160; &#160; <u>Holder&#8217;s Exercise Limitations</u>.&#160; The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to
          exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#8217;s Affiliates,
          and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&#160; For
          purposes of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Common Shares issuable upon exercise of this Warrant with respect to which
          such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates or
          Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other&#160; Common Share Equivalents) subject to a limitation on conversion or
          exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.&#160; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall
          be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance
          with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.&#160;&#160; To the extent that the limitation contained in this Section 2(e) applies, the determination of whether
          this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the
          submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
          portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.&#160;&#160; In addition, a determination as to any group
          status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding Common Shares,
          a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more
          recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding.&#160; Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder
          the number of Common Shares then outstanding.&#160; In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its
          Affiliates or Attribution Parties since the date as of which such number of outstanding Common Shares was reported.&#160; The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% (or, upon election by the Holder prior to the issuance of any
          Warrants, 9.99%) of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise of this Warrant.&#160; The Holder may, upon notice to the Company, increase or decrease the
          Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of the Common Shares outstanding immediately after giving effect to the issuance of Common
          Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>&#160;day after such notice is delivered to the Company.&#160; The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
          2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
          such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">85</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 3.&#160; &#160; &#160; &#160; &#160;&#160; </font><u>Certain Adjustments</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">a)&#160; &#160; &#160; &#160; &#160; <u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
          a distribution or distributions on its Common Shares or any other equity or equity equivalent securities payable in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon exercise of this
          Warrant), (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding Common Shares into a smaller number of shares or (iv) issues by reclassification of the
          Common Shares any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury shares, if any) outstanding
          immediately before such event and of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted such that
          the aggregate Exercise Price of this Warrant shall remain unchanged.&#160; Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of shareholders entitled to receive such
          dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Subsequent Rights Offerings</u>.&#160; In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues
          or sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Shares (the &#8220;<u>Purchase Rights</u>&#8221;), then the Holder will be entitled to acquire,
          upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any
          limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
          date as of which the record holders of Common Shares are to be determined for the grant, issue or sale of such Purchase Rights (<u>provided</u>,&#160;<u>however</u>, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right
          would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right
          to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160; &#160; &#160; &#160; &#160; <u>Pro Rata Distributions</u>.&#160; During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other
          distribution of its assets (or rights to acquire its assets) to all holders of Common Shares, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way
          of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction), except to the extent an adjustment was already made pursuant to Section 3(a) (a "<u>Distribution</u>"), at any time after the
          issuance of this Warrant, then, in each such case, then the Exercise Price shall be decreased, effective immediately after the effective date of such Distribution, by the&#160; amount of cash and/or the fair market value (as determined by the
          Company&#8217;s Board of Directors, in good faith) of any securities or other assets paid on each Common Share in respect of such Distribution in order that subsequent thereto upon exercise of the Warrants the Holder may obtain the equivalent benefit
          of such Distribution.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">86</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">d)&#160; &#160; &#160; &#160; &#160; <u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more
          related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer,
          conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is
          completed pursuant to which holders of Common Shares are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv) the
          Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively
          converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
          limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Common Shares (not including any
          Common Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;<u>Fundamental
            Transaction</u>&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental
          Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is the surviving
          corporation, and any additional consideration (the &#8220;<u>Alternate Consideration</u>&#8221;) receivable as a result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately prior to such
          Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).&#160; For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
          Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner
          reflecting the relative value of any different components of the Alternate Consideration.&#160; If holders of Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall
          be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.&#160; Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or
          any Successor Entity (as defined below) shall, at the Holder&#8217;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the
          applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of the
          consummation of such Fundamental Transaction; <u>provided</u>, <u>however</u>, if the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to
          receive from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this
          Warrant, that is being offered and paid to the holders of Common Shares of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of
          Common Shares are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction.&#160; &#8220;<u>Black Scholes Value</u>&#8221; means the value of this Warrant based on the Black-Scholes Option Pricing
          Model obtained from the &#8220;OV&#8221; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a
          period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT
          function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental Transaction, (C) the underlying price per share used in such calculation
          shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately
          prior to the public announcement of such Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction, (D) a remaining option time equal to the time between the date of the public
          announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow.&#160; The payment of the Black Scholes Value will be made by wire transfer of immediately available funds within five Business Days of the
          Holder&#8217;s election (or, if later, on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;<u>Successor Entity</u>&#8221;) to assume
          in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
          (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
          similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the Common Shares acquirable and receivable upon exercise of
          this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
          the relative value of the Common Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value
          of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall
          succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of
          the Company and shall assume all of the obligations of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">87</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">e)&#160; &#160; &#160; &#160; &#160; <u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may
          be. For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and outstanding.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">f)&#160; &#160; &#160; &#160; &#160; <u>Notice to Holder</u>.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman', serif;">i.&#160; &#160; &#160; &#160; &#160; <u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3,
          the Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
          requiring such adjustment.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman', serif;">ii.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notice to Allow Exercise by Holder. If (A) the Company shall declare a Distribution on the Common Shares, (B) the Company
          shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C) the Company shall authorize the granting to all holders of the Common Shares rights or warrants to subscribe for or purchase any shares of capital
          stock of any class or of any rights, (D) the approval of any shareholders of the Company shall be required in connection with any reclassification of the Common Shares, any consolidation or merger to which the Company (and its Subsidiaries, taken
          as a whole) is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Shares are converted into other securities, cash or property, or (E) the Company shall
          authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or email
          address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
          of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions, redemption, rights or warrants are
          to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Shares of record
          shall be entitled to exchange their Common Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any
          defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.&#160; To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public
          information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant during the
          period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman', serif;">(g)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt;" id="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: 'Times New Roman', serif;"><u>Voluntary Adjustment by Company</u>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of this Warrant reduce the then current Exercise
            Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</font></div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">88</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 4.&#160; &#160; &#160; &#160; &#160;&#160; </font><u>Transfer of Warrant</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">a)&#160; &#160; &#160; &#160; &#160; <u>Transferability</u>.&#160; This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the
          principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer
          taxes payable upon the making of such transfer.&#160; Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination
          or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.&#160; Notwithstanding anything herein to
          the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading
          Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full.&#160; The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without
          having a new Warrant issued.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the
          Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney.&#160; Subject to compliance with Section 4(a), as to any transfer which may be
          involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
          exchanges shall be dated the Issue Date and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160; &#160; &#160; &#160; &#160; <u>Warrant Register</u>. The Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate (as defined in the Warrant
          Agency Agreement), the Company) shall register this Warrant, upon records to be maintained by the Warrant Agent (or, in the event a Holder elects to receive a Definitive Certificate, the Company) for that purpose (the &#8220;<u>Warrant Register</u>&#8221;),
          in the name of the record Holder hereof from time to time.&#160; The Company and the Warrant Agent may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the
          Holder, and for all other purposes, absent actual notice to the contrary.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><font style="color: #010000;">Section 5.&#160; &#160; &#160; &#160; &#160;&#160; </font><u>Miscellaneous</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">a)&#160; &#160; &#160; &#160; &#160; <u>No Rights as Shareholder Until Exercise</u>.&#160; This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a
          shareholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of an affidavit of loss
          reasonably satisfactory to the Company evidencing the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably
          satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock
          certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">c)&#160; &#160; &#160; &#160; &#160; <u>Saturdays, Sundays, Holidays, etc</u>.&#160; If the last or appointed day for the taking of any action or the expiration of any right required or
          granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">89</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">d)&#160; &#160; &#160; &#160; &#160; <u>Authorized Shares</u>.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares a sufficient number
          of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.&#160; The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are
          charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.&#160; The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as
          provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be listed.&#160; The Company covenants that all Warrant Shares which may be issued upon the exercise
          of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
          and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Except and to the extent as waived or consented to by the holders of a majority of the then outstanding Warrants (based on the number of Warrant Shares
          underlying such Warrants), the Company shall not by any action, including, without limitation, amending its articles of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of
          securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such
          actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.&#160; Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares
          above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and
          nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be,
          necessary to enable the Company to perform its obligations under this Warrant.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
          the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">e)&#160; &#160; &#160; &#160; &#160; <u>Governing Law</u>.&#160; A<font style="background-color: #FFFFFF;">ll questions concerning the construction, validity, enforcement and
            interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof.</font></div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">90</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">f)&#160; &#160; &#160; &#160; &#160; <u>Jurisdiction; Agent for Process</u>.&#160;<font style="background-color: #FFFFFF;">Each party agrees that all legal proceedings concerning the
            interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall
            be commenced exclusively in the state and federal courts sitting in the City of New York.&#160; Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan
            for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
            it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents
            to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
            Warrant and agrees that, subject to applicable law, such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other
            manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable
            attorneys&#8217; fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting the foregoing, the Company has confirms that it has appointed Seward
            &amp; Kissel LLP, with a business address at One Battery Park Plaza, New York, New York 10004, as its authorized agent (the &#8220;</font><font style="background-color: #FFFFFF;"><u>Authorized Agent</u></font><font style="background-color: #FFFFFF;">&#8221;)


            upon whom process may be served in any suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated herein which may be instituted in any New York federal or state court, by a Holder, the directors,
            officers, partners, employees and agents of such Holder and each affiliate of such Holder, and expressly accept the non-exclusive jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents
            and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents that may be
            necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes and directs the Authorized Agent to accept such service. Service of process upon the Authorized Agent shall be deemed, in every respect,
            effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company shall appoint, without unreasonable delay, another such agent in the United States, and notify the Holders of
            such appointment. Notwithstanding the foregoing and except as set forth herein, any action arising out of or based upon this Warrant may be instituted by a Holder, the directors, officers, partners, employees and agents of the Holder (if
            applicable) and each respective affiliate of the Holder, in any court of competent jurisdiction in the Republic of the Marshall Islands.&#160; Notwithstanding the foregoing, nothing in this paragraph shall limit or restrict the federal district
            court in which a Holder may bring a claim under the federal securities laws. This paragraph shall survive any termination of this Warrant, in whole or in part.</font></div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;"><font style="background-color: #FFFFFF;">&#160;</font>&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">g)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Restrictions</u>.&#160; The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the
          Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">h)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Nonwaiver and Expenses</u>.&#160; No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
          operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies.&#160; Without limiting any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
          which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate
          proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">91</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">i)&#160; &#160; &#160; &#160; &#160; <u>Notices</u>.&#160; Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
          limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile, e-mail or sent by a nationally recognized overnight courier service, addressed to:</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">If to the Warrant Agent</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">American Stock Transfer &amp; Trust Company</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">6201 15th Ave, Brooklyn, NY 11219</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Attention:&#160; </div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">e-mail address:</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic; font-weight: bold;"><u>If to the Company</u></div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic; font-weight: bold;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">Castor Maritime Inc.</div>
        <div style="font-family: 'Times New Roman', serif;">223 Christodoulou Chatzipavlou Street</div>
        <div style="font-family: 'Times New Roman', serif;">Hawaii Royal Gardens</div>
        <div style="font-family: 'Times New Roman', serif;">3036 Limassol, Cyprus<br>
          Tel: + 357 25 357 767</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Email: <font style="font-family: Calibri, sans-serif;">&#160;</font>petrospan@castormaritime.com&#160;&#160;&#160;&#160;<font style="font-family: Calibri, sans-serif;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Facsimile: +357 25357796</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">Attn: Chief Executive Officer</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">or such other facsimile number, email address or address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or
          deliveries to be provided by the Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e-mail address
          or address of such Holder appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (a) the time of transmission, if such notice or communication is
          delivered via facsimile at the facsimile number or e-mail attachment at the email address set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of
          transmission, if such notice or communication is delivered via facsimile at the facsimile number or e-mail attachment at the e-mail address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30
          p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
          to be given. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to
          a Current Report on Form 6-K.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">j)&#160; &#160; &#160; &#160; &#160; <u>Limitation of Liability</u>.&#160; No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to
          purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Share or as a shareholder of the Company, whether such liability is
          asserted by the Company or by creditors of the Company.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">k)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Remedies</u>.&#160; The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be
          entitled to specific performance of its rights under this Warrant.&#160;The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
          to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">l)&#160; &#160; &#160; &#160; &#160; <u>Successors and Assigns</u>.&#160; Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure
          to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.&#160; The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of
          this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">92</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">m)&#160; &#160; &#160; &#160; &#160; <u>Amendment</u>.&#160; This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on the one
          hand, and the Holder or the beneficial owner of this Warrant, on the other hand.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">n)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Severability</u>.&#160; Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
          under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such
          provisions or the remaining provisions of this Warrant.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">o)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Headings</u>.&#160; The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a
          part of this Warrant.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">p)&#160; &#160; &#160; &#160; &#160;&#160;&#160;&#160; <u>Warrant Agency Agreement</u>. If this Warrant is held in global form through DTC (or any successor depository), this Warrant is issued
          subject to the Warrant Agency Agreement. To the extent any provision of this Warrant conflicts with the express provisions of the Warrant Agency Agreement, the provisions of this Warrant shall govern and be controlling.</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">********************</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-style: italic;">(Signature Page Follows)</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">93</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z231b148c70e54817b44b2d11ae933fec">

            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: bottom;" colspan="2">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: bottom;" colspan="2">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 7.76%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">By:</div>
              </td>
              <td style="width: 42.24%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 7.76%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 42.24%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Name:</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 7.76%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 42.24%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Title:</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="margin-bottom: 8pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">NOTICE OF EXERCISE</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">TO:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CASTOR MARITIME INC.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only required if
          exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment shall take the form of (check applicable box):</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman', serif;">[&#160; ] in lawful money of the United States; or</div>
        <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman', serif;">[&#160; ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
          exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">(3)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z67bae3f0597d41d688f28809ff8c42cb">

            <tr>
              <td style="width: 25%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">DTC number:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 25%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Account name:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 25%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Account number:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 25%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">[SIGNATURE OF HOLDER]</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z2eba514b693547c69e21d9fb784d5111">

            <tr>
              <td style="width: 25.85%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Name of Investing Entity:</div>
              </td>
              <td style="width: 74.15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.85%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif; font-style: italic;">Signature of Authorized Signatory of Investing Entity:</div>
              </td>
              <td style="width: 74.15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25.85%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Name of Authorized Signatory:</div>
              </td>
              <td style="width: 74.15%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za4c315232bdb48b894bf7fa81ae74db7">

            <tr>
              <td style="width: 25%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Title of Authorized Signatory:</div>
              </td>
              <td style="width: 75%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 25%; vertical-align: bottom;">
                <div style="font-family: 'Times New Roman', serif;">Date:</div>
              </td>
              <td style="width: 75%; vertical-align: bottom; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: right; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: right; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: right; font-family: 'Times New Roman', serif; font-weight: bold;">EXHIBIT B</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">ASSIGNMENT FORM</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply required information.&#160; Do not use this form to purchase shares.)</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif; font-style: italic;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zba845caa003646e5b6abf43dd5a5e86d">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Name:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">(Please Print)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Address:</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">(Please Print)</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Phone Number:</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Email Address:</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Dated: _______________ __, ______</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Holder&#8217;s Signature: _______________</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">Holder&#8217;s Address: _______________</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;"><br>
        </div>
      </div>
    </div>
    <div id="DSPFPageBreakArea">
      <hr style="page-break-after: always; color: #FFFFFF;" id="DSPFPageBreak"></div>
    <div>
      <div><br>
      </div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 4.3</font><br>
      </div>
      <div><br>
      </div>
      <div>
        <div style="font-family: 'Times New Roman', serif;">&#160;<font style="font-weight: bold;">&#160;</font></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">PRE-FUNDED COMMON SHARE PURCHASE WARRANT</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc1f2c35bacdf4bffaf06631770659eb4">

            <tr>
              <td style="width: 46.51%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Warrant Shares: _______</div>
              </td>
              <td style="width: 53.49%; vertical-align: top;">
                <div style="text-align: right; font-family: 'Times New Roman', serif;">Initial Exercise Date:&#160;&#160;&#160;June 26, 2020</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">THIS PRE-FUNDED COMMON SHARE PURCHASE WARRANT (this &#8220;<u>Warrant</u>&#8221;) certifies that, for value received, _____________, or its assigns (the &#8220;<u>Holder</u>&#8221;),


          is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#8220;<u>Initial Exercise Date</u>&#8221;), and until this Warrant is exercised in full (the &#8220;<u>Termination


            Date</u>&#8221;) but not thereafter, to subscribe for and purchase from Castor Maritime Inc., a corporation incorporated under the laws of the Republic of the Marshall Islands (the &#8220;<u>Company</u>&#8221;), up to ______ shares (as subject to adjustment
          hereunder, the &#8220;<u>Warrant Shares</u>&#8221;) of Common Shares. The purchase price of one Common Share under this Warrant shall be equal to the Aggregate Exercise Price, as defined in Section 2(b).</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><u>Section 1</u>.&#160; &#160; &#160; &#160; &#160; <u>Definitions</u>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated
          in this Section 1:</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Affiliate</u>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is
          under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Bid Price</u>&#8221; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares
          are then listed or quoted on a Trading Market, the bid price of the Common Shares for the time in question (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by Bloomberg L.P.
          (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest preceding date) on
          OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market. (or a similar organization or agency succeeding to
          its functions of reporting prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith by the Holders of a
          majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#160;&#8220;<u>Business Day</u>&#8221; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are
          authorized or required by law to remain closed; <u>provided</u>, <u>however</u>, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#8220;stay at home&#8221;, &#8220;shelter-in-place&#8221;,
          &#8220;non-essential employee&#8221;&#160; or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers)
          of commercial banks in The City of New York are generally are open for use by customers on such day.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Commission</u>&#8221; means the United States Securities and Exchange Commission.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Common Shares</u>&#8221; means the common shares of the Company, par value $0.001 per share, and any other class of securities into which
          such securities may hereafter be reclassified or changed.&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Common Share Equivalents</u>&#8221; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to
          acquire at any time Common Shares, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder
          thereof to receive, Common Shares.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Exchange Act</u>&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Person</u>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture,
          limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Registration Statement</u>&#8221; means the Company&#8217;s registration statement on Form F-1 (File No. 333- 238990).</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Securities Act</u>&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Subsidiary</u>&#8221; means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of
          the Company formed or acquired after the date hereof.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Trading Day</u>&#8221; means a day on which the Common Shares are traded on a Trading Market.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Trading Market</u>&#8221; means any of the following markets or exchanges on which the Common Shares are listed or quoted for trading on
          the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any of the foregoing).</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Transfer Agent</u>&#8221; means American Stock Transfer &amp; Trust Company, the current transfer agent of the Company with a mailing
          address of 6201 15th Ave., Ste. 3K, Brooklyn, NY 11219, and any successor transfer agent of the Company.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>VWAP</u>&#8220; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Shares are
          then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Shares for such date (or the nearest preceding date) on the Trading Market on which the Common Shares are then listed or quoted as reported by
          Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Shares for such date (or the nearest
          preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Shares are not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Shares are then reported on the Pink Open Market (or a similar organization or
          agency succeeding to its functions of reporting prices), the most recent bid price per Common Share so reported, or (d) in all other cases, the fair market value of a Common Share as determined by an independent appraiser selected in good faith
          by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">&#8220;<u>Warrants</u>&#8221; means this Warrant and all other Pre-Funded Common Share Purchase Warrants issued by the Company pursuant to the
          Registration Statement.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">98</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', serif;"><u>Section 2</u>.&#160; &#160; &#160; &#160; &#160; <u>Exercise</u>.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise of Warrant</u>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part,
          at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed
          hereto (the &#8220;<u>Notice of Exercise</u>&#8221;). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as
          aforesaid, the Holder shall deliver the aggregate Exercise Price for the shares specified in the applicable Notice of Exercise by wire transfer unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable
          Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the
          Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder shall surrender
          this Warrant to the Company for cancellation within five (5) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
          Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain
          records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice.&#160;<font style="font-weight: bold;">The
            Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for
            purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div>
        <div style="font-family: 'Times New Roman', serif;">&#160;&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Exercise Price</u>&#160;The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.01 per
          Warrant Share (the &#8220;<u>Aggregate Exercise Price</u>&#8221;), was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price of $0.01 per Warrant Share) shall
          be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of the pre-paid Aggregate Exercise Price under any circumstance or for any
          reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining unpaid exercise price per Warrant Share under this Warrant shall be $0.01, subject to adjustment hereunder (the &#8220;<u>Exercise


            Price</u>&#8221;).</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Cashless Exercise</u>. This Warrant may also be exercised, in whole or in part, at such time by means of a &#8220;cashless
          exercise&#8221; in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z10807517be6f45389d4e57bb56fb8682">

            <tr>
              <td style="width: 15.38%; vertical-align: top;">&#160;</td>
              <td style="width: 5.77%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">(A) =</div>
              </td>
              <td style="width: 78.85%; vertical-align: top;">
                <div style="text-align: justify; font-family: 'Times New Roman', serif;">as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and
                  delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#8220;regular trading hours&#8221; (as defined in Rule
                  600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
                  or (z) the Bid Price of the Common Shares on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#8217;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#8220;regular
                  trading hours&#8221; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#8220;regular trading hours&#8221; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of
                  the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#8220;regular trading hours&#8221; on such
                  Trading Day;</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze5314b5bc81948b4992f50e95ea5dfec">

              <tr>
                <td style="width: 15.38%; vertical-align: top;">&#160;</td>
                <td style="width: 5.77%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman', serif;">(B) =</div>
                </td>
                <td style="width: 78.85%; vertical-align: top;">
                  <div style="text-align: justify; font-family: 'Times New Roman', serif;">the Exercise Price of this Warrant, as adjusted hereunder; and</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze5314b5bc81948b4992f50e95ea5dfec">

              <tr>
                <td style="width: 15.38%; vertical-align: top;">&#160;</td>
                <td style="width: 5.77%; vertical-align: top;">
                  <div style="font-family: 'Times New Roman', serif;">(X) =</div>
                </td>
                <td style="width: 78.85%; vertical-align: top;">
                  <div style="text-align: justify; font-family: 'Times New Roman', serif;">the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a
                    cash exercise rather than a cashless exercise.</div>
                </td>
              </tr>

          </table>
        </div>
        <div style="font-family: 'Times New Roman', serif;"> <br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">99</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">If Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of
          the Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position contrary to this Section 2(c).</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Mechanics of Exercise</u>.&#160;</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">&#160;i.&#160;&#160; <u>Delivery of Warrant Shares Upon Exercise</u>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
          by the Transfer Agent to the Holder by crediting the account of the Holder&#8217;s or its designee&#8217;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#8220;DWAC&#8221;) if the Company is then a participant
          in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant Shares by the Holder or (B) this Warrant is being exercised via cashless exercise, and otherwise
          by physical delivery of a certificate, registered in the Company&#8217;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by
          the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company
          and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#8220;Warrant Share Delivery Date&#8221;).&#160;&#160; Upon delivery of the Notice of Exercise, the Holder shall
          be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the
          aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of
          Exercise.&#160; If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a
          penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Shares on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after
          such liquidated damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
          in the FAST program so long as this Warrant remains outstanding and exercisable.&#160; As used herein, &#8220;Standard Settlement Period&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Company&#8217;s primary Trading Market
          with respect to the Common Shares as in effect on the date of delivery of the Notice of Exercise.&#160; Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 12:00 p.m. (New York City time) on the Initial
          Exercise Date, which may be delivered at any time after the time of execution of the Underwriting Agreement, dated June 23, 2020 between the Company and Maxim Group LLC, the Company agrees to deliver the Warrant Shares subject to such notice(s)
          by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share Delivery Date for purposes hereunder. Notwithstanding anything to the contrary contained herein, the Company shall not be
          required to deliver any Common Shares upon a cash exercise of a Warrant unless or until the aggregate Exercise Price with respect to such exercise has been delivered to the Company.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">100</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">ii.&#160;&#160;&#160;&#160;&#160;<u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the Company shall, at the
          request of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by
          this Warrant, which new Warrant shall in all other respects be identical with this Warrant.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">iii.&#160;&#160;&#160;&#160;<u>Rescission Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
          to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">iv.&#160;&#160;&#160;&#160;<u>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</u>. In addition to any other rights
          available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery
          Date, and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#8217;s brokerage firm otherwise purchases, Common Shares to deliver in satisfaction of a sale by the Holder of the
          Warrant Shares which the Holder anticipated receiving upon such exercise (a &#8220;<u>Buy-In</u>&#8221;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#8217;s total purchase price (including brokerage
          commissions, if any) for the Common Shares so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the
          price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored
          (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of Common Shares that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
          Holder purchases Common Shares having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of Common Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of
          the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company,
          evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief
          with respect to the Company&#8217;s failure to timely deliver Common Shares upon exercise of the Warrant as required pursuant to the terms hereof.&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">v.&#160;&#160;&#160;&#160;&#160;<u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares shall be issued upon the
          exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall round down to the nearest whole share.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">101</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">vi.&#160;&#160;&#160;&#160;<u>Charges, Taxes and Expenses</u>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or
          transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names
          as may be directed by the Holder;&#160;<u>provided</u>,&#160;<u>however</u>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the
          Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
          fees required for same-day processing of any Notice of Exercise and all fees to The Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant
          Shares.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">vii.&#160;&#160;&#160;<u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which prevents the timely
          exercise of this Warrant, pursuant to the terms hereof.&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Holder&#8217;s Exercise Limitations</u>. The Company shall not effect any exercise of this Warrant, and a Holder shall not
          have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the
          Holder&#8217;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#8217;s Affiliates (such Persons, &#8220;<u>Attribution Parties</u>&#8221;)), would beneficially own in excess of the Beneficial Ownership Limitation (as
          defined below). For purposes of the foregoing sentence, the number of Common Shares beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of Common Shares issuable upon exercise of this Warrant with
          respect to which such determination is being made, but shall exclude the number of Common Shares which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its
          Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other Common Share Equivalents) subject to a limitation on
          conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
          ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation
          is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the
          determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of
          the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#8217;s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution
          Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a
          determination by the Holder as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in
          determining the total number of outstanding Common Shares, a Holder may rely on the number of outstanding Common Shares as reflected in (A) the Company&#8217;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a
          more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding. Upon the written request of a Holder, the Company shall within one
          Trading Day confirm in writing to the Holder the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of securities of the Company,
          including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding Common Shares was reported. The &#8220;<u>Beneficial Ownership Limitation</u>&#8221; shall be 4.99% (or, upon election by a
          Holder prior to the issuance of any Warrants, 9.99%) of the number of Common Shares outstanding immediately after giving effect to the issuance of Common Shares issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may
          increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation shall in no event exceed 9.99% of the number of Common Shares outstanding immediately after giving effect
          to the issuance of Common Shares upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in ownership of Common Shares in excess of the Beneficial Ownership Limitation will
          not be effective until the 61<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>&#160;day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
          otherwise than in strict conformity with the terms of this Section 2(e) in order to correct this paragraph (or any portion hereof), if necessary, which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein
          contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">102</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-indent: 36pt; font-family: 'Times New Roman', serif;"><u>Section 3</u>.&#160; &#160; &#160; &#160; &#160; <u>Certain&#160;Adjustments</u>.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock
          dividend or otherwise makes a distribution or distributions on Common Shares or any other common equity equivalent securities payable in Common Shares (which, for avoidance of doubt, shall not include any Common Shares issued by the Company upon
          exercise of this Warrant), (ii) subdivides outstanding Common Shares into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding Common Shares into a smaller number of shares, or (iv) issues by
          reclassification of Common Shares any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of Common Shares (excluding treasury shares, if any)
          outstanding immediately before such event and of which the denominator shall be the number of Common Shares outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately
          adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to
          receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.&#160;&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Subsequent Rights Offerings</u>.&#160;<font style="color: #000000;">In addition to any adjustments pursuant to Section 3(a)
            above, if at any time the Company grants, issues or sells any Common Share Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Shares (the &#8220;</font><font style="color: #000000;"><u>Purchase Rights</u></font><font style="color: #000000;">&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
            acquired if the Holder had held the number of Common Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately
            before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the grant, issue or sale of
            such Purchase Rights (provided, however, that, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to
            participate in such Purchase Right to such extent (or beneficial ownership of such Common Shares as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time,
            if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font>&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Pro Rata Distributions</u>. During such time as this Warrant is outstanding, if the Company shall declare or make any
          dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Shares, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or
          options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (except to the extent an adjustment was already made pursuant to Section 3(a)) (a &#8220;<u>Distribution</u>&#8221;), at
          any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of Common
          Shares acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such
          Distribution, or, if no such record is taken, the date as of which the record holders of Common Shares are to be determined for the participation in such Distribution (<u>provided</u>,&#160;<u>however</u>, that, to the extent that the Holder&#8217;s right
          to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any
          Common Shares as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
          the Beneficial Ownership Limitation).</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">103</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt;"><font style="font-family: 'Times New Roman', serif;">&#160;d)</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt;" id="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: 'Times New Roman', serif;"><u>Fundamental Transaction</u>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation
            of the Company with or into another Person, (ii) the Company or any Subsidiaries, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
            or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Shares are permitted to sell, tender
            or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Shares, (iv) the Company, directly or indirectly, in one or more related transactions effects any
            reclassification, reorganization or recapitalization of the Common Shares or any compulsory share exchange pursuant to which the Common Shares are effectively converted into or exchanged for other securities, cash or property, or (v) the
            Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger, or scheme
            of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding Common Shares (not including any Common Shares held by the other Person or other Persons making or party to, or
            associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;Fundamental Transaction&#8221;), then, upon any subsequent exercise of this Warrant, the Holder shall
            have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section
            2(e) on the exercise of this Warrant), the number of Common Shares of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#8220;Alternate Consideration&#8221;) receivable as a
            result of such Fundamental Transaction by a holder of the number of Common Shares for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
            Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one Common Share
            in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of
            Common Shares are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this
            Warrant following such Fundamental Transaction. The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &#8220;Successor Entity&#8221;) to assume in writing all of the obligations of the
            Company under this Warrant in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without</font></div>
        <div style="text-align: justify; margin-left: 36pt; font-family: 'Times New Roman', serif;">unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a
          security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent
          entity) equivalent to the Common Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
          the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the Common Shares pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital
          stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction)<font style="font-family: Calibri, sans-serif;">&#160;</font>and which is
          reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction,
          the provisions of this Warrant referring to the &#8220;Company&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same
          effect as if such Successor Entity had been named as the Company herein.</div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Calculations</u>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a
          share, as the case may be. For purposes of this Section 3, the number of Common Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Common Shares (excluding treasury shares, if any) issued and
          outstanding.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">104</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notice to Holder</u>.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">i.&#160;&#160;&#160;&#160;&#160;&#160;<u>Adjustment to Exercise Price</u>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the
          Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts
          requiring such adjustment.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 108pt; font-family: 'Times New Roman', serif;">ii.&#160;&#160;&#160;&#160;&#160;<u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever
          form) on the Common Shares, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Shares, (C) the Company shall authorize the granting to all holders of the Common Shares rights or warrants to
          subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Shares, any consolidation or merger
          to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Shares are converted into other securities, cash or property, or (E) the Company
          shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile number or
          email address as it shall appear upon the Warrant Register of the Company, at least ten (10) trading days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for
          the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Shares of record to be entitled to such dividend, distributions, redemption, rights or
          warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common
          Shares of record shall be entitled to exchange their Common Shares for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such
          notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material,
          non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 6-K. The Holder shall remain entitled to exercise this Warrant
          during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-indent: 36pt; font-family: 'Times New Roman', serif;"><u>Section 4</u>.&#160; &#160; &#160; &#160; &#160; <u>Transfer of Warrant</u>.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Transferability</u>. This Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of
          this Warrant at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to
          pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in
          the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
          anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company
          within five (5) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase
          of Warrant Shares without having a new Warrant issued.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">105</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>New Warrants</u>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid
          office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which
          may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or
          exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the Company for that
          purpose (the &#8220;<u>Warrant Register</u>&#8221;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any
          distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-indent: 36pt; font-family: 'Times New Roman', serif;"><u>Section 5</u>.&#160; &#160; &#160; &#160; &#160; <u>Miscellaneous</u>.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>No Rights as Stockholder Until Exercise; No Settlement in Cash</u>. This Warrant does not entitle the Holder to any
          voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares
          on a &#8220;cashless exercise&#8221; pursuant to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required to net cash settle an exercise of this Warrant.&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt by the Company of
          evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably
          satisfactory to it (which, in the case of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock
          certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or the expiration of
          any right required or granted herein shall not be a Trading Day, then, such action may be taken or such right may be exercised on the next succeeding Trading Day.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Authorized Shares</u>.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; margin-left: 72pt; font-family: 'Times New Roman', serif;">The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Shares
          a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its
          officers who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares
          may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Shares may be listed. The Company covenants that all Warrant Shares which may be issued
          upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid
          and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">106</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman', serif;">Except and to the extent as waived or consented to by holders of a majority of the then outstanding Warrants (based on the number of
          Warrant Shares underlying such Warrants), the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue
          or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of
          all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant
          Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and
          nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be,
          necessary to enable the Company to perform its obligations under this Warrant.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman', serif;">Before taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in
          the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Governing Law</u>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant
          shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the
          interpretations, enforcement and defense of the transactions contemplated by this Warrant (whether brought against a party hereto or their respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be
          commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for
          the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
          not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to
          process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Warrant
          and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If either party
          shall commence an action, suit or proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for their reasonable attorneys&#8217; fees and other costs and
          expenses incurred with the investigation, preparation and prosecution of such action or proceeding. In addition to and without limiting the foregoing, the Company has confirms that it has appointed Seward &amp; Kissel LLP, with a business address
          at One Battery Park Plaza, New York, New York 10004, as its authorized agent (the &#8220;Authorized Agent&#8221;) upon whom process may be served in any suit, action or proceeding arising out of or based upon this Warrant or the transactions contemplated
          herein which may be instituted in any New York federal or state court, by a Holder, the directors, officers, partners, employees and agents of such Holder and each affiliate of such Holder, and expressly accept the non-exclusive jurisdiction of
          any such court in respect of any such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said agent for service of process, and the Company
          agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. The Company hereby authorizes and directs the Authorized Agent to accept
          such service. Service of process upon the Authorized Agent shall be deemed, in every respect, effective service of process upon the Company. If the Authorized Agent shall cease to act as agent for service of process, the Company shall appoint,
          without unreasonable delay, another such agent in the United States, and notify the Holders of such appointment. Notwithstanding the foregoing and except as set forth herein, any action arising out of or based upon this Warrant may be instituted
          by a Holder, the directors, officers, partners, employees and agents of the Holder (if applicable) and each respective affiliate of the Holder, in any court of competent jurisdiction in the Republic of the Marshall Islands.&#160; Notwithstanding the
          foregoing, nothing in this paragraph shall limit or restrict the federal district court in which a Holder may bring a claim under the federal securities laws. This paragraph shall survive any termination of this Warrant, in whole or in part.</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">107</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Restrictions</u>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not
          registered, and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Nonwaiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder on the part of
          Holder shall operate as a waiver of such right or otherwise prejudice the Holder&#8217;s rights, powers or remedies. Without limiting any other provision of this Warrant, if it is finally adjudicated (without possibility of appeal) that the Company has
          willfully and knowingly failed to comply with any provision of this Warrant, which has resulted in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses
          including, but not limited to, reasonable attorneys&#8217; fees, including those of appellate proceedings, incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Notices</u>. Any and all notices or other communications or deliveries to be provided by the Holders hereunder
          including, without limitation, any Notice of Exercise, shall be in writing and delivered personally or sent by a nationally recognized overnight courier service, addressed to the Company, at 223 Christodoulou Chatzipavlou Street, Hawaii Royal
          Gardens, 3036 Limassol, Cyprus, Attention: Chief Executive Officer, or such other address as the Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be provided by the
          Company hereunder shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, e-mail address or address of such Holder
          appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (to the extent applicable as a proper method of notice hereunder) (i) the time of
          transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day after
          the time of transmission, if such notice or communication is delivered via facsimile at the facsimile number or via e-mail at the e-mail address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City
          time) on any Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the
          extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on
          Form 6-K.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder to exercise
          this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Shares or as a stockholder of the Company, whether
          such liability is asserted by the Company or by creditors of the Company.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Remedies</u>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of
          damages, will be entitled to seek specific performance of its rights under this Warrant.<font style="font-family: Calibri, sans-serif;">&#160;</font>The Company agrees that monetary damages would not be adequate compensation for any loss incurred by
          reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Successors and Assigns</u>. Subject to applicable securities laws and the terms hereof, this Warrant and the rights and
          obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the
          benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder or holder of Warrant Shares.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Amendment</u>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the
          Company, on the one hand,&#160;<font style="color: #000000;">and the Holder, on the other hand</font>.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Severability</u>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be
          effective and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the
          remainder of such provisions or the remaining provisions of this Warrant.</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman', serif;">n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Headings</u>. The headings used in this Warrant are for the convenience of reference only and shall not, for any
          purpose, be deemed a part of this Warrant.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif;">********************</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="margin-bottom: 6pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-style: italic;">(Signature Page Follows)</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" id="DSPFPageNumber">108</font></div>
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div><font style="font-family: 'Times New Roman', serif;">&#160;</font><font style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt;" id="TRGRRTFtoHTMLTab">&#160;</font><font style="font-family: 'Times New Roman', serif;">IN WITNESS
            WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zfe003bed05dd4d1eb30bf33009e3da4b">

            <tr>
              <td style="width: 45.95%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
              </td>
              <td style="width: 54.05%; vertical-align: top;" colspan="2">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">CASTOR MARITIME INC.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.95%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
              </td>
              <td style="width: 4.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
              </td>
              <td style="width: 49.37%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.95%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 4.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">By:</div>
              </td>
              <td style="width: 49.37%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.95%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 4.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 49.37%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Name: Petros Panagiotidis</div>
              </td>
            </tr>
            <tr>
              <td style="width: 45.95%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 4.68%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif; font-weight: bold;">&#160;</div>
              </td>
              <td style="width: 49.37%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Title:&#160;&#160; Chief Executive Officer</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="margin-bottom: 6pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">NOTICE OF EXERCISE</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">TO: CASTOR MARITIME INC.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">(1)&#160;&#160; The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only required if
          exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-indent: 72pt; font-family: 'Times New Roman', serif;">(2)&#160;&#160; Payment shall take the form of (check applicable box):</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="margin-left: 108pt; font-family: 'Times New Roman', serif;">[ ] in lawful money of the United States by wire transfer; or</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; margin-left: 108pt; font-family: 'Times New Roman', serif;">[ ] if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
          exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman', serif;">(3)&#160;&#160; Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z04c2edfcd41a450398ab52b7cd04f26b">

            <tr>
              <td style="width: 22.26%; vertical-align: top;">&#160;</td>
              <td style="width: 38.86%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.88%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; font-family: 'Times New Roman', serif;">The Warrant Shares shall be delivered to the following DWAC Account Number:</div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za002d526515643568449ac56210c7e31">

            <tr>
              <td style="width: 22.26%; vertical-align: top;">&#160;</td>
              <td style="width: 38.86%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.88%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z69a285628dbb4dacb20757dc9ef12e56">

            <tr>
              <td style="width: 22.26%; vertical-align: top;">&#160;</td>
              <td style="width: 38.86%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.88%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z08e252b44a844e1ba1212141ef9edc5f">

            <tr>
              <td style="width: 22.26%; vertical-align: top;">&#160;</td>
              <td style="width: 38.86%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.88%; vertical-align: top;">&#160;</td>
            </tr>

        </table>
        <div><br>
        </div>
        <div><br>
        </div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">[SIGNATURE OF HOLDER]</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="ze18df21b40fe4727a99d7f36da2e8758">

            <tr>
              <td style="width: 22.25%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Name of Investing Entity:</div>
              </td>
              <td style="width: 77.75%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z6a8401d90978450a89783fc0eec8912d">

            <tr>
              <td style="width: 46.06%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;"><font style="font-style: italic;">Signature of Authorized Signatory of Investing Entity</font>:</div>
              </td>
              <td style="width: 53.94%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z067e8dcdc21b4b4e8257593f982f7815">

            <tr>
              <td style="width: 27.01%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Name of Authorized Signatory:</div>
              </td>
              <td style="width: 72.99%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4ba3d2c4ce0f44aca5d080ba9cc2dbad">

            <tr>
              <td style="width: 25.94%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Title of Authorized Signatory:</div>
              </td>
              <td style="width: 74.06%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z29a5584ea02949258187f301c072fd31">

            <tr>
              <td style="width: 5.32%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Date:</div>
              </td>
              <td style="width: 94.68%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
        </div>
        <div><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-weight: bold;">ASSIGNMENT FORM</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 10.5pt; color: #000000; font-family: 'Times New Roman', serif; font-style: italic;">(To assign the foregoing Warrant, execute this form and supply the required information. Do not use this form to
          purchase shares.)</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: justify; text-indent: 10.5pt; color: #000000; font-family: 'Times New Roman', serif;">FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z684a10b6e502462ba6a6298e5a958bed">

            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">Name:</div>
              </td>
              <td style="width: 38.13%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">(Please Print)</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">Address:</div>
              </td>
              <td style="width: 38.13%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="color: #000000; font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">(Please Print)</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Phone Number:</div>
              </td>
              <td style="width: 38.13%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Email Address:</div>
              </td>
              <td style="width: 38.13%; vertical-align: top; border-bottom: #000000 2px solid;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Dated: _______________ __, ______</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Holder&#8217;s Signature: ______________________</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>
            <tr>
              <td style="width: 53.65%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">Holder&#8217;s Address: _______________________</div>
              </td>
              <td style="width: 38.13%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
              <td style="width: 8.22%; vertical-align: top;">
                <div style="font-family: 'Times New Roman', serif;">&#160;</div>
              </td>
            </tr>

        </table>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="text-align: center; margin-bottom: 6pt; font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="font-family: 'Times New Roman', serif;">&#160;</div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
      </div>
    </div>
    <div id="DSPFPageBreakArea">
      <hr style="page-break-after: always; color: #FFFFFF;" id="DSPFPageBreak"></div>
    <div>
      <div><br>
      </div>
      <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 5.1</font><br>
      </div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z0ea707aff86c419fa83a0109d753777d">

            <tr>
              <td style="width: 25.59%; vertical-align: top;">&#160;</td>
              <td style="width: 48.8%; vertical-align: top;">
                <div style="text-align: center; font-family: 'Times New Roman Bold', serif; font-size: 20pt; font-variant: small-caps;">Seward &amp; Kissel llp</div>
                <div style="text-align: center; font-family: 'Times New Roman', serif;">ONE BATTERY PARK PLAZA</div>
                <div style="text-align: center; font-family: 'Times New Roman', serif;">NEW YORK, NEW YORK&#160; 10004</div>
              </td>
              <td style="width: 25.6%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 25.59%; vertical-align: top;">&#160;</td>
              <td style="width: 48.8%; vertical-align: top;">&#160;</td>
              <td style="width: 25.6%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 25.59%; vertical-align: top;">&#160;</td>
              <td style="width: 48.8%; vertical-align: top;">
                <div style="text-align: center; font-family: Calibri, sans-serif; font-size: 9pt;">TELEPHONE:&#160; (212)&#160; 574-1200</div>
                <div style="text-align: center; font-family: Calibri, sans-serif; font-size: 9pt;">FACSIMILE:&#160; (212) 480-8421</div>
                <div style="text-align: center; font-family: Calibri, sans-serif; font-size: 9pt;">WWW.SEWKIS.COM</div>
              </td>
              <td style="width: 25.6%; vertical-align: top;">
                <div style="text-align: center; font-family: Calibri, sans-serif; font-size: 8pt;">901 K Street, NW</div>
                <div style="text-align: center; font-family: Calibri, sans-serif; font-size: 8pt;">WASHINGTON, D.C. 20001</div>
                <div style="text-align: center; font-family: Calibri, sans-serif; font-size: 8pt;">TELEPHONE:&#160; (202) 737-8833</div>
                <div style="text-align: center; font-family: Calibri, sans-serif; font-size: 8pt;">FACSIMILE:&#160; (202) 737-5184</div>
              </td>
            </tr>

        </table>
        <div> <br>
        </div>
        <div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z62fb56677ccc49249f82ea427fe91c35">

              <tr>
                <td style="width: 61.55%; vertical-align: top;">&#160;</td>
                <td style="width: 38.45%; vertical-align: top;">
                  <div style="text-align: justify; font-family: 'Times New Roman',serif;">June 26, 2020</div>
                </td>
              </tr>

          </table>
          <div><br>
          </div>
          <div><br>
          </div>
          <div style="text-align: justify; font-family: 'Times New Roman',serif;">Castor Maritime Inc.</div>
          <div style="text-align: justify; font-family: 'Times New Roman',serif;">223 Christodoulou Chatzipavlou Street</div>
          <div style="text-align: justify; font-family: 'Times New Roman',serif;">Hawaii Royal Gardens</div>
          <div style="text-align: justify; font-family: 'Times New Roman',serif;">3036 Limassol, Cyprus</div>
          <div><br>
          </div>
          <div style="text-align: justify; text-indent: 72pt;"><font style="font-family: 'Times New Roman',serif; font-weight: bold;">Re:</font><font style="display: inline-block; text-indent: 0px; width: 36pt;" id="TRGRRTFtoHTMLTab">&#160;</font><font style="font-weight: bold; font-family: 'Times New Roman',serif;"><u>Castor Maritime Inc.</u></font></div>
          <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman',serif;">Ladies and Gentlemen:</div>
          <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif;">We have acted as United States and Marshall Islands counsel to Castor Maritime Inc. (the&#160;&#8220;Company&#8221;) in connection with the Company&#8217;s
            Registration Statement on Form&#160;F-1 (File Nos.&#160;333-238990 and 333-239399) (collectively, the &#8220;Registration Statement&#8221;) as filed with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) on June 5, 2020, as thereafter amended or
            supplemented, with respect to public offering (the &#8220;Offering&#8221;) of 59,110,000 units of the Company (the &#8220;Units&#8221;), each Unit consisting of (a) one common share, par value $0.001 per share, of the Company (each, a &#8220;Common Share&#8221;) or one pre-funded
            warrant to purchase one Common Share (the &#8220;Pre-Funded Warrants&#8221; and the Common Shares issuable upon exercise therefor, the &#8220;Pre-Funded Warrant Shares&#8221;) and (b) one Class A warrant to purchase one Common Share (the &#8220;Class A Warrants&#8221;, together
            with the Pre-Funded Warrants, the &#8220;Warrants&#8221;, and the Common Shares issuable upon exercise of the Class A Warrants, the &#8220;Class A Warrant Shares&#8221;, together with the Common Shares and the Pre-Funded Warrant Shares, the &#8220;Shares&#8221;), which includes
            the exercise of Maxim Group LLC&#8217;s over-allotment option.</div>
          <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif;">We have examined originals or copies, certified or otherwise identified to our satisfaction, of: (i)&#160;the Registration Statement;
            (ii)&#160;the prospectus of the Company (the &#8220;Prospectus&#8221;) included in the Registration Statement; (iii)&#160;the Stockholders Rights Agreement dated November 20, 2017 (the &#8220;Rights Agreement&#8221;); (iv) the Class A Warrants; (v) the Pre-Funded Warrants and
            (vi)&#160;such corporate documents and records of the Company and such other instruments, certificates and documents as we have deemed necessary or appropriate as a basis for the opinions hereinafter expressed. In such examinations, we have assumed
            the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies or drafts of documents to be executed, the genuineness of all signatures and the legal competence or
            capacity of persons or entities to complete the execution of documents. As to various questions of fact which are material to the opinions hereinafter expressed, we have relied upon statements or certificates of public officials, directors of
            the Company and others.</div>
          <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif;">We have further assumed for the purposes of this opinion, without investigation, that (i)&#160;all documents contemplated by the Prospectus
            to be executed in connection with the Offering have been duly authorized, executed and delivered by each of the parties thereto other than the Company, and (ii)&#160;the terms of the Offering comply in all respects with the terms, conditions and
            restrictions set forth in the Prospectus and all of the instruments, agreements and other documents relating thereto or executed in connection therewith.</div>
          <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif;">Based upon and subject to the foregoing and the assumptions, qualifications and limitations set forth below, we are of the opinion
            that (i)&#160;the Shares and the Warrants have been duly authorized by the Company; (ii)&#160;when issued and delivered pursuant to the Prospectus, the Common Shares will be validly issued, fully paid and non-assessable; (iii)&#160;the Class A Warrant Shares,
            when issued and delivered against payment therefor upon the exercise of the Class A Warrants in accordance with the terms therein, will be validly issued, fully paid and non-assessable; (iv) when issued and delivered pursuant to the Prospectus,
            the Class A Warrants will constitute binding obligations of the Company in accordance with their terms; (v) the Pre-Funded Warrant Shares, when issued and delivered against payment therefor upon the exercise of the Pre-Funded Warrants in
            accordance with the terms therein, will be validly issued, fully paid and non-assessable; (vi)&#160;when issued and delivered pursuant to the Prospectus, the Pre-Funded Warrants will constitute binding obligations of the Company in accordance with
            their terms; and (vii)&#160;when issued and delivered pursuant to the Prospectus, the Preferred Stock Purchase Rights will constitute binding obligations of the Company in accordance with the terms of the Rights Agreement.</div>
          <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif;">This opinion is limited to the laws of the State of New York and the Republic of the Marshall Islands as in effect on the date hereof.</div>
          <div style="text-align: justify; text-indent: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman',serif;">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement, and to each reference to us and the
            discussions of advice provided by us under the headings &#8220;Legal Matters&#8221; in the Prospectus, without admitting we are &#8220;experts&#8221; within the meaning of the Securities Act of 1933, as amended, or the rules and regulations of the Commission
            thereunder with respect to any part of the Registration Statement.</div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z4f57a7cecac44f3c9c3553ac83d64337">

              <tr>
                <td style="width: 61.55%; vertical-align: top;">&#160;</td>
                <td style="width: 38.45%; vertical-align: top;">
                  <div style="text-align: justify; font-family: 'Times New Roman',serif;">Very truly yours,</div>
                </td>
              </tr>
              <tr>
                <td style="width: 61.55%; vertical-align: top;">&#160;</td>
                <td style="width: 38.45%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 61.55%; vertical-align: top;">&#160;</td>
                <td style="width: 38.45%; vertical-align: top;">
                  <div style="text-align: justify; font-family: 'Times New Roman',serif;">/s/ Seward &amp; Kissel LLP</div>
                </td>
              </tr>
              <tr>
                <td style="width: 61.55%; vertical-align: top;">&#160;</td>
                <td style="width: 38.45%; vertical-align: top;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 61.55%; vertical-align: top;">&#160;</td>
                <td style="width: 38.45%; vertical-align: top;">&#160;</td>
              </tr>

          </table>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
          <div><br>
          </div>
        </div>
        <div> <br>
        </div>
      </div>
    </div>
    <div id="DSPFPageBreakArea">
      <hr style="page-break-after: always; color: #FFFFFF;" id="DSPFPageBreak"></div>
    <div>
      <div>
        <div style="text-align: right; margin-bottom: 8pt; font-family: 'Times New Roman', serif; font-weight: bold;">Exhibit 99.1</div>
        <div style="margin-bottom: 8pt;"><br>
        </div>
        <div style="text-align: center; margin-bottom: 8pt;"><img width="176" height="119" src="image00001.jpg"></div>
        <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">Castor Maritime Inc. Announces Pricing of Upsized $18.0 Million Underwritten</div>
        <div style="text-align: center; margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">Public Offering</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="font-weight: bold;">June 23, 2020 - Limassol, Cyprus</font> - Castor Maritime Inc. (the &#8220;Company&#8221;) (NASDAQ: CTRM) announced today the pricing of an upsized
          underwritten public offering of 51,400,000 units at a price of $0.35 per unit. Each unit consists of one common share (or prefunded warrant in lieu thereof) and one Class A warrant to purchase one common share, and will immediately separate upon
          issuance. The gross proceeds of the offering to the Company, before underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $18.0 million. The Company intends to use the net proceeds of the
          offering for capital expenditures, working capital, to make vessel or other asset acquisitions or for other general corporate purposes, or a combination thereof.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Each Class A warrant is immediately exercisable for one common share at an exercise price of $0.35 per share and will expire five years from issuance. The offering is expected
          to close on or about June 26, 2020, subject to customary closing conditions.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Maxim Group LLC is acting as sole book-running manager in connection with the offering.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">The Company has granted the underwriter a 30-day option to purchase up to an additional 7,710,000 shares of common stock or prefunded warrants and/or 7,710,000 Class A
          warrants, at the public offering price less discounts and commissions.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">The offering is being conducted pursuant to the Company's registration statement on Form F-1 (File No. 333-238990) previously filed with and subsequently declared effective by
          the Securities and Exchange Commission ("SEC") on June 23, 2020 (the &#8220;Registration Statement&#8221;). A final prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website at http://www.sec.gov. Electronic
          copies of the prospectus relating to this offering, when available, may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at (212) 895-3745.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction
          in which such offer, solicitation or sale would be unlawful prior to registration or qualification of these securities under the securities laws of any such state or jurisdiction.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">About Castor Maritime Inc.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Castor Maritime Inc. is an international provider of shipping transportation services through its ownership of dry bulk vessels. The Company&#8217;s vessels are employed primarily
          on medium-term charters and transport a range of dry bulk cargoes, including such commodities as coal, grain and other materials along worldwide shipping routes.&#160; The Company's fleet currently consists of three Panamax dry bulk carriers.&#160; For
          more information please visit the company&#8217;s website at www.castormaritime.com</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">Cautionary Statement Regarding Forward-Looking Statements</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for
          forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and
          underlying assumptions and other statements, which are other than statements of historical facts. The Company desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this
          cautionary statement in connection with this safe harbor legislation. The words &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;pending&#8221; and similar expressions
          identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management&#8217;s examination
          of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant
          uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. We undertake no obligation to update any
          forward-looking statement, whether as a result of new information, future events or otherwise. In addition to these important factors, other important factors that, in the Company&#8217;s view, could cause actual results to differ materially from those
          discussed in the forward-looking statements include general dry bulk shipping market conditions, including fluctuations in charterhire rates and vessel values, the strength of world economies the stability of Europe and the Euro, fluctuations in
          interest rates and foreign exchange rates, changes in demand in the dry bulk shipping industry, including the market for our vessels, changes in our operating expenses, including bunker prices, dry docking and insurance costs, changes in
          governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and&#160; international political conditions, potential disruption of shipping routes due to
          accidents or political events, the availability of financing and refinancing and grow our business, vessel breakdowns and instances of off-hire, risks associated with vessel construction, potential exposure or loss from investment in derivative
          instruments, potential conflicts of interest involving our Chief Executive Officer, his family and other members of our senior management, and our ability to complete acquisition transactions as planned. Please see our filings with the Securities
          and Exchange Commission for a more complete discussion of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update any
          forward-looking statements as a result of developments occurring after the date of this communication.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">CONTACT DETAILS</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">For further information please contact:</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Petros Panagiotidis<br>
          Castor Maritime Inc.<br>
          Email: info@castormaritime.com</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Media Contact:</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Kevin Karlis<br>
          Capital Link<br>
          Email: castormaritime@capitallink.com</div>
      </div>
    </div>
    <div id="DSPFPageBreakArea">
      <hr style="page-break-after: always; color: #FFFFFF;" id="DSPFPageBreak"></div>
    <div>
      <div>
        <div style="text-align: right; margin-bottom: 8pt; font-family: 'Times New Roman', serif; font-weight: bold;">Exhibit 99.2</div>
        <div style="text-align: right; margin-bottom: 8pt; font-family: 'Times New Roman', serif; font-weight: bold;"> <br>
        </div>
        <div style="text-align: right; margin-bottom: 8pt; font-family: 'Times New Roman', serif; font-weight: bold;"> <br>
        </div>
        <div style="margin-bottom: 8pt; text-align: center;"><img src="image00001.jpg"></div>
        <div style="text-align: center; margin-bottom: 8pt; font-family: 'Times New Roman', serif; font-weight: bold;">Castor Maritime Inc. Announces Closing of Upsized $20.7 Million Underwritten Public Offering Including Full Exercise of Overallotment
          Option</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;"><font style="font-weight: bold;">June 26, 2020 - Limassol, Cyprus</font> - Castor Maritime Inc. (the &#8220;Company&#8221;) (NASDAQ: CTRM) announced today the closing
          of an upsized underwritten public offering of 51,400,000 units at a price of $0.35 per unit. Each unit consisted of one common share (or prefunded warrant in lieu thereof) and one Class A warrant to purchase one common share, and immediately
          separated upon issuance. In addition, the Company granted to Maxim Group LLC a 30-day option to purchase up to an additional 7,710,000 common shares (or prefunded warrants in lieu thereof) and/or up to 7,710,000 Class A warrants, at the public
          offering price less discounts and commissions, of which Maxim Group LLC has fully exercised its option to purchase 7,710,000 common shares and 7,710,000 Class A warrants. The gross proceeds of the offering to the Company, before underwriting
          discounts and commissions and estimated offering expenses and including full exercise of the overallotment option, were approximately $20.7 million.</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Each Class A warrant is immediately exercisable for one common share at an exercise price of $0.35 per share and expires five years from issuance.</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Maxim Group LLC acted as sole book-running manager in connection with the offering.</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">The offering was conducted pursuant to the Company's registration statement on Form F-1 (File No. 333-238990) previously filed with and subsequently
          declared effective by the Securities and Exchange Commission ("SEC") on June 23, 2020 (the &#8220;Registration Statement&#8221;). A final prospectus relating to the offering was filed with the SEC and is available on the SEC's website at <font style="color: #0563C1;"><u>http://www.sec.gov</u></font>. Electronic copies of the prospectus relating to this offering, when available, may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at (212) 895-3745.</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any
          state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification of these securities under the securities laws of any such state or jurisdiction.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">About Castor Maritime Inc.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Castor Maritime Inc. is an international provider of shipping transportation services through its</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">ownership of dry bulk vessels. The Company&#8217;s vessels are employed primarily on medium-term</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">charters and transport a range of dry bulk cargoes, including such commodities as coal, grain</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">and other materials along worldwide shipping routes.&#160; The Company's fleet currently consists of three Panamax dry bulk carriers.&#160; For more information please visit the
          company&#8217;s website at <font style="color: #0563C1;"><u>www.castormaritime.com</u></font></div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">Cautionary Statement Regarding Forward-Looking Statements</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Matters discussed in this press release may constitute forward-looking statements. The Private</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide
          prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than
          statements of historical facts. The Company desires to take advantage of</div>
        <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman', serif;">the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe
          harbor legislation. The words &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;forecast,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;pending&#8221; and similar expressions identify forward-looking statements. The forward-looking
          statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management&#8217;s examination of historical operating trends, data contained in our
          records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or
          impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. We undertake no obligation to update any forward-looking statement, whether as a result of new
          information, future events or otherwise. In addition to these important factors, other important factors that, in the Company&#8217;s view, could cause actual results to differ materially from those discussed in the forward&#8208;looking statements include
          general dry bulk shipping market conditions, including fluctuations in charterhire rates and vessel values, the strength of world economies the stability of Europe and the Euro, fluctuations in interest rates and foreign exchange rates, changes
          in demand in the dry bulk shipping industry, including the market for our vessels, changes in our operating expenses, including bunker prices, dry docking and insurance costs, changes in governmental rules and regulations or actions taken by
          regulatory authorities, potential liability from pending or future litigation, general domestic and&#160; international political conditions, potential disruption of shipping routes due to accidents or political events, the availability of financing
          and refinancing and grow our business, vessel breakdowns and instances of off&#8208;hire, risks associated with vessel construction, potential exposure or loss from investment in derivative instruments, potential conflicts of interest involving our
          Chief Executive Officer, his family and other members of our senior management, and our ability to complete acquisition transactions as planned. Please see our filings with the Securities and Exchange Commission for a more complete discussion of
          these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update any forward&#8208;looking statements as a result of developments occurring
          after the date of this communication.</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif; font-weight: bold;">CONTACT DETAILS</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">For further information please contact:</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Petros Panagiotidis<br>
          Castor Maritime Inc.<br>
          Email: <font style="color: #0563C1;"><u>info@castormaritime.com</u></font></div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Media Contact:</div>
        <div style="margin-bottom: 12pt; font-family: 'Times New Roman', serif;">Kevin Karlis<br>
          Capital Link<br>
          Email: <font style="color: #0563C1;"><u>castormaritime@capitallink.com</u></font></div>
      </div>
    </div>
    <div style="margin-bottom: 8pt;"><br>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0Q!W@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3
M%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 44F*,4 +1110 449'K29'J* %HHS10 44G--;<.E KCZ*0
M9QS2T#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA5S%:QIVW/-J9A.6QS&E^#-,T\*1 A8#K7116L4*X10*EVBBM;(XYU92=VP
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBHY)HX5S(P H DICOMY)XKG]9\6V&F0D^<I;L*\PU_XE2LS+ 2
M!["HE-(Z:.%G4/5]0\2V&GJQDE (]Q7G'B7XIM"3'9,&!'7(KS&^U^\U%BTD
MS#/:LP\G<QW9KGE49[>'RE;LOZEK]YJ%P\SW$@+]MQQ67F5VRY)/N:7 !S4B
MN,8K%NYZT:48JR1"Q8'! I_S;?>E;F@'"X/YTKE+0:,]Z0^PI:.G>@+L3FD.
M<].*".1S2].<TA6N&*3DGFE]Q^5)WZTP:L+[&F\@TXCC--SDT[D\]A3G\:;\
MP.:7OU_&D/)QG\:7,+G$(/6E[4=.,T'D=:5Q+43))XZ4A//M2CCO1C)S3-53
M 1D'?_#3&=&X/%.8D?Q?+2*8P>,,3VIJ-S.5HB)$O4F@E0?FZ5<MM)OKUPL,
M+$'TKM]$^%UW=^6\Y8!N3DU2ILY:F-C!'GT<,MQ*%MEW'Z5TFE^!]7U,@F @
M'V->T:%\-K/32&<*YQZUV=KIMO:KMCB ^E;QI]SS*V9=CR;PY\)DBD26Z4^X
M(->E:9X7T_3% CMXF/N@K;V\8'%.K912/,JXF=3<8D4:#"HJ_04^BBJ.<***
M* "DQ2T4 %%%% !1110 AS1R:,T47$'2L37?$-OH\#,[@-C(Y%0>(_$UMH]N
M=SC<0>*^>O&'C"XU2_D59#LZ"LISL=V&PLIN[V+OCOQU/K4AABE8*&_A;K7!
MK(Q!+<D^M(IR2S<YI"P)P*YI2;/?H4XP5K"QC+Y/6C+;SBD(*FG<8ZU+9N-&
M[GBD&<'BG9SWQ31T/-2 F[C%-IVT8SFFTT 4444#"ES24"G87D+CN.M- .:?
MWZTW&3UI&;C9Z"CD\4_) VKS38^#CUK1M+/H[\>U,TC!SW%L+3Y3*178^&M&
MDU2]CC*?(2.<53T/19=1OE2-3L[U[KX5\,0Z?;QR%!O'-7&FV<^)Q*P\78V-
M%TM+&T2,( 0.N*UZ0# I:[$K*Q\O.;F[L****9 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ4W'-0V:-\VPI!7G-)UYZ4K<XS2$@'&*$)P?47WS^%(:*2K2)LD'XT@&.]*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***:6V]>E "MGM1G"Y-9]_K-I8Q[I
M)5!]*\\\2?$>.*)XX",] 0*AS2.BCAJE5Z([W4=?M;!"7D (]Q7E_B7XF,9)
M(;9_EZ9!%>?:MXCO]4<_O65:RE48W2-EO>N>=2Z/:P^6<KNT7+[6;R_D9GE?
M!/\ >K/*L3EB?K3MXSTQ2,W-<\I,]NE1C#H'M2_S[4F.,@TG3WI(N5EL!)SS
MUHP<].:,>]+[9_&FR4[B<YZ<T@SDX%+CW_&FCKUH .32448R* NPP?PI3G%'
M;K28XZT"#ZT'F@#WI,8/6FV/DL'(.#1WQ0?3-(>F,_C4$<S0'/:D^M.4XX/Y
MTC%#U;%4DR7/N)Q_#S36+!<D<4];9W/[KYC[5LZ1X8O]3F"^2P7UJN5LSG6C
M27,8*S9^51FM?3O#>I:HZA(3M/?!KU30/A7&-DLY'J037I.G^'K.P0*D2\5O
M"DSR\3F<7L>8>&_A>#$DEXA!^AKTK3?#=E91JJP1Y48^[6R(PH 7@"GUT**1
MX]7%3GU&)&B#"J!]!3Z**HY@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ I,4M% '!?$PR_P!AR>5G[O:OFB9V-TX;KGO7V!K>EIJ=A+$P
M'*FOG;QAX+GT^9YT0[0U<U6#;/9RZO&*L<.Q(&*%X7VH92"0_!%*%#+PU8;'
MNZ2U&8RW%.8X ! IN-AI7Z ]:">>P=*3GO2?C1^-(/:,0]>::06Z4['/7\:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M16D3SOPY\,TMMKW* \>@KT#3]$M+!=L<8!^E:@&!P,4M:Q@D>14Q-2INQNW
MPM*.E+15V.<2EHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4X[!_%37#L<*"3[5J:5X;N]088A<Y/7;329G*I&/4S/FD(6(;C[5NZ)X6O\
M4IE4HVT]Z]+\,_#%(HDGG09;GD"O2-/T.ST^,>5& 0/2NB%/N>+7S-*\4><Z
M%\-$B*O-R>O)KT>PT2SL8U"1+N'>M%<8X%.KHC!(\>MB)U-QF.PXIP'%+2#.
M>:=CGN+1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3FEHH #
M2#/>EI&Z4 +2$@#)-5+K4+>SB+RR  #O7EWBCXCB+=%;GVR!4RFDCIH86I6=
MHG;:_P"*K;2U90XW8]17CWB/QO<W\TB1R,$)QD-7/7^LW6JRM+)*<'M67O#O
MM-<=2;9]+@\OC2U:)7EDF<LTC/GNQS1CUH*A#@'K3<'.<_A6-SU4DE9"<_A1
MGUH/'?-&/>@&-Y[]:7)QTYI#2XXZ_C0(3!Z]Z"21Q1VQG\:4@8ZTF T>U 'I
M1U]J/TIW$'08[4F,\=J4<\Y_"C'/6BXA#Z&@DY'%&.>N:3IWHN%Q&R>U-\QE
MXQ3U'/)ILA"M@<^]-$-MB^6CC<3\WI35>56VA013EV;<EN:L6EK/>2B.*(G/
M&11R-A*48J[(&"=C\Q[5;LM&O;V0"*+*GOBNY\+_  XGO9EFN<JHYP3UKUG2
M/"MEI\0'E*2.];4Z3/)Q691CHCSGPY\-#(B27*=LG(->GZ1X<LM,@")$A([E
M:UTC2-=J# IV.:ZXQ21X-;%3J-Z@JJHPH 'M2T451S!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 )M7T%  '0"EHH"X4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BDI,T";'44@H/ H&)GOVK$UCQ':Z;"Q9USCUJ
MIXB\2QZ7#)AAN4'O7B>N>()M3G;;(QR?6LJE1):'J8/+Y5O>>Q:\5^*[C4[U
MU1SY8X')KE&*ELORQHW,"<\GWIHR>:X)S=SZC#894581AS@=:% !Y'-.!(^E
M!)/TK--W.ZRM<7<IX YIN!VHY/48%&"*LS]IS: :0X ]J7FC% #>"OM2]J#G
M'%'.*!"8!ZTTX!Z4ISVI.?2@0'DTN#2'<!D"A79^&&!2)6K ;<T'Z&G,@49S
M3?,<\;1BG8VY5881S\HXIY ,?OZ4Y5D+A(5W$UV'ACP5<ZK.))XR%'L:UC"Y
MY^)KJFKG.Z+H=QJ5QM$+E?7;7KWA3X?16KI<7,>1UQ@5U>@>&+32;< 1(6]U
MKH% 48  'M73"G;<^=Q69SG[L=B*WM8K9 L:@ 5*%YYIU%;6/*<F]Q#[4E.H
MIDV$ I:**!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@!IS2CI2TE%Q6&N,]>!7-^)?$4.E6[(7PQ7CFKVO:S%I
M=J69AD@UX)XJU^;5M0DVN=H.*QJ3L>I@,'*M*[6A#K^N2WERS>8Q7=TS6&Q,
MQW]#3U52,,V2:=M"# KBE(^PH15*-B,9SDBCDT=^M%0;>8=*,$TH&>](>.]
MF&<#%-IV,C.?PIM%Q:!VYH(/?\*3'?-.'US19@Y\J$.:.101@]:0\\9HO87F
M)RYP.M.Y48QS33P.#SZTY3N&"<55TRK.0WD'('6@?-P1Q1*P3O4MM:2ZB/W(
M.?:FHW,IM4=61)&7G$4/S$UVWAKP3<:A-&T\?R$C)P:U_ _@&1F^UW0.1T!-
M>O6&GPVD05$ Q733I::GA8[--U$IZ/H-MI<*B.-=P'7%:X7\*=THZUTJ*2/G
M)U'-W8M%%%,@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $- I:* "L[4-12TC8LP&/4U
M=FE$49<]J\D\<>*,F2"-\<D<&LZDN5'9@\,ZT[&%XV\227MZT$<F5 [&N'0X
M9B1R>M2.[SN7<DY[FF[L'&*X9SN?;83#1HQ0P1[VW#C%.8A>"*,D<]*#\W6L
MMSHFE)Z#>.W2CCO1THY-,2"CCN*7.*.>PH$QIZTAI_..G%-(.,]J!,;GMBEQ
MCI2@X[4IYP:I#4.8;]:3'H*>Y##WIJ2-$>0*ED7L[#00O4?A0X &?TITA"_O
M?XO2M72/#MQJTJD*2"?>G"+)G65-7*NF:8^J2A!$S#..!7LOA'P+#9V\<LL?
MS8SR!5_PCX0ATRU1I(E+GDY6NV1%10J@  =J[J=-6NSY?,,RE4;C$9! EO&$
M08%24M%;GB-MZL;2BEHH%8****!A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F[CF@U
MFZSJ"6%A)*QP0*3=BH1<Y<J,#Q;KZV%NZAN<5X3?WK7]XTK-U/2M_P 5>(AJ
M-RR@D\XKE H Q_%7%6E<^RR["*E!-CCPW'2C ZYS28Q]:%(YX^M<C=SU'.^@
M9[9S1C ZT87L*0_I5I:%+1"?C11CCBC\* % SWHQ[XI#1QW%!+#''7\*3IWI
M>,>]'&/>@0VE7Y,Y/6D/M1_K< =NM,3J.(!?FSG(HD=7'EK]XTK$(-@&:Z/P
MGX9?5+P2-$VT>HK2$;LQK3C&/,V5-!\+76J7**0=A/6O=_#WAF#3;= 4&X#K
M4V@Z!#I\"83!'M70 8KKA22U/E,=CY5'RQV$"A0 .!3J*0YS6QY746BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !36;:,TZHYV"PL3V% T>:?%+5/
ML]LJK(.4Z9KP.S;SM09V.>:[[XJ:D9=0:-7)VC&,UYO9RF.X4YZFN6H]3Z#
M0Y4F=(ZY=12/B-_4TJ$RQY%(N<X(KED?3T)75@^]ST-'T_&@YS[4O..161<U
M83CL*2E )/(H.>XJTQ)W&\9HR#UZ4#(-')/%-BL(,9I2 ?KVI<8II&1O':LV
M6M 4,&]Z;+(.G>I%D#1%GXQ5O2-(EUB_2)%)1CC-:1BV<=>OR(NZ#X=DU"=#
ML)!/7%>[^&= AT[3XODPV.>*K^&_#4>G6R!D&0/2NK50J@#H*[:-.VY\KF&-
M]J^6( 8&!2T45T'DB4M%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N8\9Y_LHX]
M#73US/C)2VEGG'!I/8TI?$CY1UHM_;MU_O53YQTJ_K<937+K)_BJF2"OI7))
MZGT%!>X-C)'2MRQNMB ,<CWK!Z'K4R2D=ZS:.NE)IG4%C,N0.*55('-5-/NU
M\H*QYJ_(N] 5-9L]:E531"Z'(-+N(&TCFD4,#AN:?A<=<U#1<M1N["8/6DY/
M04G5L9_&ECX;&:14)68@W#/%=)X/T9]0U6)PN0IR:YX+OF"CN:]A^&^F^7F0
MK_#7325V>?FN(2INQZ%I=FMK:JH0#@=!5^D'  I:[DK(^'E)R=V)@>E+113)
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %
MHI**!7%HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%(!0 M%%% !112
M9 H 6BF-(J]3BHFO;=#AI *5T-1;V18HK+G\0:9 </=(&]*QKWQWIMJ"5F1B
M/:DYI&D*%2>R.MI"P!QFO,[SXIP)GRD#?05SM_\ %.9PPCB(]\?_ %ZEU$=-
M/ 59;GM4D\<?+,!^-4I=;LH3AY /Q%> 7/C[4;E2JNPSWQ61/KVHS\F=A4.K
MV.ZGDTG\1] 7OC73;4$^<./<5SU[\4+.('R9 3]17B,MQ=3\/.:@\H@Y:3-9
MNJSLIY1!;H])U'XNZAO9;95*_4?X5A7'CW5[X'S"4!]&KEED13CR\TYR[=$P
M/2L95&^IW4\!3ALC2EUZ\8Y:XDY_VC5.2_N93DROC_>JN@"\O^5.+ _=J'*Y
MTQP\([(<6D<\NWYTNSNQ.::BG/6G,.VZC4T4(KH-) .1UI5+-]:9N2(Y+9J.
M2^CZ @4["<XHM^42..M)EHQQS63)J!YP^*IO?2MP'-/D,98E(WS=6RC]Z^&]
M*IRZLZ\1@%?6L1G>0\G)J>'3M1NL"&W=L^E6J9R3QJ3W)9]2EDZ\?2JQN2W5
MCFNHTGX>:KJ&"\3H*[S2O@^=J-,W/<$U:IG'4QOF>-+#<W3A40G/2MJQ\&ZM
M>XV0$Y]C7T+I'PWT^RVL\:L1[UUEKHME:@;(%&*V5,\ZKC>S/!-#^#M[/(C7
MT953UX->EZ/\+-)TLB0*';T9:] "A1@"EJU!(XYXF<C-L]#L;-<);1?]\"KZ
MQ1I]U%'T%/HJS!ML****!!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!=
MPBXMWC(SN&*\!^)GAA[$F:.,89N3BOH6L#Q3HD>KZ3-&R@N1Q43C=&]"IR2/
MD IL8GN*=RPW8KHO%7AJYT>^;*'9G-<V9 QXX%<LXGT%"I="$4A.>,4[M28J
M#H:N(!3J04M.X)!R#2TE%(I)"Y(IRD=S2 9ZFC:".M(;8_+#E'(_&K=KJU[9
ML&CF?C_:-4!GH#3@6!QBG<EQ1VEC\2=5M,#>QQZM76:=\8[T*JSA0![C_"O'
M<,3TIPSTJHS:.>MAH55L?1NG_%K3I%47,P5C[BMR#XBZ+-P+@9^HKY8V'.?,
MQ4BRSQ_=G-:>V.5Y=$^M+?QAID[ +,,GW%7EUZQ;_EJ/S%?(::IJ"?<N6'O4
MJZYJX_Y?7JE6,GEJZ'UV-8LVZ2C\Q3QJ=J1Q(/S%?(Z^(]73_E]?]*F7Q9JX
M_P"7MZI543_9C/K/^T;?&?,'YTG]I6W_ #T'YU\H?\)?J^>;MZ#XLU=NEV]+
MVP++&SZO.J6H&3(/SI/[5M/^>@_.OD\^*M7(_P"/MZ:?$^L?\_DE+VP_[+/J
M\ZU9 \RC\Q44GB'3X^LP_,5\H?V_K!ZWLGZ4TZOJCGYKUZ/;%?V4?4\GB_2X
M^#.,_456F\>:+ NZ2X 'U%?+[7UZ_P!Z\:HWN+AE^>Y+"CVQ4<K74^E9/B9H
M2]+G]1_C5&?XJ:4I_=S@CZBOG(NY_C- +=<U+JFT<LIH]ZG^+UJI.V08^HK*
MF^,LPD(BVE?7(KQO:'YQ1@#C%2ZS-5EE+J>JS_%^\DR.!^(K*N/B?J$H.&(^
MAK@ HZFG?*.U0ZK-XY=31U4WQ U.4%?,89_VJS)?%&I/UGD!_P!^L<XSP*7K
MQC\:7,V:1PT*>R+3ZQJ$QR9Y/^^C49N[QOO2N?\ @1J(';QC\:,E_:E<OV<>
MP]I)3UD8_C3.3U.:4*1UH S1=E*"% [@<4N/4<4G0_TI>_\ 2BY7*+@T=>O:
MD_&E QWS46*Y@Z\XIZY/UIHI1UICN+02>U%' [T7&A>:"&/TI",]Z<&VT7&(
M,CMQ3OF[CBDSD9'Y49)HN',.H'OUI,'%'RKU- .:!L[NE.4GTYI-Z#JV:C:Y
MC7H11RLSE)$VQV/R#)I?,\H8<#/>L^2_/1#CWJE)=2,W+$TU!F3KQBC6:>$'
M(:H9=0"\)R*S-TDIPBDU>M- U"]^Y QJU YYXM$4FHNRX%56G<]S78Z=\--5
MOF7?$Z*>^:]&T/X*QQ;);B<-W*D__6K10.*ICDNIX;;VUQ=-A$8D^U=+IO@'
M5M0VGR#M;V-?1>G>!=(L% ^RHQ'>M^'3K2W 6.)5QZ5JJ9QSQ]U8\*T?X..S
MAKE6'X&O0-)^%NE6:!G4%O=:[\(JC@4ZM;(XIUY2,BR\.Z?8X\N",X_V!6FD
M$2?<C5?H*DHIF+DWN%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWX8RVBO/:QG .>%KS*ZL9[*0I+!("#U*U@XM:'K0JQ>MRO129%*.:SL=::'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ?KBIXK.\N#A$+$^HIJ!G+$I%AI8$_U3;CZ&H_MLPZ(#6M9>!->U  Q6W'J
M?\*ZC2_@[JMPR_:Q(BGKC-4J9SSQB6[/.9;R1CC&/I3 9WZ FO=M/^"EG$0T
MTDA/O74:?\+M'MP-\>['J*M4V<L\=%=3YIATJ]N"-B$@_6MNR\#ZQ>*"D!*G
MV-?3=OX0T>WP%M(^/]FM2'3+2!<1P(/H*M4S"68=CYXTOX/W]QAKF-E!]C7:
M:7\%M.0J]PS CM@_XUZT%V\!0!3BN1U-:J"L<DL1-G*Z;X TC3MI6)'QZI71
MQZ=9Q8V6T2X]$%3JNWOFG4TD8RG)[L:$5>B@?04ZBBF0%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'KTIK0Q/\
M>C4_44XCFEHL!6:PM''S6\1_X"*KRZ'82C!M8?\ O@5HT4K(I2:V,&3PGIDA
MR;>+_O@5 W@G26.?(C_[XKI:#2Y44JD^YRQ\":23GR8_^^*/^$$TG_GC'_WQ
M74 8I:?*A^VJ=SG(_!>EQGB"/_OBIX_"VFQG(@C/_ *W**.5"]K/N48])LD7
M M8N/]@5,MC;)]V",?115BD[T[(ER8U8D4<*!]!3@ *6D!HL3<6D(R<TM% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1129!H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0YI::SA1DD5CW_ (IT
MS3B1<3!2/<4TFQ.26YL'.:0NJ]6 _&O.=:^+.D6B$6TX9_3(KS_4_B[J,TA^
MR8(^HK:-"4C*55(^@)+ZWB!+3Q\?[0K/G\2Z? <-/'_WU7S5<^/]7NF;<[ G
MJ U9<NN:C.26FDY_VC6\<(WN9/$V9],S^.M+@.#(A^C5GS?$S28NX/\ P*OF
MPWMV?O32'_@1J)YYB/\ 6N?QK3ZFD1]:/H]OBOI"_P#Z_P#ZU-'Q9T@\8_7_
M .M7S>#(_61OSI2LF/OMCZTUA8$_6#Z0'Q9T@]OU_P#K58B^)^DRC(('_ J^
M9\RC^-OSI1/(G'FN#]:?U2 UB&?4L7Q TJ500ZC_ (%6A;>*].N?NSQC_@5?
M**W-Q_#-)G_>-21ZMJ%LV4GDS_O&H>$B5]9/KR/4K2096>/_ +Z%6%FC?[LB
MGZ&ODRV\9ZO"RD2N<>K5T=A\4]2M77)R!UR:PEAFMC2.(3/I(].*!G'->2:3
M\8+:3:+V0)Z\BNWT_P <:+J6W[/<9)]Q_C6,J4D;*I%G2;N<4M0PSK.-R$%?
MK4U9M6+3N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% "4V0-CY3BG51U6_2PM&D<XX.*%&[LA-V+'VB%!B25
M?=J07=J/^6\?_?0KYV\6^/[Z/49([:1MN[C#5@-XZU@ $R/_ -]5U+"R9DZR
M1]4_:[?_ )[Q_P#?0H^V6W_/>/\ [Z%?+7_"P-7*X,C9_P!ZF+X[UIFP'?\
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MF^)6EQ=6!_X%7S>;V\<9>:3'^\:@>ZF;@R/^=:?4S)XEL^CF^*VD+_\ K_\
MK4S_ (6QI+'C^?\ ]:OG!GE/5V_.C]Z.=[?G5?54+ZPSZ4'Q5TD\_P!?_K5;
M@^(^ES<A@!_O5\PB27/WV_.I%N;A3\LKC\:/JB&L0?547C72Y<8E09_VJT8-
M?L)R L\?/^T*^2%O[U3E9Y/^^C5RV\0ZG:L"LTA_X&:AX0M8D^NENH'^[,A^
MC5("#T-?+=K\0]8M&#;F('JU=II'QG?Y5O"JCOR*QEAI1-85XR/<:*XK2_B-
MHNIH!]H^?TR*ZFTU"VND!AD#9Z<UBX-;FJFF7**:I)ZTZHM8H**** "BBB@
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M'T;152PEEDMD,@P2*MU@U9V-D[JX4444AA1110 4444 %%%% !1110 4444
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M^GAE:YQ5*[;+NHZU?:DQ\R9CDU3C&W[ZY-*Z;!N6D#&3J:[(4U$YG-L0C\*
M0._X4K9'W_F^E-"22'$4$A;V4U;G&(*#9(6;;48Z]*T[/0-4NERD$@_X :T[
M?P)K-PWRQNOU6L'7B6J+L<ST]Z _:NUA^&FL.>0?^^:L-\+=5QD#]*7MHA[%
MG!_3\Z/8_G792?#?6(^@./\ =K.N?!.L0]8G/T6K59"]DSG]I[&C:WK5V?1=
M2MA\UM*<?[!JJ8+I?O0R+]5-/VL6+V<B+;ZFFX53]W-*0X/STX%<\<4URR#W
MHDD4LT9W0R&/Z5O:/XQU32YU8W+NH/2N?YQUIA([=:3I18*I*Y[OX:^*$5TZ
MQW1"$^HKTK3];M+] 8YE.:^05X_> D,O(K=T;QMJ&F2KLD8*#[URU<,CIIUV
M?6E)D9KS3PI\1(M36-)Y!O(&<FO18)XYT$D; @^AK@E3<=SLC-26A/111698
M4444 %13'$35+44X_<M]*:$]CY[^,3[KN  _\M/Z&O-<!0 .?>O2/BTH^U1'
M82 _/%>;_,R_(C ?2O6HM'F5$Q#GM1^E*-X'W3^5(5D_NG\JZ+F-@.?2EH&\
M#E3^5(5DS]T_E1<+!SGI2_YQ2_O,8VG/TINV3=]T_E1<+"X(IQZ#BF_.?X3^
M5)^\_NG\J?.DM1<K8X]>E!YZ?G3?WA_A/Y4?O!QM/Y5//$I4V*1V-&#VI6#"
M/)0_E0F2M"DF'*T)C/:@<G'3VI/G!YI3C.1]ZKLB092IY'X4GO\ I2G>QRS#
M-&&49"D^])Q8"8Q2].V:7YW'"G/TIN)/[I_*I*M(,>U. IH\S^Z?RH/F=E/Y
M47%RR%//&**0;^ZG\J4K)_=/Y55PLQ"3Z4M!$AQ\I_*DVR9^Z?RHN%A1][GB
MG.=JY49IFR1VQM/Y4K;T&W:?RJ9,:0U&+$Y%=7X$7&NP$?WJY79*5)53^5=3
MX 64:W#D$#/.16$C56/I_3CFUCY_AJY5+30!:I]*NUY4_B/1I_"@HHHJ2PHH
MHH **** "BD.:6DF 44A8*,D@5BZQXCL],@=WE3('3=5QBV]!.26YL22I$N7
M; KG=8\7Z=IRD>>I8#I7D/B3XJ3R2/%;R''3@FO.[_6+K493+*Y.[W-==/"M
M[G/4K=CU;Q#\56$<D5MU/ (%>;ZCXJU34=WF7#E2>E8@RQ^8Y-2#"#YN:ZXX
M9(XYUI7(V+.V^1MWM2$'LO%/;8W"CFD!8<9K>-.,3/G;%4 #IFC)'2D7<2<&
MG"&8_=C8_053G%(.5L,GN<T>]2QZ=?2G"6\O_?!K0B\+:M.O$$@!_P!@UA*L
MKC5*1D_C3<MZXKHX_ FL$@F-\?[M75^'VJD?,C?]\TN:.]R_9,Y $GO2X]>?
M:NKE^'^JH>$;_OFJTG@;65/^K?/^[5<\>XO9LYS /08I<$5JS^&-6MS\T$A/
M^X:HR6%]%P]M+_WP:I2@^I+IR*Y^F:,9Z&G-#,O5&7ZBFJIQG<!3]WN)Q:$V
M+T*9]ZDCGEMFS"2I]J8,YZTXG H<$Q<S.@TWQEJEBZ$3/A37HNC?%4R;$G7;
MCJ2*\9P[_=8"FDNO>L98=,UA5:/K/2/%>GZA"A$Z[B.E;ZNKC*G(KX]L->N]
M.=6C=N/K7IWACXK.S1PW4A]#DFN*IAFMCKA7TU/=J*QM'U^TU2 /'*F?]ZM@
M,#T.:YI1<79G1&2DKH6BBBI*"BBB@ HHHH **** "BBB@ HHHH ***2DW8!,
M5YM\4LC2WP:]+KS7XI'&FM6U'XT955[I\[L#YCD^O2F^_P"E.E)\YOK2;">3
M7KP2L>;,,<9I..U+N["F]#\O6M'8S5QU&* DI&2C8^E*%DQQ&V/I2N.S$HP:
M-LAY,;8^E+B4?\LVQ]*+BLQ/THP:-DG>-ORI<2]#&WY47"S$_P XHP>M&R3/
M^K;/TI=LIX\ML_2BX68F<BC!':@)*#Q&WY4N)3TC;\J+CY1.?K0ON* LH_Y9
MM^5*4F(W!6 ^E%PL!..U)D-QTI QZ,II< ]!3#83R_>D,.SD'=3LD'!IY&WH
M12LGN*[0^*^NH!F*1DQZ5NZ3XZU737^:=Y%]*YPDMP>M&W XZUFZ,66JC1[/
MX?\ BSYTB1W*;?4D5Z7I'BO3]3PL<ZEB.E?)8)5N#6KINNW>C3K-"Y&.O6N:
MKAET.B%=H^OPP89!I:\4\*_%4W#)%=R>W)->O66I6]]"LD4BD$9X-<,Z4HG9
M&HI%VB@45F:!1110 4444 %%%% !1110 4444 %%%% !112'D4 %4[W4H+*(
MM*X&!ZU7U;6K;3+=GED P.]>">.?',U]>/%:RD*..*WI47(RJ5%$Z3QI\3&A
MDEM;-\CID$5Y+?ZE<ZLS-/*YR<_>JIYKRL9)OF8G/-(<L,J, 5Z5.@HGGRJ.
MY&F+<\<_6GG8YW'BE608P4R:C; .?TK:ZB9W;)"P?KQBEWQXQG+5<TS1+S6'
M MHF8=\5ZAX8^%[.D;W:<]3DUE*NDC6-%R/*[/3+R_EVPQ$_A79:5\,]0OE#
MO&1D\\&O=-(\'Z;IL>/LZ%O6MZ*VBA&(T"BN*IBF]CHAANYY+IGP=LD57G9M
MW<8/^-=;9?#K2+0#"*Q'JM=E17,ZLF=$::1E6_A_3K=0%MHN/]@5<73[5>EO
M%_WR*LT5#DV5RHA^R6PZ01_]\BE^RV__ #QC_P"^14M%%V58A^R6W_/"/_OD
M4TV5K_S[Q?\ ?(JQ12NQ6,^71[&7.ZVB_P"^!63>>"M+O,YB1?HM=-15<\NY
M/)$\VOOA+I<X<H2&(XP#_C7$ZO\ "*>V1WME9@/8U[_374,I##(-:1KRB1*C
M&1\EWWAC4].)#0G:/8U@R*T;XD!%?85QHUC=*1);J<^M<1K_ ,,;.[#R0HJD
M]@:Z88GHS"6'ML?.GF*%^4T]44C<>M=AXD\ 7NCN98XF=#V!KC95>)]KC:P[
M5UQFI'-*FXB/)N^3&*FMKJ:R8-%*X(]#40D&,,G7O1M(.[J*T<4R=4>M^#/B
M?)$D=I=OT !)(KV/2=:MM3@#Q."3[U\@!CNWQG:WJ*[/PAXSN=)N!'+(2N1U
MKAJT+[([*=4^H,T @UA>'-=BU>PCD!&2*W1BN&47%V9U1::%HHHJ2@HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** &YYXI6("Y-+BL3Q)JL6G:;*[
M. X'2FE=BD[(\]^*7B;R+7["KXW'/!KPF5S*Y;))S6[XNUJ35M3W]54D5AQ?
M*"VW/M7J4*5D>95E=W$WEAM-&47O3=^9#Q4D$/G7")CJ:['9(R4=1HPQRW2G
M$K_#TKN)?!DZZ1Y_DG!3.:X4H87,6,L#BL.;70<H:"R8"#'6D&  P/(YIP7/
M#?*:805.,<>M:VNM0B['JOPM\3_9KP6SR$[QCDU[U#*)8U8'J*^/=*O'T_4X
M)D.W#<U]*^!M=74M/4L^6 KS<33L[H[J,[Z'9444=ZXCJ"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "FLVT$GM3JYOQ9K2:58LQ?!Q515
MW8F3LKG.^//&<6E1F&.3YBOJ*^>]4U";5;Z2:9V(+$]:T?$FLRZMJDS$EESQ
M6'NYV[<5Z=&FDM3SJLVV/ 13E::VV0X!YJ3 4;!SGO4#C!P#S75=)&"5W<<T
MH1=HY/2M#3-$N]1D"Q(3GZUT/A#P;<ZQ>1>9"1'G.37O6A^#;+38D/E*6 KE
MJXA1.NG1N>5Z#\)YY1&]TAVMR<@UZ-IGPXTJQC!:-2?=:[9$6-0JC  IW6N"
M5>4CJC2BC*M=%T^V3:EO%Q_L"KRV=LOW8(Q]%%3;0.U+63DV:**1$+>$=(D_
M*E\F+_GFOY5)12NQD1MH#UB3_OFF-96K#FWC/U458HIW8K(S)]#T^=2&MHN?
M]@5A7WP^TJ\C8>6JY]%KL,452J274GD1Y#J7P>LV5FA+%NW!K@-7^&^H6.XI
M$<#V-?3M036<$X(DC#9]:UAB)1,Y4$SX[N-+N[*0K,A"U6)0=3S7U-K?@>QU
M)25C53BO)_%'PXFL5DE@C+@<X!KMI8E/J<E2BXGF2MGBE+(O&!FI;FVFLY"L
MT10YXS4((/++72YIHP46F36NH36$HEC=@0>@->T_#OQQ)=H+>9B2".IKQNPT
MZ74;E8HXR03U%>X^ ?! L[<3R#:Q-<-5HZ:?-T/4X)/-A5QWJ2F0QB*)4':G
MUY[/06P4444 %-=0ZE3WIU% ''>(? MGKDBM-V.>E8O_  J/2L=3^1_QKTNB
MM%5DMC)THMZGF?\ PJ+2^N3GZ'_&E_X5)I>.I_(_XUZ715>WGW#V,.QYG_PJ
M/2QW/Y'_ !I3\(]+]3^1_P :]+HH]O/N'L8=CS0?"/2P>I_(_P"-!^$>EGC)
M_(_XUZ711[>?</8P['F?_"HM+]3^1_QH_P"%1Z6>I/Y'_&O3**7MIA[*)YI_
MPJ/2^N3^1_QH'PCTL\DG\C_C7I=%'MI#]E$\<\0_#2RL=/DDC[*3TKQ6_C^Q
MW3(O8U]6>+QG1IL''RFOE?6.=2D'7!KKHU'):G+6BHE4,S]J4JH.<TOF<8V8
MIN?XC^5=RO:Z.-K4="D,MRJ,YP:]J\*?#;3-6T2.XD8Y)]/_ *]>+VA$EZGR
M8YKZB^'JX\+1?[W]!7#6JSBMSJI4E+<P5^$6DJ?O'\C_ (T?\*DTLGDG\C_C
M7I0%+7*Z\^YU*C$\U/PCTHG.3^1_QH_X5'I6<Y/Y'_&O2J*2K374?LHGFH^$
M>E9SD_D?\:#\(]*'()_(_P"->E44_;S[A[&!YI_PJ+2@>"?R/^-!^$>E^I_(
M_P"->ET4>WJ=P]C#L>:#X1Z6#C)_(_XT'X0Z2W5C^1_QKTNBCV\^X>QAV/,S
M\)-, P"?R/\ C5_1_AM8:;<K,I(9>G%=[14NK-]1JE!="*"%8(PB]!4M%%9M
MW+2L%%%% PHHS10 4444 %0S3I;QL\APHJ.]O8K.%GD8# SS7COCKX@_NWM[
M9^2<<"M*=)S9$YJ)T7C+XAV^FPF.WD!D^HKQ'6?%=[JUPS&5\'MNK*N[NXOI
MC),Q;GO4.Q1TZUZ5*@DCSZE;43R@6WL23[TKRC&U12C/I36<*>5K>ZB8\TGN
M(@-#8!ZDBIX+>>^E6&WB)+'M7H/A7X:W=W*&NXV52.YJ95DD:1IN1Y]!!+,P
M$2$Y]JZ33/ NIZBP_<D*?8U[KH_P^TZPVL\2/CWKJH=/M;<8BA5?I7'4Q78Z
M(8?N>-Z+\'4D3=>;E/T-=CI_PPTJU4;ADCU6N] P,"EKEE6DSHC1BC M?"NE
MVQPL$9^J"M--+LXQA;:+_O@5;P*#S4.39:@B$6=MC_41_P#?(I?LMO\ \\8_
M^^14PHI795B'[+;GK#'_ -\BD-G:G_EA'_WR*GHI78K(HRZ592CYK:+_ +X%
M9USX4TRY4AH(QGT05OTF!5*<ELR7!'G^H?"W2KL''R_0?_7KC-7^#A1V-GN8
M=NM>Z45<:LD2Z46?*&J>!]3TR1LQ'CV-<]/#/"VV5"#]*^P[G2[2[!\V%6SZ
MUR6M_#FPU ,T:*AQV-=,,5W,)X?L?,:*2W!-/9AC KO_ !+\.;^Q,CVT;,J\
M\&N"EAEM7*31E2/6NZ-6,CEG3:$1P%VD"F(A1]Z,1]*>&5AD"DW,>@IR29%V
MCHM!\7WFC7 Q*Y7(ZM7MOA+Q];ZD(XYY &/N*^;R #DC)]*MV&H75A<)+$S
M YXKEJT[F].IRGV(DBRJ&0Y!J3->/>!?B$LTBVUS)R1CD5ZW;W,=S&'C8,".
MU<$X.+.V$U(GHI*6LS4**** "BBB@ HHHH **** "DI:*30!7FGQ3S_9K8KT
MHUYM\4C_ ,2QJWH+WT957[I\[R ><V?6F[_FV]J>S;9V)&>:C)S+NV\5[,4K
M'FR:N/*J!G-:&@VD5_?K&YXW8K-.3UZ5L^%TV:K$0>KUG.ZU'!)GN.G_  QT
MRXL89)!@L@/2K7_"J=(_R/\ Z]=GI6?[,MO^N:_RJ[7ERK3ON=\:,&MCS_\
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M0/+_ +IKY6U+/]K2_4U]4>+O^0/+_NFOE?4L?VM+]37=A=CBQ!6;.:/KUH)
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M'6N!+8^4\&OI/XA: +NS\U5R<'M7SOJ-F;:^='&,&O1H5+G!6A8@.>..M-;
M&.]/,G04TKN<-7>U='&MSN?A[XF>QU**WF;9&..:^C+.^2[LTFA.]3W%?'/G
MM!.) >0:^@OA9XF2\TQ;-G^93W->9B*?5'H8>9Z@IRN32T@(/2EKA.P****
M"BBB@ HHHH **** "BBB@ HHHH **** "D)P*6@]* .'^)-QM\-3X/.PU\S3
MN3(2.2:^B?B:_P#Q))P/[IKYS.?-.#7HX:*2."O+44#;@YR3UHEYD!QFC&#0
MS8KN2T..^MS2T.(3:K&N,U]-^#;<1:1&,<XKYL\*D'6XR?2OI[PR0=,3'I7G
MXMG=ADC;I*6DKSV=HM%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .>\7?\
M('F_W37RMJ7_ "%I>.YKZI\7?\@>;_=-?*VI9_M:7ZFN["['%B"L>3TQ29YZ
M4-G/)I?KUKT5L<74FLO^/Q#COTKZA^'O_(KQ<8^;I^ KY=L]WVU.>]?47P^_
MY%B+/7=_05Y^*V.S#[G64445P'<%%%% !1110 4444 %%%% !1110 4444 %
M%%% !2&EJCJ=ZMG:/(2!@4TKNPF[(Y3QWXICTK3IDC<>:%/%?--]>2WMZ\[D
MMN.<5V'CC71J-]-M?.2>]<2@)KU*%&QY]6HV/9L*,+38U')-/7J=U1NV#\O3
MO75*R1SQN]"0[Y"$1<Y[UW_@;P/)?7<5Q*I\O<"<UE>"/#\VLZDH"$P@<\5]
M':%HJ:79K$% P*X:U:QU4Z=RSINF06%NJ1Q@$#K6A2 8%+7GMW9W)6"BBBI0
MPHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F*S-5TBWU&W
M99(@216I133:=Q.*9\U>._!TNEZ@US%"3&P[5P!W!\,N/:OKCQ+HJZO8F/ .
M >U?.7C+P[+H]P[A2%SCI7HX>LFK,X*U*S.6)'11FD( '3-'*+\O?K35+;O:
MN_1HYMF:&B:G/IM^LR$@ ]*^D_ WB2/5M,56<&4'D5\ON6!RIKL?A_XD?2-4
M)D;Y6P!S7!B*>AT4JK3/J"EJGIEXM_I\-PISO&:N5YS/004444AA1110 444
M4 %%%% !7FGQ3_Y!C<UZ77FGQ3Q_9K9K:A\:,ZOPGSO(<ROQWH[=*67_ %S?
M6DYQ7K'E3W%S@=*U?#?_ "%X>,_/65@D5J^&@?[7BP?XZ*OP%4MSZQTK_D%V
MO_7)?Y5<JGI7_(+M?^N2_P JN5XCW/5CL%%%%(H**** "BBB@ HHHH ****
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MQ8Z;OZ"OEZR_X_$.._2OJ'X>_P#(KQ<8^;I^%>?BMCLPVYUE%%%<!W!1110
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M<!Z^GM)@6"PB &.*\[$RZ'=0B7Z***X3M"BBB@ HHHH **** "BBB@ HHHH
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MAHJL6=;16;;:W970^2>/G_:%7(YXVZ2H?H:AQ:+33)J*0$'H:,TABT4AHYH
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M-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;SFG44 (:YKQ9K*:
M;8R9;!QQS6_<S+%;R.3C:I-?/_Q'\3M-.88I-PS@XK2G%MF-222L<'KFJR:I
MJLSNQ/SG'-9[<, *. 2Q&2W-&[=VYKVJ,;(\V;NQ&Z<]:GM(?M=S%$O)+ 5"
MO+88<>M=U\.O#AU'68V=?E4YS45W9#@F>I_#[PTMA;+(Z=1W%>B@8  [57LK
M=;:V2-1C JS7CSES,]2$;(****SZEA1113 **** "BBB@ ICQAU*GH:?10!X
MA\3/"^QIKR-.,DY KQI5_>%7SQ7UWX@TR/4K!XF4'(KYD\8Z2^DZY(@CVICB
MO0PTSAQ$>QA-@=#31C/S4Y/NY(SFF<G.!FO1>L=#B6C+VF7AL=2CG#$;3GK7
MT[X1UY-6TN*0MEBH[U\JA\+@C\:]-^''B1K:>*V8_(,#->;7@V=E&2N?0PZ4
M57M;E)[=9%;(-6 <C(KA:.]!1112 **** "BBB@ HHHH **** "BBB@ HHHH
M *0JK?> /UI:* ,/5_#=EJ<9#Q)G_=KS;7?A*EPSO;J<]L U[)GGI2UK&M**
MLC.5*,G=GRGJ_@'5-,#,L3$+]:YIH;JU8K)']>*^Q[C3K6Y5EEB#9]:YO4/
M6F7BL! BD]ZZ(8JVYA+#]CY6:1-W4^]/!0]#7M>I_!U$,DD,@.3D '_ZU<3J
M7PZU*U?]U;NX]C77"NGU.>=%HXO:#R#1A?XS@5J7/AW5+0_/:N*SY+6>/_61
M$5JIQ;W,>629#AB< G%&U ?GZT[!3M2!AW&:I\K!7'9V_P"J8YJ6*^N8#E9G
M#>FZH#R>.*<!@<C/O4NG%E<[1L6GBK4[5@4E<X_VJZ/2_B=?VT@\QR1WRU<)
MD$X'%+L YVTGAXL:KM'M5A\7H\J)7&._(KLM-^(>EWNW,PY]Q7S%N _AJ1+F
MXB.Z.4K["L*F%CT-8UY'V%::A;7J;X9 1]:M@U\FZ5XWU72Y!^]=U]*],\,_
M%<2R)'=+C/!)%<<\/);'3"LGN>ST5C:5XDL=4 \J92V.@K8!!&17.XM:,W33
MV%HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .=\7?
M\@>7_=-?*^I8_M:7ZFOJGQ=_R!YO]TU\K:E_R%I>.YKNPNQQ8@K$@'BDQGGM
M2GD],4F>>E>BMCBZDUD1]L0=LU]1?#W'_"+Q8Z;OZ"OEZR_X_$.._2OJ'X>_
M\BO%QCYNGX"O/Q6QV8;<ZRBBBN [@HHHH **** "BBB@ HHHH **** "BBB@
M JIJ)_T&7Z5;JIJ/_'C+]*:W$]CYC^(!!U+K_'7(A<$$5UOC\_\ $RZ8^>N2
MR<CBO7I;'EU-QS'/THW*649[TX].E1KQ*O'>M:ETC.&Y[]\(D LB?>O5Z\I^
M$3 V1P>]>JUX];XSU:?PBT445D:!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5Y1\3X5:"1CUQ7JQKRWXEN/
MLD@([&MJ/Q&57:Q\^1D;<=Z>OZU''R",?C3_ &KUZ;T/*GN.XP:[3X:2$:Y$
M!W-<4HX-=K\-D)UR(X[U-7X6:T=SZ:@_X]X_I4E1P?\ 'O']*DKQ#U0HHHH
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M "+$6>N[^@KY=LB/MB#MFOJ+X>X_X1>+'3=_05YV*V.S#[G64445P'<%%%%
M!1110 4444 %%%% !1110 4444 %5K\;K*0>U6:BN5WV[KZBFMQ/8^9/B+;L
MFHAC_?KC>*](^*MF8)T;'5Z\R'7K7K47H>756I+N[=Z$7<XQUIG&>M.)"X-=
M$W[IBM&>Y_!]P(9%)Z-7KZG->%?"6]"[U8X^:O<XCNC!'>O'KJSN>G0=T.YS
M2T45@= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSMP\M;'4T4@.:6N$[0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOUY35G8]).Z"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-V=SZ_4Y (IU8?AG5TU;3(IPV=R@UMYYKR9*SL>E%W0M%%%(H**** "BBB@
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M)%4OG/:F,H/W.HJ1G&P#N:C"^3(K-T-:S5T8P/3?A?XP?3KO^SY7PCC/)KZ
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ML^@VQ*8RM=;5'2;?[-ID$.,;5Q5ZO'F[R/4BK(****DH**** "BBB@ HHHH
M**** "BBB@ HHHH **** .>\7?\ ('F_W37RMJ7_ "%I>.YKZI\7?\@>;_=-
M?*VI9_M:7ZFN["['%B"L>3TQ29YZ4-G/)I?KUKT5L<74ELS_ *:G%?4/P]/_
M !3$7&/F_H*^7K/=]M3GFOJ+X??\BQ%GKN_H*\[%;'9A]SK****X3N"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!*6DI:2W IZC8QW]JT,@!4C'-?.WC
MCPE+IMS)-' =A-?2M9.MZ-!JUJT<R \<5O2J.+,ZD%)'R%*H3&?O#M2KF:,A
MN,=*['QOX-GTO4I)8HSY1Y&!7''=(-B?*5ZYKU(5$SS90:&(NQ2N<@]ZL6=W
M+I\ZSQD\'-5QQ\C]33P1]P_=K9I-$*33/=/!'C^*X5(;B4+VYKU>UNHKJ%9(
MG# ^E?'$4S6D@> D$5Z5X,^(\UF%@NI#M!P,DUYU>AU1V4:W<^A**P](\1V>
MJ1*4E3<1_>K9#9Z'-<3BUN=:DF/HI!TI:@H**2EHN 4444P"BBB@ HHHH **
M** "BBB@ HHHH **0D 9) K'U;Q%9Z9$Q>5,@?WJ:38FTC0NKV&TC+2N%QZU
MXQXY^(8626"V?=R0,"LGQC\19+NXDAMY/ESC@FO-9&%Q(9)#ECSFNZEA]-3D
MJUAUW=RWUR;F4D[N,&F,H"9%,*N6PI^44F23M'45W0@H(XY-R8+E3DC-.&9C
MM5<T_*_ZK&7;@8KN/!7@BYU"X2:1#Y6><BLYU$BHP;-GX?\ @XS-%/+#\I .
M37NMC:)9VRPH,**@TO2XM-M4AB4!5&*T!Q7F5:KDSOI4^47M2 DFEHK$W"BB
MB@ HHHH **** "BBB@ KS7XI?\@QJ]*KS7XIC_B6L>]:T/C1E6^$^=I21,W'
M>CMTITIS*V>N:;SBO81Y4MQ,<5K^&?\ D+0\9^:LK!(K5\,Y_M>+G^.E5^ T
MI;GUEI?_ ""[7_KDO\JMU4TO_D%VO_7)?Y5;KQ'N>K'8****0PHHHH ****
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M;OZ"OEZR_P"/U/EKZA^'O_(L1<8^;^@KS\5>QV8?<ZVBBBN [@HHHH ****
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M739&ANH7WCJ2M4PC[]RL OI7T_XB^'^G:SN<HJOC^%:\?\0?#2_TZ:1K>,E
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M##V-+2QC3+8'J(ES^57*9&JHH51@#BGUR,Z4K*P4444AA1110 4444 %%%%
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDI:2N 44E+3
M***2@!:*** "BBB@ HHHH **** "BBBE8 HHHI@%%%% "8I:** $Q1BEHH"P
M4444 %(#FEHH **3'-+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 F!2T44 %(1D8I:*0"*NT4M%%, HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I,4M% "8HQ2T4"L%)BEHH&&**** $(S0!BEHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****3 *
M***: :5S2@8%&*6@$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %(1DTM% !28I:* $Q1BEHH"P4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !144TZ0KES@5G/XCTV-]K7* T%*,GL:U%5;74+6\&8)0X
M]JM4"::W"BBB@04444 %%%% !1110 45GWNLV5@P6XG5"?6H(O$6GSG$=PK4
MKHM4Y-72->BF1R+*@93D&GTR HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHI&8*,F@!:*S+C7M/MG*2W"JP[&F0^
M(M-F;:MRA-+F1I[*;5[&M13(Y%E0.IRIZ&GTS/8**** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HJO<WD-JA:9PJCN:S6\3Z8O\
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M>)&L+CR&<X+=S7T):S">VCD!^\H-==.2:L?.8R@Z<^;N2C/>EHHK0XPHHHH
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MXTF3Z5\][E-^ XX+5R5%J?09=%<ER] -8N(PT7F'([ U(+?7@?NR^_RFO9?
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M:OHDB8!'':N0\2>&)=)O&9D/E*<\"LHZ'7.I"K)Q9])Z5?QWUHCHX;(ZUHC
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M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7*>-?\
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MSVV'_4K4E1P_ZE:DKJ1\U+<****!!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%)GUH X'XC -I$GTKYZ 6&^W.3C=7T/\0^-+D[U\\7D8EF(
MS@YZ5QU7J?0Y;?D/9_!WC/2]-M(UN9MH ]175_\ "R/#_4W/ZC_&O ].\-:E
M>(#'&[(>E7F\%:MVA>G";2L*OA:4ZEY,]N_X63X?_P"?GGZC_&C_ (61X?\
M^?KGZC_&O$?^$*U8#_4O2?\ "%ZM_P \7K3VLNQ@\%1OI(]M_P"%C^'1R;KG
MZC_&G1_$C0)7VQW.3]1_C7B*^"M5=B&A<#UJ:V\$ZK#<JRPOC-"J2[&<\+1B
MOB/HG3M8M=27,#[N,UHUQ7@BPN+2$B>,J=O>NTK5-GG58J,K(6BBBJ,PHHHH
M **** "BBB@#G?%?_(/D_P!VOF;6/^0H^/[U?3/BS_D'O_NU\S:N/^)HY/\
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MCI4C++&^!_LUM^$->BTR\!D&TCUKWW6/#-GJ<9#1(#CLM>+>-_ DFF9N+<$
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M5T+8^>J_&Q,4M%%,S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**3-+0 TD#K7E/Q*\2>3;SVJ-S@BO0]:U%+*RD<N 0.YKYI\5ZQ+JNJR!'W;
MF/0UE-GIY=0YI<S,;RVN)-R#+$UW?A/P)/JRB29"BD]ZF\#^#I+R9))4..O(
MKW;3-/CL+2.%% VBLXPN]3OQN.5-<L=SEM'^'NGV #2QK(<=S70IX>TQ.EHF
M:U:*W4$MCPYXBI-ZLH#2K)>!;+36TFQ/6U4UHT4[&7//^8RI/#VF2K@VB<US
M>J_#VPN0S11*I/I7<T4G!,VAB*D-F?.7BOP%<:9FYB0E0>@-<(RM'+AAM8'I
M7UWJ>GQZA9M"Z@@UX!X[\(M87$D\*$ 9/2L)PL]#V\'C^>/)(ZOX:^)#+-':
MR-P!BO7T8,H([U\I>&=4DTO4X6+;<N :^E= U..^LHRK@G'K5TSAQ^'Y??B;
M-+36S0IK8\GFUL.HHHH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *SM8!^QMCTK0K/U=MMFQ/I2>QI2^-'S5XZ_Y#;#'..M=?\*U/S<X^:N3\
M<H6UIGW#&.E=9\+0XSN.1NXKGMJ?05G>D>YP_P"J7Z4\]*9#_J5^E25T(^<E
MN(!032T4Q+0*Q_$.FQZAI<R,H+$<5L4UUW(1ZTFM"H2<9)H^6/%.E'3=1\O&
MW))S76_#?Q/)'J,.GNQV%@,U;^*6DG[6LXQ@9KSWP[<-:ZU&X8 !Q7/JF?2*
M/MJ%SZP0JRY!R/6GUF:)-YVFQOG.0*TQTKH6Q\U)6DT%%%%,04444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!B>)O^01-_NFOES5SC4&&W^*
MOJ3Q+G^R)L==IKY;U8,=4?<PSNKEKJ[1[^4I.$KGLOPIS]F_&O6:\H^%H_T7
M@]Z]7%;4_A/.S!6K,*2EHK0X0HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@!,4M%% !1110 R7_ %9KP7XH<:J^:]YD!V'->#_%-<ZFXR,U
M$]CT<O=IG,?#\$^+8FV\;3_,5].6IS;K]*^9OAX)!XJC0L,%?ZBOIJU&VW4'
MTJ*1KFDDY(FHHHK8\D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** $[TM%% !7+>- 3ISX_NUU-<KXU<KI[X/\-3/8WPSM51\UW(;^
MV6R,?-7OGPR'_$J?\*\"N3*^M-EA]ZO??AF&&F-N.>E94[GM9A*]-'H(Z4M)
M2UN?/!1110 G>EI.]+0 4444 %%%% !1110 4444 %%%% !1110 4444 %(>
ME+2'I0!Y/\6/^/4<=Z\=T4?\3=,<_-UKV/XLJ39C! YKQS0E?^UDPP^]7+*]
MSZ/!M>P1]/\ AH8TR/\ W16Y6'X:5O[-CR?X16Y71'8\*O\ Q&%%%%48B%0>
MHH"@#@4M% 7"C%%(<T +61XD_P"01)6MG%9/B/G2)*4MBZ?QH^9O%2M_:CG'
M&>M=]\-O]<ORUP/BMI/[4=0PQFO0/AH&$RY(-<\-&?18F2]@CVN'B):EJ)!F
M-:E%=)\Y+<****"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D
M(YI:1<]Z .!^(F#I<HZU\].N-07C^*OH3XB@_P!ER[3@U\_!6^W!I&'#5SSE
MJ?0Y=4_=V/H7X>J/[/A_W:[RO,O ^NV%M:1I)-&I"]VKLO\ A*-,_P"?F+_O
ML5I"2L>=C*4YU6TC:-%8H\4Z8?\ EYB_[[%!\4:8!_Q\Q?\ ?8J^9')]7J]C
M9YI16)_PE6F?\_,7_?8H7Q1II)_TF+_OL4<R']6JKH;E%8J>)M->546YB)/^
MV*UHIHYEW(X8>QIF<H2CNB2BBB@D**** "BBB@ I,BEIA!IHENQ@>*H)KBR9
M8AG*U\_:IX4U.34RPB/+>AKZ>D167#+FJITRT9LM N:QE#F9Z&'Q7LHV:.&^
M'.DW-C:GSU*GBO2.U0Q6\<*XC4"I16B5D<M6I[2=Q:***9F%%%% !1110 AS
M2T4G>@#Q7XI:'?:AJ4;6R%L ^M<GX2\,:I#JI,D1'([&OH^6SMYVS)$&-,CT
M^UB?<D !]:CEU.V&+Y:?)8CT>)H=/C1QA@*OTT# P.*=5G&W=W"BBB@04444
M %%%% !1110 4444 %%%% !1110 4444 %%%% "8H/ I:#TH!(\O^(#ZC,&A
MMU.TCM7ENC>"]3DU%'FB)4MDD@U]+3V,%PVZ2(&ECTZU3[L*BDXG?3Q?LXV1
MF^'M*2QLHQL ;'I6[2* HP!@4M"5CCG-S=V%%%%,@**** "BBB@!.@KF_%&A
MQ:GI\B[06*GM72TUE!7!&:35RZ<W!W1\NZEX0U);X^5$<(V1@&O2_AZ=2ML1
MW*D <<UZ:=-LV.XP+DT^*PMH3F.(+4J)UU,9SQM8F4%D4^U. Q2]!15G!97N
M%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH 0G%+129Q0 53U*(RV
MK*/2KAI"NX8-#V'%VE<^;O&7AG4[G77:*,E,>]=5\.=%OK$GS8R/F]Z]=DTZ
MUE;+P@GUIT%E! 3Y<86L^5W.^6,O#EL3P@B)0>N*?24M:'GWNPHI#0 : %HI
M#0*!=3S?XD:1<7UF?(7<V:\>L_">KQ7BR>2>&]Z^HYH(YQMD0,*A72[,?\L5
MK/DU/2IXYPI\AF>%XYHM+B248( KH*8D:QC"K@4^K2."<N9W"BBBF2%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 9/B&%IM*E5!EB#BOFW
M4O"6K3ZBS"([2WO7U,R*Z[6&15;^S+,G/D+FHE&[.O#XET58\\^&ND7>G08G
M4@>]>G5%'!%",1H!3P.:M*R,*U5U)\PZBBB@S"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I,TM)UH$QLH)C(%>*_$30+V\OWDB0
MM^=>VU4N+&&<[G0-4RC<Z*%7V<KGSWX$\.ZG;>)XY98B$ ZX/K7T1"I$"AO2
MH8-/M8FWI %;UJWBE"-F/%5O:O84=*6D I:LYD%%%% PHHHH **** "BBB@
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MP0\QQA:R4'<[)XOF@HDL.1$N>M/HHK4XF%%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
1BB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #0 3(# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 445'-/%;0O-/*D42#+.[  #W)H DJIJ.IV.DVC76H745M O5Y&P/P]
M3["O-?%?QDM++S+7P_$+N<<&YD'[M?H.K?H/K7CFLZYJ>O7ANM3O);B3MN/"
M^P'0?A6,ZR6BU/5PV55:GO5/=7XGJWB?XVI'OMO#EKO;I]JN!Q_P%>_X_E7D
M>L:[JFO71N-3O9KF3/&]N%^@Z#\*HFI;2RNM0NDMK.WEGG<X6.-2Q/X"N:4Y
M2W/:HX6C07N+YE0TL-O-=3+#;PR2RL<*D:EF)]@*]9\,_!&^O-ESX@N/L<1Y
M^SQ$-(?J>B_K^%>OZ#X5T7PU!Y>EV$4+8PTN,R-]6/-7&C)[Z')B,SI4](>\
M_P #Y_T;X/>*]659)K>/3XC_ !738;_OD9/YUG^.OA[<>!X[)KC4;>Z:ZW )
M&I!7&.<'MS7TOKNNV'AS29M2U&81P1#_ ($Y[*H[DU\J>,/%-YXOU^;4KK*I
M]R"'.1$@Z#_$^M54A""MU,L)B,1B)\STBCGJZ?P'XMO/"?B."XAE;[+*X2YA
M[.OT]1VKF*ZOX?>%;GQ1XFMX$1A;QMOFD[*HZ_X?C64;WT.^HHN+Y]NI]9*P
M9 PZ$9%+2*H50HZ 8%+7>?(A1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !14<T\5M \T\BQQ1C<[N<!1ZDUX]XT^+,
MDQDL/#CF./H]X1AF_P!P=A[]?I43FH+4Z<-A*N)ERP7SZ'<^+/B!I'A5&B=_
MM-_CY;:(\C_>/\(_7VKPKQ/XTUGQ3.3>W!2W!REM%Q&OX=S[FL*1WED:21F=
MV.2S'))J(UQSJRF?387+Z6'5]Y=_\AII$BDFD6.)&=V.%51DD^PKJ_"G@'6/
M%<H>"/R+$'#W4HPOT7^\?I7NGA;P)HOA6)6M8/.O,8>ZF +GZ?W1["G"E*6I
M&+S"E0]W>7;_ #/*_"OP;U'4MEUKKM86QP1".96'OV7\>?:O9="\,Z1X;M1!
MI=E'",?-)C+O]6/)K6HKKA3C'8^=Q&,JUW[ST[!1115G*?,/Q5\37VN^+KJT
MG$D-K82-## W&,=6(]3_ "Q7!&OJ/QW\-=.\91_:486FJ(N%N N0X]''?Z]1
M7EEC\#_$<NI>3>O;0VJMS,LF[(]AUKDG3ES=SZ/"8NA[)*_+8XGPQX5U'Q5J
MD=G8Q%LGYW/W5'<D]A7U%X2\)6'A'2%L[10TK &:8CF0_P!!Z"I_#?AG3?"V
MEI8Z="% 'SR$?-(?4FMBMJ=/EU>YYN-QSK>Y#2/YA1116IYP4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'5M7LM#TZ6_O
MYA%!&.IZL>P [DTNK:K::+ILU_?2^7!$,D]R>P [DU\[>+O%U[XKU(S3$QVL
M9(@MP>$'J?4GN:RJU5!>9Z.7Y?+%2N](K=_HBSXS\>7_ (JG,2[K;3D/R6X;
M[WNWJ?T%<>:>:NZ1HU]KNHQV.GP-+.Y[=%'<D]A7"VY/4^LC3IT*?+'1(H10
M2W,Z0P1M)*YVJB#)8^@%>O\ @OX1(@CO_$BAF/S)9 \#_?(Z_0?_ %JZ[P9X
M!T_PI LSA;G4F'SW!7[OLGH/?J:Z^NNG02UD?.X[-7-N%#1=QD44<,2Q1(L<
M:#"H@P /0"GT45T'B!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZBBBB4G)W81BHJR$P/2O*/CS_P BSIG_ %^'_P! :O6*\G^/7_(LZ7_U^?\
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MJUEX:LH-;NOM.H*G[U_3T4GN0.,]ZXOXT>)?[*\,+I,#XN-1.U\'D1#[WYG
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MQNO_  C$%X-,G.T?ZTCF3/H&P/\ ]=3*26YK2HRJWY>G]?>>BT4451D%%%%
M!17"6J>(=>UO7!;^(Y;&"SO3!'$ELCC&U3U//>K-GJ&O:'XJL-&U>\BU*UU%
M)/L]RL0CD1T&XA@#@C'>HY_(Z'AVM%)7M>VO:_8[*BBBK.<***YN[U2\B^(6
MFZ8DN+.:QEE>/ Y8, #GK2;L7"#FVEZ_<=)1113("BBN<UO2=<N+F:ZL?$<M
ME (\B!;9' ('/)YYI-V+A%2=F['1T5Y[X0A\3Z_H.GZS/XIE03$L\ M(\85R
M,9Z\X_6O0J47=7*JT_9RY;W:]0HHHJC(**YS7]3N[+Q)X;M8)=D-Y<2I.N =
MX$9(_6NCI)W+E!Q2;Z_YV"BBBF0%%</XW\57GAGQ#H!CWM82^<UY&B;CL7;\
MWK\N2:[2*XAFMDN8Y4:%T#K(#\I4C.<^F*2DFVC6=*481F]F245P_ACQ;/XB
M\;ZM!$Q_LJ&W4VN5QYF&VF0'T)!Q]*[BB,E)70JM*5*7++<****9F%%<)-+K
MVL>/-9TNSUV33[:RA@=%2!'R77)Z_2NAT;2M7L+F234->EU&-DPL;VZ1[3GK
ME:E2OT-IT5!7<E>R=M>OR-JBBBJ,3E/B3_R3W5_^N0_]"%4]4T;6-/NHM>\+
M1Q/=W,*PWEM*VU)?EPLG^\OZBNGUS1X-?T:YTNY>1(;A=K-&0&'.>,@^E78T
M$421KDA%"C/M4.-V=,*_)327=W72SM_D>::_H*:!I_AJ)I3<7D^N0S7=RWWI
MI3G)^G8#TKTZLK6M!MM<-B;F25/L5TEU'Y9 RR] <@\5JTXQLV35J^TC&^^H
M44451@<]XVU__A'/"UW>H?\ 2&'E6ZCJ9&X&/IU_"N4MS&O@/_A'V\,ZX]J]
MN5DN/LR[C(?F,FTMN^]S^5=OJ6@VNJZKIU]=/*WV!VDB@R/++D8#,,9)';FM
M6H<6V=4*T:<$DKN]_P#+^O,Y;X?Z\==\*0/,Q-W:DVUP&&#N7N1[C!KJ:R;'
MP_:Z=KVH:M;22H]^%\^'(\LLO1@,9SUSSWK6JHW2U,JSA*;E#9A1113,CSK2
M;7Q%/X@\3MHVIV5K"-2(=)[8R$ML7G.1@8Q4FB0WD?C_ &>*IA/JJP,VFR1
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9ZFLXII['95J1G!6ET6ENR[FY1116AQG_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
